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Résumé 
Les macrolactones sont des squelettes structuraux importants dans de nombreuses 
sphères de l’industrie chimique, en particulier dans les marchés pharmaceutiques et 
cosmétiques. Toutefois, la stratégie traditionnelle pour la préparation de macrolactones demeure 
incommode en requérant notamment l’ajout (super)stœchiométrique d’agents activateurs. 
Conséquemment, des quantités stœchiométriques de sous-produits sont générées; ils sont 
souvent toxiques, dommageables pour l’environnement et nécessitent des méthodes de 
purification fastidieuses afin de les éliminer.   
La présente thèse décrit le développement d’une macrolactonisation efficace catalysée 
au hafnium directement à partir de précurseurs portant un acide carboxylique et un alcool 
primaire, ne générant que de l’eau comme sous-produit et ne nécessitant pas de techniques 
d’addition lente et/ou azéotropique. Le protocole a également été adapté à la synthèse directe de 
macrodiolides à partir de mélanges équimolaires de diols et de diacides carboxyliques et à la 
synthèse de dimères tête-à-queue de seco acides. Des muscs macrocycliques ainsi que des 
macrolactones pertinentes à la chimie médicinale ont pu être synthétisés avec l’approche 
développée. Un protocole pour l’estérification directe catalysée au hafnium entre des acides 
carboxyliques et des alcools primaires a aussi été développé. Différentes méthodes pour la 
macrolactonisation catalytique directe entre des alcools secondaires et des acides carboxyliques 
ont été étudiées.  
En outre, la stratégie de séparation de phase en macrocyclisation en débit continu a été 
appliquée lors de la synthèse totale formelle de la macrolactone ivorenolide A. Les étapes-clés 
 ii 
de la synthèse  incluent une macrocyclisation par le couplage d’alcynes de Glaser-Hay et une 
réaction de métathèse d’alcènes Z-sélective. 
Mots-clés : Macrolactonisation, macrolactones, macrodiolides, esters, catalyse, 
hafnium, synthèse totale formelle, ivorenolide A, macrocyclisation, séparation de phase, débit 
continu 
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Abstract 
Macrolactones are important structural motifs in numerous chemical industries 
particularly in the pharmaceutical and cosmetic markets. However, the traditional strategy for 
the preparation of macrolactones remains cumbersome, often requiring stoichiometric or excess 
amounts of activating reagents. Consequently, stoichiometric quantities of by-products are 
generated. They are often toxic, environmentally damaging, and/or require tedious purification 
methods to remove them.  
The following thesis describes the development of an efficient hafnium-catalyzed direct 
macrolactonization between carboxylic acid and primary alcohol functionalities, generating 
only water as a by-product and without the need for slow addition or azeotropic techniques. The 
protocol was also adapted for the direct synthesis of macrodiolides from equimolar mixtures of 
diols and dicarboxylic acids and for the selective head-to-tail dimerization of seco-acids. 
Macrocyclic musks and macrolactones relevant to medicinal chemistry were synthesized using 
the developed approach. A hafnium-catalyzed esterification protocol between carboxylic acids 
and primary alcohols was also developed. Different methods for the direct catalytic 
macrolactonization from secondary alcohols and carboxylic acids were studied.  
Furthermore, the phase separation strategy for macrocyclization in continuous flow was 
applied in the formal total synthesis of the macrolactone ivorenolide A. The key steps of the 
synthesis include the Glaser-Hay alkyne coupling macrocyclization and a Z-selective olefin 
metathesis reaction. 
Keywords: Macrolactonization, macrolactones, macrodiolides, esters, catalysis, hafnium, 
formal total synthesis, ivorenolide A, macrocyclization, phase separation, continuous flow 
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1.  Introduction 
A macrocycle is defined by the IUPAC as being a cyclic molecule containing twelve or more 
atoms in its ring skeleton,1 although it is common in the literature that cycles containing a ring 
of eight or more members are considered macrocycles. Generally, it is thought that macrocycles 
have floppy conformations, easily interchangeable at low temperatures. However, in practice, 
only a few conformations are stable enough to have an appreciable population at ambient 
temperature.2 As an example, only two conformers of cyclohexadecane, the simplest sixteen-
membered ring cycloalkane, contribute to more than a quarter of all populations at room 
temperature (Figure 1.1). In comparison, all other possible conformers have an individual 
contribution lower than 4 %.3  
 
Figure 1.1. The two most populated conformers of cyclohexadecane calculated by molecular 
dynamic studies: a) conformer (4,4,4,4) and b) conformer (3,4,4,5).  
The following sections (1.1 and 1.2) will provide a brief background into two of the most 
common applications of macrocycles in aroma chemistry and medicinal chemistry. 
1.1. Macrocycles in Aroma Chemistry 
Aroma chemistry is defined by the synthesis and the application of aroma compounds in 
various fields of the industry. Aroma compounds are chemicals which possess an odor, pleasant 
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or unpleasant, and are also known as fragrances or flavors, the latter also affecting the sense of 
taste.4 Aroma chemicals are by definition volatile and therefore usually have a relatively low 
molecular weight. They can be found in Nature and have an enjoyable presence in food and 
spices. Macrocyclic musks are an important class of molecules comprised within the category 
of aroma compounds. 
Musks are a type of aroma chemical which are divided into three categories based on their 
structure: nitro-musks, polycyclic musks and macrocyclic musks. Musks have a sweet and fruity 
smell and have been synthesized for over a hundred years for their olfactory properties. 
However, nitro-musks, such as musk ketone 1.1, were found to be explosive and carcinogenic 
(Figure 1.2).5 Some countries, like Japan, have banned their usage, while others have restricted 
it. For example, since 1979, the USA does not allow the use of nitro-musks in cosmetics that 
may potentially be ingested and, since 1993, Germany has removed them from all detergents.6 
Polycyclic musks, such as Galaxolide (1.2), were synthesized as an alternative to nitro-musks, 
but have weaker olfactory properties and there have been concerns about their bioaccumulation.7 
Despite other concerns regarding their toxicity and biodegradability, polycyclic musks are still 
widely used in the aroma chemical industry.7  
 
Figure 1.2. Musk ketone 1.1, a member of the nitro-musks and Galaxolide (1.2), a member of 
the polycyclic musks. 
Macrocyclic musks are naturally occurring compounds, but they were not commercially 
produced before the late 1990’s due to challenges associated with their synthesis.8 They can be 
divided into two categories: macrocyclic ketones, naturally found in animals, and macrocyclic 
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lactones, naturally found in plants. As examples, Muscone (1.3) is isolated from the testicular 
glands of the musk deer and Exaltolide® (1.4) is found in blackberries (Figure 1.3).5 
Macrocyclic musks have not shown any appreciable bioaccumulation or toxicity and are 
biodegradable, all while maintaining olfactory properties that are more powerful than those of 
nitro- or polycyclic musks.8 
 
 
Figure 1.3. Commercial macrocyclic musks: Muscone (1.3), Exaltolide® (1.4), Zenolide (1.5), 
isoambrettolide (1.6) and dihydroambrettolide (1.7).  
Today macrocyclic musks are commonly found in many perfumes, detergents, shampoos, 
shower gels and soaps.9 Their worldwide production is considerable; in 2008, Exaltolide 1.4 
was produced at an annual amount of up to 1000 metric tons and the same quantity was 
applicable to Zenolide (1.5). Other notable manufactured macrocyclic musks are 
isoambrettolide (1.6) and dihydroambrettolide (1.7), each being produced at an annual amount 
of up to 100 metric tons (Figure 1.3).10 
1.2. Macrocycles in Medicinal Chemistry 
In medicinal chemistry, most orally active drug-candidates are designed to obey Lipinski’s 
rules:11 compounds should have 1) no more than 5 hydrogen-bond donors; 2) no more than 10 
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hydrogen-bond acceptors; 3) a molecular mass inferior to 500 Daltons and 4) a partition 
coefficient12 comprised between -0.4 and +5.6. In contrast, biologically active macrocycles 
often possess large molecular weights and can be disregarded as promising drug candidates for 
failing Lipinski’s rules. Although other guidelines13 for producing drug candidate compounds 
suggest that molecules having ten or less rotatable bonds and a polar surface area equal or less 
to 140 Å would better predict the oral activity of a drug candidate. Even though macrocycles 
would fulfill the latter criteria, they are still scarcely explored in drug design. 
Macrocyclic structures can often have a rigid conformation that would facilitate binding 
onto the target and would satisfy the “ten or less rotatable bonds” requirement. As such, 
macrocycles can be considered to have an advantage over most linear molecules in medicinal 
chemistry. However, the synthetic challenges associated with macrocyclization often make 
linear compounds the most preferred option when designing a compound with biological 
properties. Notably, two of the most well-known antibiotics in the world, Erythromycin 1.8 and 
Vancomycin 1.9 (Figure 1.4), are macrocycles which rely on a bacterial synthesis for production 
as a chemical synthesis is considered too costly.14,15 
 
Figure 1.4. Examples of macrocyclic antibiotics: Erythromycin 1.8 and Vancomycin 1.9. 
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The isolation and total syntheses of a variety of biologically potent macrocycles are reported 
by academic research groups in the literature.16 The syntheses of these macrocycles most often 
possess a common feature: a challenging macrocyclization step that would make their synthesis 
unfeasible on an industrial scale. In the early stages of drug design, medicinal chemists are also 
reluctant in using a macrocyclization step when building libraries or when studying SAR 
(structure activity relationship).16 Nonetheless, some R&D groups have built synthetic 
macrocycles, such as BILN-206117 1.10 and SB-T-205418 1.11, which possess promising 
potency (Figure 1.5). BILN-2061 1.10 is a NS3-protease inhibitor which has shown anti-viral 
effects in humans and SB-T-2054 1.11 was found to be as active in terms of cytotoxicity as the 
commercial anti-cancer drug Taxol (paclitaxel). 
 
Figure 1.5. Potent synthetic macrocycles: BILN-2061 1.10 and SB-T-2054 1.11.  
1.3. Synthetic Challenges in Macrocyclization Reactions 
Although macrocycles have numerous applications in the chemical industry, challenges 
associated with their synthesis remain a preoccupation for organic chemists. It is important to 
understand that direct transposition of catalytic methods for intermolecular reactions, and for 
intramolecular ring closing of small cycles, to the synthesis of macrocycles is not often possible 
due to inherent thermodynamic constraints of macrocyclic precursors which will be be discussed 
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hereafter. Therefore, the development of synthetic strategies aimed specifically toward the 
synthesis of macrocycles is needed. 
Macrocyclization reactions present challenges due to issues regarding both entropy and 
enthalpy. Thermodynamic laws associated with entropy state that a system always tends to 
disorder; however, a macrocyclic system is more ordered than its acyclic counterpart, often 
having a conformational population that is nearly homogeneous.2 Thermodynamic laws 
associated with enthalpy point to three types of strain that can influence the formation of a 
macrocycle:19 1) Pitzer strain, also known as torsional strain, is described as the result of forcing 
bonds to be in an eclipsed conformation to allow for alignment of  reactive orbitals; 2)  Baeyer 
strain arises from the deformation of bond angles to allow for the appropriate alignment for 
cyclization, and 3) Prelog strain, or transannular strain, reflects repulsive interactions of atoms 
across the ring. Moreover, it has been described that the probability of an encounter between 
two reactive functionalities decreases as the number of atoms between them increases.20 As a 
result of the above thermodynamic factors, macrocyclization reactions often require long 
reaction times and high reaction temperatures, the latter of which can promote decomposition 
of one or more of the reactants, reagents or catalysts. 
 Pioneering work by Illuminati and Mandolini has been utilized to graphically represent 
the challenges associated with the formation of large rings.21 When the formation of different 
ring-sized lactones was explored, 4- to 6-membered ring lactones were found to be the fastest 
produced under the conditions reported in Scheme 1.1. The slowest ring-closing reactions are 
those that  form 8- to 12-membered ring lactones. The rates of cyclization reach a plateau at 13-
membered rings which are similar to the ring-closing of α-lactone 1.13 (n = 1).  
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Scheme 1.1. Rate of formation of different ring-sized lactones by cyclization of 
bromocarboxylates. 
1.4. Traditional Synthetic Strategies in Macrocyclization  
As a result of the inherent unfavorable thermodynamic properties of macrocyclization, 
several synthetic strategies have been developed by chemists. As early as 1933,22 it was 
demonstrated that macrocyclization in a highly diluted medium would favor intramolecular 
reactions over intermolecular processes. As the undesired oligomerization is a second order 
reaction, decreasing the concentration of the reactants affects the rate of the reaction 
exponentially (Scheme 1.2). 
-5
-4
-3
-2
-1
0
1
2
3
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
lo
g 
k
ring size
 8 
 
Scheme 1.2. Reaction rates of both macrocyclization and oligomerization reactions. 
The high dilution strategy for the synthesis of macrocycles has evolved to the point 
where the typical concentration for macrocyclization tends to be in the low mM range. During 
the synthesis of the previously mentioned SB-T-2054 1.11,18 the ring-closing step was achieved 
by a Ru-promoted reaction at a concentration of 2 mM in dichloromethane (Scheme 1.3). To 
put it in perspective, if one gram of the precursor 1.14 (1163 g/mol) were to be cyclized at a 2 
mM concentration, 430 mL of solvent would be required. Further extrapolation to the kilogram 
scale would suggest 430 L of required solvent. Not only are the solvent requirements not 
environmentally friendly, but they are costly and not easily applicable to industrial production 
scales. In addition, a total of 75 mol % of Ru complex (added in three portions) was needed to 
achieve complete conversion after five days, pointing to the need for improved reactivity for 
macrocyclization. 
 
Scheme 1.3. Ru-promoted macrocyclization for the synthesis of SB-T-2054. 
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 Alternatively, a way to achieve high dilution using less solvent is to employ slow 
addition techniques. A syringe pump is used to slowly add the linear precursor (at times, a 
reagent or a catalyst can also be added simultaneously) to the reaction flask, so that at any given 
moment, there is only a small amount of the reactive species in solution. Although slow addition 
techniques can be viewed as a greener alternative to standard high dilution, at industrial scales, 
the concentrations are often still too low and the slow addition infrastructure is tedious and 
cumbersome. Despite these drawbacks, the process can result in high yields of desired product. 
For example slow addition was used in combination with high dilution to obtain macrocyclic 
musks Exaltolide® 1.4 and dihydroambrettolide 1.7 from the corresponding seco acids, 1.15 
and 1.16 respectively, in almost quantitative yields (Scheme 1.4).23 
 
Scheme 1.4. Macrolactonization employing both high dilution and slow addition for the 
synthesis of macrocyclic musks. 
 An alternative strategy to improve the efficiency of macrocyclization reactions is 
conformational control, whereby structural modification of the macrocyclic precursor favors a 
conformation that brings the two reactive functionalities closer in space. The main 
disadvantages of the strategy are: 1) the addition of synthetic steps, specifically the installation 
and cleavage of groups added to enforce conformations and, 2) the limitation in the choice of 
substrates, which must have the necessary functionality for the structural modifications. An 
example of conformational control in the synthesis of macrocycles is the use of auxiliaries that 
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enforce conformation via π-stacking. A perfluorophenyl ring-containing auxiliary can be 
covalently attached to the diene 1.17 to help favor cyclization through non-covalent interaction 
with the core of the precursor promoted by π-stacking of rings with complementary electroninc 
properties (Scheme 1.5).24  
 
Scheme 1.5. Conformation control of a macrocyclization by attachment of an auxiliary.  
Other methods of conformational control that do not require covalent attachment of an 
auxiliary include chelation of the functionality within the acyclic compound with metal ions25 
or through systematically planned intramolecular H-bonding.26 In the latter aforementioned 
strategies for conformational control, the addition of synthetic steps is mostly avoided, but the 
substrate scope remains limited. 
1.5. Conclusions 
Synthetic macrocycles are omnipresent in many fields of the chemical industries, including 
aroma chemistry and medicinal chemistry. Nevertheless, the synthesis of macrocycles remains 
problematic because of unfavorable thermodynamics. The most common approaches to 
overcome the challenges of macrocyclization are costly and not environmentally friendly.  
The present thesis will focus on the development of strategies in macrocyclization for the 
formation of relevant molecules in aroma chemistry and medicinal chemistry. The strategies are 
designed to exploit catalysis and limit the production of by-products,27   as the industries are ever 
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more aware and concerned about sustainability.28 The thesis will first discuss the development 
of a direct catalytic macrolactonization reaction (Chapters 2 to 5), and will then present the 
application of a phase separation strategy in complex molecule synthesis (Chapters 6 and 7). 
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2. Macrolactoni zation via Formation of the Ester 
Functional Group  
Macrolactones, a category of macrocycles that incorporate an ester moiety, are present 
in numerous fields of the chemical industry, notably as perfumes, as insecticides and as 
pharmaceuticals. As representative examples, Exaltolide® 2.11 is a macrocyclic musk widely 
used in detergents, soaps and perfumes, Spinosyn A 2.22 is found in the commercial biopesticide 
Spinosad, and Erythromycin 2.33 and Epothilone B 2.44 are a common antibiotic and a cytotoxic 
drug candidate, respectively. Given the popularity of macrolactones, a number of 
macrocyclization reactions have been developed for their synthesis. Some of the more common 
routes to macrolactones involve formation of carbon-carbon (C-C) bonds. Intramolecular Wittig 
reactions remain a staple of macrocyclization strategy, but alternatives that rely upon catalysis 
such as ring-closing olefin metathesis (RCM) and intramolecular Pd-catalyzed cross-coupling, 
have become the widely used methods. Despite the emergence of an increasingly varied toolbox 
for the synthesis of macrolactones, the most common method remains the macrolactonization 
from a corresponding seco acid.5 The following chapter describes a brief overview of the 
stoichiometric and catalytic methods for macrolactonization that result in the formation of an 
ester linkage (R2-O-C(O)-R1). 
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Figure 2.1. Macrolactones as perfumes, insecticides and as pharmaceuticals. 
2.1. Challenges Associated with Macrolactonization from a Seco 
Acid 
Macrocyclization is a challenging transformation that generally suffers from slow rates 
of ring closure and allows for competing intermolecular oligomerization or substrate 
decomposition to plague the desired cyclization. In addition to the typical difficulties of 
macrocyclization, macrolactonization from seco acids has inherent challenges of its own. The 
condensation between an alcohol functionality and a carboxylic acid functionality is a reversible 
process, in which the water produced as a by-product can participate in a ring-opening 
hydrolysis.  In an analogous intermolecular esterification reaction, the problematic equilibrium 
is controlled via LeChatelier’s principle,6 whereby adding an excess of one of the two reagents 
pushes a reaction towards the desired ester product. In many esterification processes, the alcohol 
is often a cheap and abundant reagent and can be used as the solvent for the reaction. In addition, 
the equilibrium can be influenced by the removal of water from the reaction mixture through 
the addition of molecular sieves or the installation of a Dean-Stark apparatus.7 Esterification 
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often requires activation of one or both of either the carboxylic acid or hydroxyl functionalities. 
The Fischer esterification is a prime example that exploits a strong acid, such as sulfuric acid, 
to catalyze the addition of the alcohol to the carbonyl group of a carboxylic acid.8 When 
comparing the intermolecular esterification and intramolecular macrolactonization, it is clear 
that Fischer-type esterification protocols cannot help promote the latter, where the reactive 
functionalities are intrinsically equimolar. As such a number of methods have been developed 
to effect macrolactonization without invoking problematic equilibria. 
 
Scheme 2.1. Condensation reactions between alcohol and carboxylic acid functionalities: a) 
Equilibrium-controlled lactonization. b) Fischer esterification following LeChatelier’s 
principle. 
2.2. Stoichiometric Methods for the Synthesis of Macrolactones 
In general, chemists perform the direct macrolactonization of seco acids using not more 
than a handful of different general protocols. Unfortunately, they all share a major drawback in 
stoichiometric activation of the carboxylic acid moiety or, in some cases, activation of the 
alcohol moiety, which produces a stoichiometric waste by-product that is often toxic or difficult 
to remove during purification of the desired product. As it is generally the case in 
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macrocyclization reactions, high dilution and slow addition techniques are also trademarks in 
macrolactonization. 
 
Scheme 2.2. Stoichiometric-activated macrolactonization. 
2.2.1. The Yamaguchi Macrolactonization 
The Yamaguchi reaction, first reported in 1979,9 involves formation of a mixed anhydride 
from 2,4,6-trichlorobenzoyl chloride 2.5 and a carboxylic acid and subsequent esterification to 
synthesize macrolactones. The seminal report stipulates the necessity of slow addition and high 
dilution reaction conditions; the mixed anhydride is slowly added to a refluxing solution of 
DMAP in toluene, where conversion of the anhydride to a DMAP-adduct takes place prior to 
cyclization (Scheme 2.3). The Yamaguchi macrolactonization is arguably the most employed 
methodology in macrolactonization, with over 340 publications having reported using the 
protocol,5 most often in the context of total synthesis of natural products. Its popularity is most 
probably linked to its reliability to promote macrocyclization over oligomerization due to the 
high reactivity of the slowly added intermediate in the DMAP solution. In other words, the 
cyclization is the dominant pathway because the concentration of the reactive precursor remains 
low all along the slow addition step. 
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Scheme 2.3. Macrolactonization via the formation of a mixed anhydride: the Yamaguchi 
protocol.  
As the Yamaguchi cyclization is often a late-stage step in the synthesis of complex 
macrocycles, some modifications to the general protocol are often used and are typically 
substrate specific. For instance, in Carreira’s synthesis of leucascandrolide A 2.8 (Scheme 
2.4),10 oligomerization was observed during macrocyclization and was presumed to be due to 
intramolecular hydrogen bonds which enforce a conformation that is not conducive to ring 
closure. Using a highly polar solvent such as DMF to compete for hydrogen-bonding sites 
allowed the formation of the desired 14-membered macrocycle 2.7 in 49% yield. Several other 
modifications have been reported to the original protocol, notably by Yonemitsu.11 In addition, 
different reagents have been developed to aid in the formation of the initial mixed anhydride: 
2,6-dichlorobenzyl chloride 2.9,12 m-nitrobenzoic anhydride (MNBA) 2.1013 and pivaloyl 
chloride 2.1114 are among published alternative activating reagents (Figure 2.2).  
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Scheme 2.4. Macrolactonization via a modified Yamaguchi protocol for the synthesis of 
leucascandrolide A 2.8. 
 
Figure 2.2. Other common reagents for the formation of a mixed anhydride. 
2.2.2. The Corey-Nicolaou Macrolactonization 
 Another popular method for macrolactonization of seco acids is through the formation 
of a thioester, a method inspired by the biosynthesis of macrolactones.15 The most common 
procedure was reported by Corey and Nicolaou in 1974.16 The method relies on the activation 
of both the carboxylic acid and the alcohol functionalities (Scheme 2.5). The 2-pyridine thioester 
intermediate can be formed after the addition of 2,2’-dipyridyl disulfide 2.12 and 
triphenylphosphine (PPh3) to a solution of the seco acid in xylene. The reaction mixture 
containing the thioester is then slowly added to refluxing xylene to promote cyclization in a 
highly dilute medium. An internal proton transfer, facilitated at a high temperature, forms a 
zwitterionic species which undergoes an electrostatically driven cyclization.  
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Scheme 2.5. Macrolactonization via the formation of a thioester: the Corey-Nicolaou protocol. 
The Corey-Nicolaou approach has been used in the synthesis of many complex 
macrocycles,5 notably for intermediates in the preparation of the antibiotic C-1027 chromophore 
2.15 where other traditional methods, such as the Yamaguchi macrolactonization, were proven 
unsuccessful.17 Though no specific equivalents were reported for the activating reagents, slow 
addition over six hours, and a total reaction time of twelve hours at a 1 mM concentration were 
needed to obtain macrocycle 2.14 in a 56% yield (Scheme 2.6). 
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Scheme 2.6. Macrolactonization via Corey-Nicolaou protocol toward the synthesis of C-1027 
chromophore 2.15. 
In the procedure, two by-products are generated in stoichiometric amounts. It has been 
reported that elimination of the by-products can be problematic.18 Indeed, a difficult 
chromatographic separation is necessary to isolate the desired macrolactone from 
triphenylphosphine oxide and thiopyridone, but also from residual triphenylphosphine and 2,2’-
dipyridyl disulfide. The difficulty has prompted chemists to propose alternative reagents to the 
reaction (Figure 2.3). Thionylchloroformate 2.16 can be synthesized, isolated and be used to 
promote the lactonization reaction, making the use of triphenylphosphine unnecessary and, thus, 
limiting the amount of generated by-products.15 Disulfide 2.17 requires milder conditions and 
its steric hindrance prevents side reactions.19 Disulfides 2.18 and 2.19 were also found to be 
more reactive than the seminal disulfide 2.12.20 
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Figure 2.3. Alternative reagents to the Corey-Nicolaou protocol. 
2.2.3. The Boden-Keck Macrolactonization 
 The use of carbodiimide reagents in combination with DMAP is well established in the 
synthesis of esters and amides and is known as the Steglich reaction.21 Boden and Keck have 
published a modification allowing the transposition of the protocol to macrolactonization. 
Indeed, the standard Steglich reaction conditions were found to produce fair amounts of the 
side-product 2.20 when applied to the macrolactonization of seco acids (Scheme 2.7).22 As the 
cyclization reaction is slow, the N-acyl urea 2.20 is formed preferentially and is unreactive to 
cyclization. However, adding the hydrochloride salt of the amine base (DMAP-HCl) can 
effectively promote cyclization by accelerating the proton transfer steps. 
 
Scheme 2.7. The ineffective traditional Steglich reaction and the Boden-Keck-modified reaction 
conditions applied to macrolactonization. 
Macrocyclic musks were synthesized using the Boden-Keck approach in excellent 
yields.22 For example Exaltolide® 2.1 was formed in 95% yield by the slow addition of seco-
acid 2.21 to superstoichiometric amounts of the activating reagents (Scheme 2.8). The Boden-
Keck procedure has been utilized in many total syntheses,23 but a major drawback associated 
with the method is the stoichiometric production of the N,N’-dicyclohexylurea. Due to 
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complications arising from the toxicity and purification of the urea,24 several modifications have 
been published which include the use of supported DCC,25 or the use of EDC-HCl,26 to help 
with the purification of the desired macrolactones.  
 
Scheme 2.8. The Boden-Keck procedure for the synthesis of Exaltolide® (2.1). 
2.2.4. The Mitsunobu Macrolactonization 
 Direct macrolactonization from seco acids can also occur via activation of the alcohol 
functionality, such as in the Mitsunobu reaction. In the Mitsunobu procedure (Scheme 2.9), an 
azodicarboxylate reagent, often DEAD 2.22 or DIAD 2.23, is reacted with triphenylphosphine 
and the macrocyclic precursor. An alkoxyphosphonium intermediate is produced and an 
intramolecular cyclization can occur via an attack of the carboxylate moiety. Slow addition of 
the seco acid to the in situ formed intermediate 2.24 or 2.25 is necessary to selectively produce 
the macrolactone. Indeed, when slow addition is not used, the major product obtained from the 
reaction conditions is often the head-to-tail cyclic dimer.5 The stoichiometric by-products 
formed include a hydrazide and triphenylphosphine oxide. Roush and co-workers have 
described the challenges associated with purification from the by-products,27 and it should be 
noted that supported reagents have been used to facilitate the purification step.28  
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Scheme 2.9. General procedure for the synthesis of macrolactone via the Mitsunobu reaction. 
 The Mitsunobu macrolactonization approach has been exploited in many total syntheses 
of natural products, notably for the synthesis of previously mentioned leucascandrolide A 2.8.29 
The reaction time for the cyclization of precursor 2.26 (15 min) is quite impressive, but excess 
PPh3 and DEAD were necessary to produce macrocycle 2.27 in 65% yield with a clean inversion 
of configuration (Scheme 2.10). 
 
Scheme 2.10. Macrolactonization via the Mitsunobu protocol for the synthesis of 
leucascandrolide A. 
2.3. Catalysis in the Synthesis of Macrolactones 
 In recent years, organic synthetic chemists have developed catalytic alternatives to the 
stoichiometric macrolactonization reactions that form the ester moiety of macrolactones. In 
2006, White and co-workers reported a first macrolactonization protocol via an allylic C-H 
oxidation from ω-alkenoic acids.30 The reaction proceeds via a Pd(II)-catalyzed C-H bond 
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cleavage, and an oxidative C-O bond-forming event is subsequently promoted by benzoquinone. 
Slow addition and high dilution are not necessary, hypothetically because the catalyst activates 
both reactive moieties simultaneously as in the intermediate 2.30 depicted in Scheme 2.11. The 
study of the scope of the reaction pertained to 14- to 17-membered macrolactones with yields 
varying between 52 and 63%. Some limitations include long reaction times and the need for the 
precursors to possess a terminal olefin. 
 
Scheme 2.11. Macrolactonization via Pd-catalyzed allylic C-H oxidation. 
 More recently and similarly to White’s method, Breit and co-workers have developed a 
Rh-catalyzed propargylic C-H oxidation to produce macrolactones bearing an exocyclic olefin 
at the ω-position.31 Once again, the bis-activation of the reactive functional groups permits 
reaction conditions which are moderately diluted without the need for slow addition. 
Furthermore, no stoichiometric oxidant is necessary in the procedure, therefore there is no 
stoichiometric by-product formed, and relatively low catalyst/ligand loadings are required. 
However, the reaction is air-sensitive and must be performed under an inert atmosphere. The 
scope of macrocycles that could be formed included 12- to 23-membered ring macrolactones 
and included polypeptides such as 2.33 as shown in Scheme 2.12.  
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Scheme 2.12. Macrolactonization via Rh-catalyzed propargylic C-H oxidation.  
2.4. Summary  
Macrolactonizations of seco acids typically rely on stoichiometric activation of the 
carboxylic acid and/or the alcohol moiety. The stoichiometric by-products formed can be toxic 
and can render purification steps laborious. In addition, much like macrocyclization reactions 
in general, slow addition and high dilution are required to avoid oligomerization. Some catalytic 
methods have been developed for the synthesis of macrolactones that by-pass the reactivity 
problems of the condensation of alcohols onto carboxylic acids, but also suffer from long 
reaction times and limitations in the choice of substrates. 
2.5. Inspiration and Research Goals for Improving 
Macrolactonization 
 The intermolecular synthesis of esters has recently moved away from methods such as 
the Fischer esterification or stoichiometric activation methods, towards catalytic dehydrative 
condensations.32 Indeed, catalysis-based esterification methodologies have been developed to 
promote esterification between equimolar amounts of alcohols and carboxylic acids. As 
examples, Blanchfield and co-workers have shown that boric acid can effectively catalyze the 
selective esterification under azeotropic reflux in toluene but the method was limited to α-
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hydroxyacids (Scheme 2.13a). A more general methodology has been published by Yamamoto 
and co-workers in which HfCl4(THF)2 catalyzes the esterification of various carboxylic acids 
with alcohols, also under azeotropic reflux in toluene (Scheme 2.13b). However, these methods 
have not found common applications for the intermolecular synthesis of esters by synthetic 
organic chemists, perhaps due to the fact that they do not tolerate the presence of water and 
require azeotropic reflux conditions. Curiously, these methods have not been applied to the 
synthesis of macrolactones. 
 
Scheme 2.13. Catalytic dehydrative condensations: a) boric acid-catalyzed esterification of α-
hydroxyacids and b) Hf-catalyzed esterification of carboxylic acids.  
  A direct catalytic macrolactonization procedure from seco acids would be a much needed 
alternative to the stoichiometric methods used for the synthesis of macrolactones. Thus, the next 
three chapters will be dedicated to the development of catalyzed direct macrolactonization 
protocols for the formation of macrolactones and macrodiolides that are relevant in aroma and 
medicinal chemistry-type industries. The research goals would place an emphasis on catalysis, 
preferably using commercially available compounds as catalysts. In addition, the protocols for 
macrolactonization will aim for simplicity: catalysts must be "water-tolerant" (no azeotropic 
conditions necessary) and no tedious slow addition techniques should be necessary.  Preferably, 
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the method developed for macrolactone synthesis would be applicable to the synthesis of 
compounds relevant to aroma chemistry and medicinal chemistry.  
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3.1. Abstract 
Efficient direct macrolactonization of seco acids can be catalyzed by Hf(OTf)4 in high 
yields, forming water as the sole byproduct. The Hf(OTf)4 catalyst possesses unique reactivity 
characteristics relative to other Lewis acids, as it promotes macrolactonization over hydrolysis 
even in the presence of excess water. In addition to forming a variety of macrolactones and 
benzolactones (55−90%), intermolecular direct esterifications of carboxylic acids and alcohols 
were also possible and demonstrated compatibility with common carbamate, silyl ether, 
alkoxymethyl ether, and acetal protecting groups. All of the macrolactonization and 
esterification processes developed are operationally simple, “one-pot” reactions that exploit a 
commercially available catalyst without the need for slow addition or azeotropic techniques. 
3.2. Introduction 
Macrolactones are one of the most common cyclic motifs found in Nature. In addition to 
their application in pharmaceuticals,1 macrolactones have had a tremendous impact on the 
cosmetic industry.2-4 Macrocyclic musks have attracted increased attention from the perfume 
industry as they do not exhibit the toxicity or bioaccumulation properties associated with 
traditional nitro-aromatic and polycyclic musks.5 In 2011, it was estimated that the market for 
flavors and fragrances was worth over 21 billion dollars.6 The production of macrocyclic musk 
is of considerable industrial impact; for example in 2008 the production of the 16-membered 
Exaltolide® (2)7 was on the order of ~1000 metric tons.8 Consequently, synthetic chemists in 
both academia and industry have continued to develop new strategies to prepare macrolactones, 
where Exaltolide® and its derivatives have often served as targets for new methodologies. 
Olefin metathesis,9 most recently employing Z-selective catalysts,10 as well C-H 
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functionalization have recently been explored for the synthesis of macrocyclic musk-like 
structures.11 Surprisingly, catalysis has rarely been examined for macrocyclization from the 
commonly occurring seco acids.12,13 Macrolactones formed via condensation of the 
corresponding seco acid are equilibrium-controlled processes where the reverse hydrolysis 
reaction can be problematic. While in an analogous intermolecular esterification the alcohol can 
be added in large excess (often as the solvent) in order to push unfavorable equilibria towards 
the formation of the desired ester,14 the stoichiometry of the alcohol and acid functionalities in 
macrolactonization remains fixed in a 1:1 ratio. In 1936,13a Carothers reported a Lewis acid 
catalyzed transesterification process for the formation of macrolactone 2. Following thermal 
polymerization of the seco acid 1, MgCl2 was used to promote “back-biting” of the oligomer to 
afford macrolactone 2, which was concurrently distilled away from the reaction mixture as it 
formed, thus controlling any unfavorable equilibria. 
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Figure 3.1. Traditional macrolactonization strategies. 
Current strategies to promote macrolactonization from seco acids involve stoichiometric 
activation of the carboxylic acid,15 which is eventually eliminated as a thermodynamically 
favorable leaving group. (Figure 1).  Some of the more popular strategies employing this concept 
for macrolactone synthesis include the Corey–Nicolaou,16 Boden/Keck,17 Mitsunobu18 and 
Yamaguchi lactonizations.19 In each of the above examples, reactions are normally all conducted 
under high dilution conditions and the stoichiometric by-products can be toxic and difficult to 
remove even via chromatographic separation.  The Yamaguchi macrolactonization has been 
particularly favored amongst synthetic chemists since its inception in 1979, as almost 200 
examples of the macrolactonization protocol have been reported.20 Recently, modified 
anhydride reagents inspired by the Yamaguchi method have attracted increased attention for the 
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synthesis of naturally occurring macrolactones.21  Surprisingly, efficient catalytic direct 
macrolactonization of seco acids is rare and underdeveloped.8 Herein, we report on a hafnium-
catalyzed macrolactonization protocol for the formation of macrolactones that produces water 
as the only by-product. 
3.3. Discovery of Hf(IV)-Catalyzed Macrolactonization 
In developing an ideal direct macrolactonization of seco acids, several goals were identified.  
First, an operationally simple, "one pot" process was desired which avoided the use of azeotropic 
techniques (drying tubes, Dean-Stark traps) and slow addition/high dilution apparatus (syringe 
pumps). Second, the direct macrolactonization would produce water as the only by-product.  
These goals present significant challenges for catalysis, as a suitable Lewis acid must not only 
possess sufficient acidity to activate the macrocyclization, but must retain that reactivity even 
as the reaction media becomes increasingly "contaminated" by water. An additional requirement 
is that the Lewis acid must also refrain from catalyzing hydrolysis of the desired macrolactone. 
Although a thorough investigation surveying a wide variety of Lewis acids from across the 
periodic table was envisioned, particular focus in the present study was placed on lanthanide-
based Lewis acids, including Lewis acids based on elements of groups III and IV that have 
demonstrated the ability to promote Lewis acid catalysis in aqueous media.22 The 
macrolactonization of seco acid 1 to provide Exaltolide® 2 was selected as a model substrate for 
cyclization (Figure 3.2).23 The investigations began with various oxophilic Lewis acid catalysts.  
Although these Lewis acids are known to react readily with water, no precautions to exclude 
water (such as adding drying tubes or molecular sieves) were taken and no slow addition 
techniques were exploited (Figure 2). As expected, titanium, iron, magnesium, boron and 
aluminum catalysts in general did not afford any of the desired macrolactone 2 (entries 1→10), 
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and either quantitative recovery of the starting material 1 was observed, or the highly acidic 
conditions caused decomposition of 1.  Some productive macrocyclization was observed when 
using copper-based catalysts.  While CuCl2 and CuBr2 did not promote any macrolactonization, 
both Cu(OAc)2 and Cu(OTf)2 resulted in unsatisfactory yields of macrocycle 2 (25 and 54% 
yield respectively).  While AgOTf and ZrCl4(THF)2 did provide low yields of the macrolactone 
2 (22 and 13% respectively), other transition metal-based Lewis acids displayed little reactivity 
even with other electrophilic complexes of Zr, Zn, Pd, Ni and Co. 
 
 
Figure 3.2. Optimization of a Lewis acid catalyzed macrolactonization process. 
 a Isolated yields following silica gel chromatography.  Remaining mass balance is unreacted 1 unless otherwise 
noted. b No trace of 1 was isolated.  c Polymerization of  1 is observed.  d Lower catalyst loadings provided lower 
yields.  When 2.5 mol % Hf(OTf)4 was  used 72% of 2 and 27% re-isolated 1 were obtained. At a concentration of 
10mM, 32% of 2 was obtained along with a complex mixture of cyclic and acyclic dimers.  Lowering the 
temperature resulted in low conversions, even when the catalyst loading was increased. 
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Next, Lewis acids from groups III and IV, including lanthanide-based Lewis acids were 
investigated.  Given the success of electrophilic triflate catalysts for macrocyclization of 1, 
Sc(OTf)3 (45%), Sm(OTf)3 (21%) Dy(OTf)3 (13%) and Yb(OTf)3 (38%) were evaluated and 
showed encouraging but low yields (entries 22→25).  Interestingly, when Hf(OTf)4 was used 
an 83% yield of the macrolactone 2 was isolated.24 Yamamoto and co-workers reported that 
efficient direct intermolecular esterifications using low loadings of HfCl4(THF)2 were possible, 
albeit under azeotropic reflux.25,26  Disappointingly, when the hafnium-based catalysts 
HfCl4(THF)2 and Hf(On-Bu)4 were investigated in the protocol without the use of azeotropic 
techniques, only low yields were obtained (entries 26 and 27).  Given the success of the 
Hf(OTf)4 complex, the possibility of catalysis via in-situ formed HOTf was investigated.  In a 
control reaction, it was found that HOTf did catalyze the macrolactonization (1→2), albeit in 
much lower yield (39% vs. 83% with Hf(OTf)4).  Consequently, macrolactonization using 
Hf(OTf)4 with added (i-Pr)2NEt (50 mol % or 10 equiv of base with respect to Hf(OTf)4) to 
quench traces of protic acids was performed.  In the macrolactonization with added base, the 
desired macrolactone 2 was isolated in 79% yield.27 The almost identical yields obtained in 
either the presence or absence of added base suggests that successful macrolactonization is due 
to catalysis via the Hf-based Lewis acid. 
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Figure 3.3. Evaluation of various Lewis acids for a catalytic macrolactonization strategy.  
The most efficient complex is judged to have yields of macrocyclization under the optimized conditions (blue), 
under the optimized reactions conditions in the presence of excess water (red) and provide high recovered yields 
of macrolactone 2 under hydrolysis conditions (green). a All entries represent isolated yields following silica gel 
chromatography. b The re-isolated yield of 2 remained high (>80%) even when using 1000 equiv. of added H2O.  
As stated previously, no precautions were taken to exclude or remove water from the 
reaction media during the macrolactonization reactions.  Hence, efficient Lewis acid catalysis 
must not only be able to promote macrolactonization in high yields, but must be able to do so in 
the presence of water without catalyzing the reverse hydrolysis reaction.  Consequently, all 
Lewis acid catalysts that displayed some activity for macrocyclization were re-evaluated in two 
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additional control reactions.  First, the macrolactonization was performed under the identical 
reaction conditions utilized in the catalyst survey, but the reaction solvent (PhMe) was pre-
treated with an excess of water (200 equiv).  Under these conditions, the majority of the 
complexes which demonstrated some measure of activity for direct macrolactonization were 
now significantly inhibited (isolated yields in 2 shown in red, Figure 3). Gratifyingly, the 
Hf(OTf)4 catalyst maintained the same level of reactivity (83% yield of macrolactone 2). 
Second, all active Lewis acid catalysts were evaluated for their ability to catalyze the hydrolysis 
of macrolactone 2.  Exaltolide 2 was resubmitted to the macrocyclization conditions with added 
excess water (500 equiv.) for 24 h and then the remaining macrolactone was isolated (isolated 
yields of recovered 2 in green, Figure 3.3). In general, most catalysts promoted some degree of 
hydrolysis of the macrolactone 2.  Once again, the Hf-based Lewis acids demonstrated ideal 
reactivity patterns for direct macrolactonization, as they were poor hydrolysis catalysts and 
greater than 80% of 2 could be re-isolated, even when 1000 equiv. of excess water was added. 
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Table 3.1. Substrate Scope of the Hf(OTf)4-Catalyzed Macrolactonization.  
 
 Macrocycle Yield (%)a  Macrocycle Yield (%)a 
 
a Isolated yields following flash chromatography.
  
Given the unique ability of Hf(OTf)4 to catalyze the macrolactonization reaction, the 
synthesis of various macrolactones was investigated under the optimized conditions (Table 3.1). 
The medium 13-membered macrolactones 4 was prepared in 55% yield28 (the smaller 11-
membered macrocycle 3 could not be formed under the optimized conditions). Larger rings such 
as the 16- and 17-membered macrolactones 2 and 5 were isolated in higher yields (83%29 and 
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87% respectively).  The yields of the macrolactones obtained via Hf catalysis are either 
comparable or higher than those obtained using stoichiometric methods.  Cardenas and co-
workers prepared the 13-, 16- and 17-membered macrolactones using a Boden/Keck-type 
method in 69-78% yield, but stoichiometric amounts of EDC, HOBt and DMAP and high 
dilution/slow addition techniques were required.30 Recently, Zhang and co-workers reported a 
hypervalent iodine(III) reagent for the preparation of macrolactones 2, 3 and 5 in 56-94% 
yields.31 Although the iodine-based reagent was recyclable, the procedure still required 
stoichiometric DMAP and PPh3 as co-reagents and subsequent purification/separation of the 
associated by-products (PPh3O) was necessary. Given the abundance and biological activity of 
benzolactone natural products,32 the synthesis of four different macrocycles with benzoic acid 
cores was investigated.  The 14- and 16-membered macrolactones 6 and 7 were each isolated in 
good yields (90% and 84% respectively).  The presence of an alkyne spacer in an analogous 
macrolactone 8 was well tolerated, albeit the product was isolated in a lower yield (56%). When 
the ring size was increased, the 26-membered ring 9 was isolated in 72% yield. The synthesis 
of other 17-membered macrolactones related to the isoambrettolide33 family of musks was also 
investigated (entries 9 and 10). Macrolactonization afforded (9Z)-isoambrettolide 10 in good 
yield (72%) without any isomerization of the cis-olefin.  Protection of the diol moiety of erythro-
aleuritic acid as its bis-pivaloate ester and subsequent macrocyclization afforded the 
macrolactone 11 in 73% yield.  Finally, macrolactonization of more strained rings, such as the 
1,3-diyne containing 21-membered macrolactone 12 also proceeded in high yield (86%). The 
Hf(OTf)4-catalyzed protocol also evaluated in the cyclization of structures has enolizable 
stereocenters and steric bulk adjacent to the reacting carboxylic acid. The 19-membered 
macrolactone 13 derived from iso-leucine was cyclised in 74% yield. Similarly, the 22-
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membered dipeptide macrocycle 14 was formed in 57% yield.  Both macrocycles 13 and 14 
were obtained without any observed epimerization. 
Table 3.2. Evaluation of Functional and Protecting Group Compatibility in the Hf(OTf)4-
Catalyzed Esterifications. 
 
 
         Ester Yield (%)a Ester Yield (%)a 
 
a Yields following flash chromatography. b With added Hünig’s base (50 mol %). 
To further probe the functional group tolerance of the Hf(OTf)4-catalyzed 
macrolactonization, several intermolecular esterifications were performed (Table 3.2). The 
esterification of a simple aliphatic acid and alcohol to provide the ester 15 occurred in 
quantitative yield (99%, entry 1). Esterification provided Boc-, tosyl-, and Cbz-protected 
glycine derivatives in good yields (72%). Both TBS and TIPS-protecting silyl ethers were 
utilized in the esterification to afford the corresponding esters 19 and 20 in 66 and 62% yield 
respectively (entries 5 and 6).  The addition of Hünig’s base (50 mol %) was necessary to avoid 
cleavage of the TBS and TIPS groups.  Similarly, MOM and acetate protected alcohols were 
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also tolerated and esterification afforded the corresponding esters 21 and 22 in 77 and 89% 
yields respectively. Both acetonide-protected diols and ketone groups were tolerated and the 
esters 24 and 23 were obtained in 77 and 92% yields respectively.  A propargyl ester 25 was 
compatible with the esterification protocol and was isolated in 78% yield.34 Additionally, 
carboxylic acids bearing furan and thiophene heterocycles were easily esterified and the n-
pentyl esters 26 and 27 were isolated in 75 and 89% yields respectively (entries 10 and 11). The 
esterification protocol also demonstrated selectivity for condensation with primary alcohols 
over secondary or tertiary alcohols or primary amines to provide the ester 15.35 
In an effort to understand the reactivity of the Hf(OTf)4 complex in direct 
macrolactonization, several control experiments were performed (Scheme 1). The 
intermolecular esterification of 1-pentanoic acid with 1-pentanol was performed with both 
Hf(OTf)4 and Dy(OTf)3.  The stability and catalytic activity of Dy(OTf)3 in water is largely 
attributed to the cation’s large ionic radii and favorable hydrolysis constants.22c Although Hf-
derived Lewis acids do not possess the same hydrolytic stability as the lanthanide triflates, both 
Hf(OTf)4 and Dy(OTf)3 provided identical yields of the ester 15 (~99%). Interestingly, when 
the esterification of benzamide with 1-nonanol was examined under identical reaction 
conditions, only Hf(OTf)4 promoted the formation of the ester 29 (58% yield).36 The useful 
Lewis acidity of Hf-based complexes for a variety of transformations is well documented.37 
Finally, esterification of 1-pentanoic acid was carried out with a secondary alcohol (3-pentanol). 
While Hf(OTf)4 did afford any of the desired product, Dy(OTf)3 provided a 60% of ester 28. As 
a whole, these preliminary studies suggest that the direct esterification/macrolactonization is 
influenced by the Lewis acidity, hydrolytic stability and steric bulk of the catalyst. 
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Scheme 3.1. Investigations into the mechanism of the Hf(IV)-catalyzed esterification.  
3.4. Conclusions 
A protocol for an efficient direct Hf(IV)-catalyzed macrolactonization of seco acids has 
been described.  Following a survey of  > 25 various Lewis acids, Hf(OTf)4 was identified as 
the most efficient catalyst, promoting macrolactonization in high yields at relatively high 
concentrations (5 mM).  Further investigations into the activity of the Hf(OTf)4 complex 
demonstrated that: 1) Hf(OTf)4 is significantly more efficient relative to other Lewis acids in 
catalyzing direct macrolactonization even in the presence of excess water and 2) Hf(OTf)4 is a 
poor catalyst for hydrolysis of macrolactones.  A variety of macrolactone and benzolactone 
skeletons could be prepared, including important macrocycles for the perfume industry.  
Intermolecular direct esterifications of carboxylic acids and alcohols were also possible and 
demonstrated compatibility with common carbamate, silyl ether, alkoxymethyl ether, and acetal 
protecting groups.  All of the macrolactonization processes developed are operationally simple, 
using commercially available catalysts, “one-pot” reactions without the need for slow addition 
or azeotropic techniques.  Importantly, the catalytic process forms environmentally benign water 
as the only by-product.  Preliminary investigations demonstrate that the Lewis acidity, 
hydrolytic stability and steric bulk of the catalyst play important roles in the macrolactonization. 
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The effectiveness of the Hf(IV)-catalyzed macrolactonization should be highly useful, given the 
prevalence of macrolactone structures in pharmaceutically and biologically active products and 
current interest in sustainability in reagent selection for industrially relevant processes. 
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4.1. Abstract 
Efficient direct synthesis of macrodiolides via catalysis using Hf(OTf)4 is possible in 
high yields, forming water as the sole by-product. The first protocol for the direct synthesis of 
macrodiolides from equimolar mixtures of diols and dicarboxylic acids was developed (58-96 
%).  In addition, modification of the reaction concentration allows for the synthesis of head-to-
tail macrodiolides from the corresponding seco acids. The catalytic preparation of the 
macrodiolides using a commercially available catalyst without the need for slow addition or 
azeotropic conditions provide an operationally simple alternative to protocols which employ 
toxic tin catalysts or stoichiometric activation strategies. 
4.2. Introduction 
Macrodiolides make up an important class of macrocyclic natural products.  The 
macrocyclic dilactones are structurally diverse1 as they can be found as both hetero- or 
homodimers, in a wide array of rings sizes, and decorated with various functionality. Not 
surprisingly, the macrocycles have been shown to exhibit a wide range of biological activities 
including antibiotic, antifungal, and antileukemic activities.2 Macrodiolides have also had a 
striking impact in the cosmetic industry,3-5  as the yearly worldwide production of macrocycle 
diolide musks such as Astratone® and Zenolide® is estimated at ~1000 metric tons. In general, 
the synthesis of macrodiolides involves a macrolactonization event and is consequently prone 
to competing oligomerization and high dilution reaction conditions.6,7 Template-directed 
cyclodimerizations have also been employed to improve macrodiolide synthesis.8  
Macrodiolides formed via the corresponding seco acids typically involve stoichiometric 
activation of the carboxylic acid employing a Yamaguchi,9 Corey–Nicolaou,10 Boden/Keck,11 
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or Mitsunobu lactonization (Figure 4.1).12 In each of the above examples, the stoichiometric by-
products can be toxic and difficult to remove even via chromatographic separation. A catalytic 
alternative employing the closely related seco-esters involves the use of distannoxane 
catalysis,13 which can effectively promote the synthesis of head-to-tail homodimers in good 
yields.14 Perhaps due to the difficulties in preparing macrodiolides from the corresponding seco 
acids, the development of catalytic C-H functionalization15 and olefin metathesis strategies16 for 
the synthesis of macrodiolides has also been recently reported.  
 
Figure 4.1. Syntheses of macrodiolides. 
 Recently, our group has reported that Hf(IV)-catalysis can be employed to promote 
direct macrolactonization of seco acids, generating only water as the stoichiometric by-
product.17 Given the interest in macrodiolide frameworks, the lack of catalytic methods for their 
synthesis is surprising.  Herein, we report the development of a Lewis acid-catalyzed synthesis 
of macrodiolides, including the first efficient diolide synthesis from diols and diacids in a one-
step process. 
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4.3. Results and Discussion 
An ideal direct synthesis of macrodiolides from a diacid and diol would involve a "one 
pot" process which would avoid the use of azeotropic techniques (drying tubes, Dean-Stark 
traps), slow addition/high dilution apparatus (syringe pumps) and allow for all starting materials 
to be added simultaneously.  Previous work identified lanthanide triflate Lewis acids as capable 
of promoting macrolactonization even in the presence of aqueous media18 without catalyzing 
the hydrolysis of the desired macrodiolide.  Consequently, a survey of the ability of various 
transition metal triflates to catalyze the formation of the 16-membered macrodiolide 3 from 
diacid 1 and diol 2 was investigated (Table 4.1). 
Table 4.1. Optimization of a Lewis acid catalyzed macrodiolide synthesis. 
 
Entry Catalyst Yield 3 (%)a 
1 Zn(OTf)2 <5 
2 Cu(OTf)2 50 
3 Sc(OTf)3 34 
4 Dy(OTf)3 18 
5 Sm(OTf)3 0 
6 La(OTf)3 29 
7 Yb(OTf)3 17 
8 Hf(OTf)4 67
b 
9 Hf(OTf)4 55 
10 Hf(OTf)4 92
c 
11 Hf(OTf)4 84
d 
12 Hf(OTf)4 90
e 
a Yields following chromatography. b With 5 mol % Hf(OTf)4. c 48 h. d With 200 equiv of water added. e 
Macrodiolide 3 was resubmitted to the reaction conditions with 500 equiv. of added water.  The yield reported 
represents the yield of recovered 3.  
 
The evaluation of Lewis acid catalysts began with Zn(OTf)2, which afforded only trace 
amounts of the desired macrodiolide 3 (Table 4.1, entry 1). Low yields of 3 were also observed 
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with other catalysts such as Sc(OTf)3 (34 %), Sm(OTf)3 (0 %) and Yb(OTf)3 (17 %), Dy(OTf)3 
(18 %) and La(OTf)3 (29 %).   Higher yields of macrodiolide 3 were observed with Cu(OTf)2 
(50 %) and Hf(OTf)4 (55 %). Finally, extending the reaction time to 48 h provided a slight 
increase in the yield of 3 to 92 %. When the catalyst loading of Hf(OTf)4 was decreased to 5  
mol %, a drop in the yield to 67 % of macrodiolide 3 was observed.  It was found that Hf(OTf)4 
was remarkably tolerant to aqueous reactions: 1) when 200 equiv. of water was added to the 
reaction mixture, Hf(OTf)4 remained highly active forming the desired macrodiolide in 84 % 
yield and 2) Hf(OTf)4 did not catalyze ring opening of the macrodiolide product, as submitting 
3 to the optimized reaction conditions resulted in almost quantitative recovery of the macrocycle 
3 (90 %).19 The exact mechanism by which the Hf(OTf)4 complex functions is still under study.  
It is known that similar reactivity exhibited by lanthanide triflates is attributed to the cation’s 
large ionic radii and favorable hydrolysis constants.20 The Lewis acidity of the Hf(OTf)4 
complex21 is well documented and both Hf(OTf)4 as well as other hafnium complexes
22 have 
been demonstrated to promote direct amidation, suggesting a mechanism proceeding by 
activation of the carboxylic acid.  Some zirconium complexes have also demonstrated activity 
in amidations.23 To evaluate the efficiency of the newly developed method, the synthesis of 
macrodiolide 3 from diacid 1 and diol 2 was examined using common stoichiometric activation 
strategies (Scheme 1). When a Mitsunobu-type macrocyclization was pursued, the desired 
macrodiolide was obtained in only 23 % yield, while requiring stoichiometric DIAD/PPh3 and 
slow addition of the diol 2. Using DCC as a coupling agent (Steglich-type esterification) for the 
synthesis of macrocycle 3 did not result in any formation of the desired product, even when 
employing slow addition of the diol 2. A Yamaguchi-type macrolactonization did not afford any 
of the desired macrolide, however a Corey/Nicolaou approach afforded a 35 % yield of the 
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macrocycle 3.  It should be noted that the 35 % yield is based on 1H NMR data, as Ph3PO 
contaminated the final product and was difficult to remove completely from the product. 
 
Scheme 4.1. Alternative syntheses of macrodiolides using stoichiometric activation methods. 
With optimized conditions in hand, the synthesis of a variety of macrodiolides from their 
corresponding diacids and diols was investigated (Table 4.2). Treating 1,4-butanediol or 1,5-
pentanediol with a dicarboxylic acid afforded the 15- and 16-membered diolides 4 and 5 in 58 
and 60 % isolated yields. The synthesis of larger ring sizes was found to require longer reaction 
times, but still afforded the diolide products in excellent yields. Upon extension of the reaction 
time to 48 h, the 18- and 19-membered diolides 6 and 3 were isolated in 96 and 92 % yield 
respectively. The Hf(OTf)4-catalyzed macrolactonization could be used to prepare very large 
macrocycles: the 33-membered diyne-containing macrodiolide 7 was isolated in 62 % yield and 
the 27-membered macrodiolide 8 was isolated in a similar 64 % yield. A 16-membered 
cyclophane derived diolide 9 was prepared in 79 %. Similarly, the incorporation of heterocycles 
into diolide structures was well tolerated and the 16-membered furan-containing macrocycle 10 
was obtained in 79 % yield. To demonstrate the efficiency of the protocol on more complex 
substrates, the synthesis of macrocycles containing stereogenic centers or chiral bicycles was 
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performed.  Macrodiolides 11 and 12, derived from enantiopure tartrate derivatives, were 
isolated in good yields (58 and 65 % for the 15- and 18-membered macrocycles respectively) 
after 48 h.  Similarly, two macrodiolides 13 and 14 were prepared based upon a 
norbornanedicarboxylic acid structure.  The 15- and 18-membered macrodiolides 13 and 14 
were both isolated in 68 % yields after 48 h. 
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Table 4.2. Substrate Scope of the Hf(OTf)4-Catalyzed Macrodiolide Synthesis.
a 
 
entry product yield  (%)a entry product yield (%)a 
 
a Isolated yields following flash chromatography. b Macrocyclizations were run over 48 h. 
 In an effort to expand the substrate scope of the methodology, the optimization of the 
method towards the synthesis of head-to-tail type macrodiolides was pursued (Table 4.3). The 
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seco acid 15 was initially treated with Hf(OTf)4 at 10 mol % at a higher concentration (10 mM) 
to try and force dimerization.24 The desired 22-membered macrodiolide 16 was obtained 
following purification in 54 % yield.  None of the corresponding 11-membered macrolactone 
was isolated.  Performing the macrocyclization under more dilute conditions (5 mM) 
surprisingly afforded a lower yield of  31 % of the desired macrodiolide 16, however dropping 
the catalyst loading again to 5 mol % re-increased the yield to 51 % (entry 3).  When the catalyst 
loading was further decreased to 2.5 mol %, at 5 mM a 37 % yield was obtained, but by simply 
extending the reaction time to 48 h, a yield of 74 % of the desired head-to-tail dimer 16 could 
be obtained.25 Furthermore, a smaller 18-membered macrodiolide 17 could be formed under the 
optimized conditions in 77 % yield (Table 4.4). In addition, macrodiolides based upon both 
meta- and paracyclophanes could be prepared (macrocycles 18 and 19 in 72 % and 74 % yield 
respectively).  
Table 4.3. Optimization of a catalytic synthesis of head-to-tail macrodiolides from the 
corresponding seco acids 
 
Entry Catalyst Loading  
(mol %) 
Concentration ([mM]) Yield 16 (%)a 
1 10 10 54 
2 10 5 31 
3 5 5 51 
4 2.5 5 37 
5 2.5 5 74b 
a Yields following chromatography. b 48 h reaction time. 
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Table 4.4. Substrate Scope of the Hf(OTf)4-Catalyzed Head-to-Tail Macrodiolide Synthesis.
 
 
entry product yield  (%)a entry product yield (%)a 
 
a Isolated yields following flash chromatography. 
4.4. Conclusions 
A protocol for an efficient catalytic synthesis of macrodiolides has been developed. The 
Lewis acid, Hf(OTf)4, was identified as the most efficient catalyst and its utility was 
demonstrated in a rare example of the synthesis of macrodiolides derived from equimolar 
mixtures of diacids and diols.  In addition, through optimization of the catalyst loading and 
reaction concentration, optimization of a protocol for the synthesis of a head-to-tail 
macrodiolide was demonstrated from the corresponding seco acid. The macrocyclization 
processes developed herein are catalytic, producing water as the sole by-product.  In addition, 
the reaction conditions exploit a commercially available catalyst and are “one-pot” reactions 
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without the need for slow addition or azeotropic techniques. Given the prevalence of 
macrodiolides in biologically active natural products, in macrocyclic musks, their utility for 
macrocyclic library generation, and the absence of toxic stoichiometric by-products, the Hf(IV)-
catalyzed macro-cyclizations should be highly useful.  
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5. Direct Catalytic Macrolactonization from Secondary 
Alcohols and Carboxylic Acids 
5.1. Introduction 
 Many macrolactones found in Nature possess substitution in the ω-position.1 In the 
corresponding linear precursors, the substitution, normally in the form of a secondary alcohol, 
augments the complexity of the macrolactonization reaction. The secondary alcohol 
functionality of the precursors for macrolactonization possesses increased steric hindrance, 
defined stereochemistry as well as modified electronics. As discussed previously, 
macrolactonization of seco acids having secondary alcohols typically occurs through 
stoichiometric activation of either the alcohol or the carboxylic acid.  The mode of activation is 
often determined through cyclization of an enantioenriched macrocyclic precursor: 1) retention 
of configuration implies attack of the hydroxyl group onto the carbonyl, while 2) inversion of 
configuration or racemization implies attack of the carboxylic acid onto an activated hydroxyl 
group. It should be noted that isotopic labelling of oxygen can also be used to reinforce 
mechanistic proposals.  
It was envisioned that employing the previously developed catalytic method of 
cyclization using Hf(OTf)4 as a Lewis acid would represent an improvement over established 
methods for macrolactonization involving secondary alcohols.  The absence of an activating 
group on either the carboxylic acid or the alcohol would help to diminish the steric effects during 
the cyclization process, and would produce only water as the by-product. An added benefit of 
investigating the cyclization of secondary alcohols would be to help elucidate mechanistic 
details of the Hf-catalyzed esterification. As discussed in the preceding chapters, an ideal 
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catalytic system for macrolactonization would have to tolerate the presence of water in the 
reaction medium.  Consequently, an effort was made to develop new reaction conditions that 
would not require azeotropic heating or the addition of drying agents, such as molecular sieves. 
In addition, for practicality, slow addition was avoided. In the following chapter, a variety of 
catalyst systems were evaluated to develop the first direct catalytic macrolactonization from 
carboxylic acids and secondary alcohols. 
5.2. Preliminary Results with Hf(OTf)4 as Catalyst 
Preliminary studies on the possibility of performing macrolactonization using seco acids 
containing secondary alcohols began with both inter- and intramolecular studies (Scheme 5.1 
and 5.3). First the Hf(OTf)4-catalyzed method developed in Chapters 3 and 4 was applied to the 
esterification of valeric acid 5.1 and 3-pentanol 5.2. Unfortunately, no desired ester 5.3 was 
produced. Instead, 5.1 was recovered in quantitative amount as opposed to 5.2, which was not 
recovered, but converted to non-isolable side-products.  
 
Scheme 5.1. Attempted catalytic esterification of secondary alcohols in an intermolecular 
process. 
In parallel, an intramolecular macrocyclic precursor was synthesized in four steps from 
the commercially available 15-hydroxypentadecanoic acid 5.4 (Scheme 5.2). The seco acid 5.4 
was first esterified using methanol and the alcohol functionality was oxidized to the 
corresponding aldehyde 5.5 using PCC in a combined yield of 85 %. Addition of 
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ethylmagnesium bromide afforded the secondary alcohol 5.6 in 40 % yield. The reaction was 
closely monitored by TLC to avoid competitive addition on the ester moiety and the starting 
material 5.5 could often be isolated (≈10-30 %) and resubmitted to the reaction conditions. 
Finally, saponification of 5.6 produced the desired macrocyclic precursor 5.7 in 86 % yield.  
 
Scheme 5.2. Synthesis of seco acid 5.7, possessing a secondary alcohol. 
When seco acid 5.7 was treated to the Hf(OTf)4-catalyzed macrolactonization 
conditions, only undesired elimination products 5.9 were observed (the internal alkenes were 
identified by 1H NMR analysis (Scheme 5.3)). When the cyclization of seco acid 5.7 was 
repeated with the addition of Proton Sponge® to quench traces of HOTf, elimination was again 
observed. It is not clear if the formation of elimination products suggests the ability of Hf(OTf)4 
to activate the alcohol group during macrolactonization, or whether alcohol activation became 
the dominant pathway due to slow macrocyclization. As a result, a broader survey of possible 
catalysts for macrolactonization of seco acids containing secondary alcohols was undertaken. 
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Scheme 5.3. Attempted catalytic macrolactonization of a secondary alcohol seco acid. 
a
 Same results were obtained with the addition of Proton Sponge® (50 mol %). 
5.3. Evaluation of Different Catalyst Systems for 
Macrolactonization of Seco Acids Possessing Secondary 
Alcohols 
 The evaluation of a catalytic activation system for macrolactonization of seco acids 
bearing secondary alcohols began with a survey of different transition metal-based and 
lanthanide-based Lewis acids that exhibited activity in macrocyclization of precursors bearing 
primary alcohols. Using a selection of catalysts surveyed in previous studies, esterifications 
were first examined on an intermolecular model (5.1+5.2→5.3, Table 5.1). First, another 
hafnium-based catalyst, HfCl4(THF)2, a complex known to promote esterification under strictly 
anhydrous and azeotropic conditions,2 produced 24 % of the desired ester 5.3 when a catalyst 
loading of 5 mol % was used without any precaution taken to remove water from the reaction 
medium (entry 1). Increasing the catalyst loading to 20 mol % produced only a modest 
improvement in yield (40 % of 5.3, entry 2). Another Hf-based Lewis acid showed no 
conversion toward esterification (entry 3). While Sc(OTf)3 (entry 5) did not provide appreciable 
yields of ester product, the lanthanide-based catalyst Dy(OTf)3 (entry 4) afforded a 60 % yield 
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of the desired ester 5.3. Softer Lewis acid Cu(OTf)2 also promoted esterification to afford 5.3 
in 55 % yield (entry 6), but disappointingly, boosting the catalyst loading did not further improve 
the yield (entry 7). As Cu(OTf)2 is known to produce HOTf in the reaction medium,
3 the addition 
of either Hünig’s base or Proton Sponge® was investigated but did not improve the yield. The 
use of Cu(OAc)2, in which the ligand has a weaker conjugate acid, did not produce any 
esterification product (entry 8).  
Table 5.1. Brief catalyst survey for the intermolecular esterification. 
 
Entry Catalyst Catalyst Loading 
(mol %) 
Yield (%) 
1 HfCl4(THF)2 5 24 
2 HfCl4(THF)2 20 40 
3 Hf(OnBu)4 5 < 5 
4 Dy(OTf)3 5 60 
5 Sc(OTf)3 5 0 
6 Cu(OTf)2 5 55 
7 Cu(OTf)2
a 10 32 
8 Cu(OAc)2 5 < 5 
a Addition of Hünig’s base (50 mol %) or Proton Sponge® (50 mol %) did not affect the yield. 
In addition, the cyclization of the macrocyclic precursor 5.7 was also surveyed with 
various transition metal-based and lanthanide-based Lewis acids (Table 5.2). The investigations 
began with Cu(OTf)2, which was identified during the studies of the intermolecular version of 
the reaction. Once again, Cu(OTf)2 was able to promote the reaction, albeit in lower yield than 
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what was observed in the intermolecular case (34 % of macrocycle 5.8, entry 1). To discern if 
water was having an effect on the catalysis, the reaction was repeated with the addition of 200 
equivalents of water (entry 2). Unfortunately, the addition of water significantly altered the 
reaction profile, as no macrolactonization product was observed and elimination products were 
isolated. Increasing the catalyst loading had a detrimental effect, as no desired macrocycle could 
be isolated when 10 mol % of Cu(OTf)2 was added (entry 3). As the lanthanide catalyst 
Dy(OTf)3 was found to be a promising candidate from the intermolecular studies, it was 
evaluated next (entry 4). In contrast to the intermolecular esterifications, Dy(OTf)3 did not 
promote any macrocyclization.  In addition, none of the other lanthanide-based or transition 
metal-based Lewis acids tested afforded significant yields of the desired macrolactone 5.8 (entry 
5 to 12). 
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Table 5.2. Catalyst survey for the intramolecular esterification. 
 
Entry Catalyst 
Catalyst Loading 
(mol %) 
Yield (%) 
1 Cu(OTf)2 5 34
a 
2 Cu(OTf)2
b 5 < 5a 
3 Cu(OTf)2 10 < 5
a 
4 Dy(OTf)3 10 < 5
a 
5 Sm(OTf)3 5 15
a 
6 Sm(OTf)3 10 < 5
a 
7 La(OTf)3 5 < 5
a 
8 Yb(OTf)3 5 < 5
a 
9 Sc(OTf)3 5 < 5 
10 HfCl4(THF)2 5 < 5 
11 ZrCl4(THF)2 5 < 5 
12 AgOTf 5 < 5 
13 
 
5 < 5 
14 
 
5 < 5 
15 
 
5 < 5 
16 
 
5 < 5 
a A mixture of elimination products was observed. b 200 equiv. of H2O were added.  
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Following the disappointing results with metal-based Lewis acids, an alternative option 
was envisaged using boronic acids. Boronic acid catalysis (BAC) has been recently developed 
to promote activation of alcohols and carboxylic acids in a covalent fashion.4 Numerous 
reactions5 can be promoted by BAC, and often in a milder environment than other previously 
established methods.5p,5q As an example, 3,4,5-trifluorophenylboronic acid (1 mol %) can 
promote the condensation between benzoic acid and benzylamine in 80 % yield in 22 hours 
(Scheme 5.4).6 
 
Scheme 5.4. BAC direct amidation of benzoic acid. 
It then seemed reasonable to think that BAC could efficiently produce macrolactones 
directly from carboxylic acids and secondary alcohols. Four catalysts were then tested (entries 
13 to 16, Figure 5.1) in the cyclization of the intramolecular macrocyclic precursor 5.7. 
However, the precursor was recovered in quantitative yield in all cases, and the BAC method 
was not pursued any further.  
 Brønsted acid catalysis is also a possible alternative in the synthesis of esters from 
secondary alcohols. Dodecylbenzenesulfonic acid (DBSA) can play a dual role of catalyst and 
surfactant (Scheme 5.5) to catalyze esterification between fatty acids and fatty alcohols in 
water.7 The fatty substrates are solubilized in the hydrophobic interior of the DBSA droplets, 
and Brønsted-acid activation, by the sulfonic acid moiety of DBSA, promotes the dehydrative 
esterification. The water formed during condensation is preferentially ejected out of the 
hydrophobic droplet, preventing reversible hydrolysis. As such, the micellar catalysis controls 
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the equilibrium, favoring the formation of the ester even when an equimolar amount of alcohol 
is used. 
 
 
 
Scheme 5.5. Direct esterification of fatty acid using a surfactant-type catalyst.7 
Given the potential to develop a macrolactonization using water as solvent, often a key 
goal among the principles of green chemistry,8 the macrocyclic precursor 5.7 was submitted to 
the reported reaction conditions used for intermolecular coupling. Disappointingly, DBSA did 
not demonstrate any reactivity and the seco acid 5.7 was recovered in quantitative yield (scheme 
5.6).  
 
Scheme 5.6. Attempted DBSA-catalyzed macrolactonization of seco acid 5.7. 
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5.4. Mechanistic Discussion of the Hf-Catalyzed 
Macrolactonization 
The direct catalytic macrolactonization using Hf(OTf)4 from primary seco acids has been 
demonstrated to afford good yields of macrocycles, producing only water as the sole by-product.  
In addition, preliminary explorations demonstrated that the Hf(OTf)4 catalyst was one of the 
few Lewis acids surveyed which retained its activity to promote macrolactonization when water 
was directly added to the reaction mixture.  In addition, when the product macrolactone was 
resubmitted to the reaction conditions with an excess of added water, very little ring-opening 
was observed (Scheme 5.7). However, the methodology developed was not effective for the 
macrocyclization of secondary seco acids. The following section presents several mechanistic 
scenarios although no definitive mechanism has to date been elucidated. 
 
Scheme 5.7. Macrolactonization via Hf(OTf)4 catalysis. 
 
Considering that Hf(OTf)4 has been synthesized for the first time only in 1995,
9 there is 
still little information available about its properties as a Lewis acid catalyst. We know that it is 
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a rather large molecule with the four OTf groups, but with a strong acidity due to the additive 
electron withdrawing effect of the four groups. It is interesting to note that titanium can 
accommodate up to only three OTf groups, as opposed to Zr(IV) and Hf(IV) which can 
accommodate the four groups, both having a similar atomic radius (between 0.72 and 0.75 Å).10 
It would have been useful to compare the reactivity of Hf(OTf)4 with Zr(OTf)4, but the latter 
was not commercially available and there was no information regarding its stability to air. On 
the other hand, Hf(OTf)4 is known to be air stable and also stable at 300 °C
10 and would not 
degrade during the course of the macrolactonization reaction, in refluxing toluene.  
5.4.1. Thermodynamic Parameters in Macrolactonization 
The most common mechanistic possibility would involve an addition/elimination type 
mechanism similar to what is accepted for typical Brønsted acid-catalyzed (Fischer) 
esterification. Such esterifications are known to be reversible processes with similar activation 
energies between key intermediates (Figure 5.1).11 The activation energy necessary to reach TS-
1 from the protonated intermediate Int-1 is very similar to the activation energy required to form 
TS-2 from Int-3, leading to the formation of a thermodynamic equilibrium as the principle of 
microscopic reversibility states that for an equilibrium reaction, each mechanistic step must be 
at equilibrium, meaning that the catalyst promotes both the esterification and the hydrolysis 
through the same mechanistic pathway. In Fischer-type esterification processes, the forward 
reaction can be driven by either using an excess of one of the reactants or by removing the by-
product (water) from the reaction mixture according to the equilibrium constant equations. 
 (1) 𝐾𝑒𝑞 =
[𝑒𝑠𝑡𝑒𝑟][𝑤𝑎𝑡𝑒𝑟]
[𝑎𝑙𝑐𝑜ℎ𝑜𝑙][𝑎𝑐𝑖𝑑]
 
(2) 𝛥𝐺° =  𝛥𝐻° − 𝑇ΔS° 
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Figure 5.1. Energy diagram and thermodynamic equations related to a Brønsted-acid catalyzed 
esterification reaction 
 
  When considering the thermodynamic parameters of a general macrolactonization, one 
is to expect a similar equilibrium. In considering the entropic parameter (ΔS), there are two 
factors to take into account, one which favors the cyclization and the other favoring the 
hydrolysis. The macrolactonization of seco acids is a unimolecular process, activated by a 
catalyst, which produces two molecules: a macrolactone and water. The increased disorder 
brought by the generation of two molecules in the system is thus favorable to cyclization. 
However, the macrolactone formed is often more rigid than the seco-acid and would thus favor 
the hydrolysis process.12 The enthalpic parameter (ΔH) would also be similar to the 
esterification reaction; the same types of bonds are cleaved and formed in the reactant and in 
the products and the most stable conformer of 5.16 could have a similar energy than the one of 
5.4. Indeed, in large non-substituted macrocycle, the ester moiety is capable of adopting the 
more stable Z-geometry (as opposed to, for example, the ester moiety in tetrahydro-2H-pyran-
2-one which is forced to adopt an E-geometry). As such, the thermodynamic factors lead to an 
equilibrium constant which would not favor either the formation of the macrocycle or the 
hydrolysis. 
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5.4.2. Kinetic Parameters in Macrolactonization 
  We also have to consider the kinetic factors to understand why the reaction proceeds in 
such good yield. As the reaction is conducted in a highly diluted medium, bimolecular reactions, 
such as both oligomerization and hydrolysis, are slowed down as the concentration of the 
reactants are directly affects the rate of the reaction (Scheme 5.8). Although both the hydrolysis 
and the macrocyclization undergo via reverse mechanisms (microreversibility), they have 
different molecularity and order of reaction. It is then possible that the reaction is kinetically 
controlled rather than thermodynamically controlled. A simple control reaction to verify the 
hypothesis would be to run the reaction for a longer time to reach thermodynamic control and 
to compare the conversion and the yields. However, good yields were also obtained in 
intermolecular esterifications, in which the rate of both the forward and reverse reaction are 
similarly affected by the concentration (Scheme 5.8, (3) and (4)). Kinetic control then seems to 
not be a plausible explanation. 
(1)  𝑟 = 𝑘[seco acid] 
(2)  𝑟 = 𝑘[seco acid][seco acid] 
(3)  𝑟 = 𝑘[𝑚𝑎𝑐𝑟𝑜𝑙𝑎𝑐𝑡𝑜𝑛𝑒][𝑤𝑎𝑡𝑒𝑟] 
(4)  𝑟 = 𝑘[𝑎𝑐𝑖𝑑][𝑎𝑙𝑐𝑜ℎ𝑜𝑙] 
(5)  𝑟 = 𝑘[𝑒𝑠𝑡𝑒𝑟][𝑤𝑎𝑡𝑒𝑟] 
Scheme 5.8. Rate equations of macrolactonization (1), dimerization (2), macrolactone 
hydrolysis (3), esterification (4) and ester hydrolysis (5) reactions. 
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Moreover, the equilibrium constant and the rate of the hydrolysis reaction can be 
influenced through removal of water from the reaction mixture, thereby driving the Hf(OTf)4 
macrolactonization reaction to completion. Although no precaution was taken to remove water 
from the reaction mixture of the Hf(OTf)4-catalyzed macrolactonization of seco acids, one 
cannot be certain how much water remains in the mixture during the course of the reaction. As 
the reaction is conducted in toluene (which forms a heterogeneous pressure maximum azeotrope 
with water)13 using a water condenser, one can assume that just enough water produced during 
the course of the reaction is being collected in the head-space of the round-bottom flask or glass 
joints, to allow the reaction to proceed in good yield. It should be noted that control reactions 
were performed in which excess water was added and the reaction still proceeded in good yields. 
Some control experiments were performed to assess the importance of water removal and 
solvent effects in the macrolactonization (Table 5.3). When more polar ethereal solvents such 
as 1,4-dioxane (b.p. 101 °C, entry 2) or 1,2-dimethoxyethane (DME, b.p. 85 °C, entry 3) were 
used, only the starting seco acid 5.4 was recovered after 24 hours. However, when 
chlorobenzene was used (b.p. 132 °C, entry 4), 88 % yield of 5.16 was isolated. It is intriguing 
to see that only both arene-containing solvents provided reactivity. It is a possibility that PhMe 
and PhCl destabilize the macrocyclic precursor by interactions with the carboxylic acid or the 
alcohol. They could also force it to adopt a conformation that is prone to cyclization. Such 
destabilization of the precursor changes the thermodynamic properties of the reaction and could 
thus favor the formation of the macrolactone. As the solvent scan is relatively limited, it is 
difficult to make any firm conclusions.  The inability of DME or 1,4-dioxane to promote 
reactivity could be due to competitive coordination of the solvent for available Lewis acidic 
sites on the hafnium catalyst. Another possible conclusion would be that DME and 1,4-dioxane 
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retain water to a greater degree than PhMe or PhCl.  An additional control experiment was 
performed where the water condenser was exchanged for a sealed tube vessel. The sealed tube 
was placed in an oil bath so that only the reaction mixture was submerged and the head-space 
remained above the oil bath. While Hf(OTf)4 was still able to promote a good yield of the desired 
macrolactone 5.16, the yield dropped from 88 % to 69 % (entry 5). Although the water formed 
would still be able to be separated from the reaction mixture and therefore from the equilibrium, 
the increased internal pressure of the sealed tube14 could partly force the molecules of water to 
condense back into the mixture which could explain the slight drop in yield. Such results could 
support that the removal of water from the reaction mixture is important to obtain a good yield.  
Table 5.3. The Hf(OTf)4-catalyzed macrolactonization in different solvents 
 
Entry Solvent Setup Yield (%) 
1 Toluene (PhMe) Round-bottom flask with water condenser 83 
2 1,4-dioxane Round-bottom flask with water condenser 0 
3 1,2-dimethoxyethane 
(DME) 
Round-bottom flask with water condenser 0 
4 Chlorobenzene 
(PhCl) 
Round-bottom flask with water condenser 88 
5 Toluene (PhMe) Sealed tube vessel 69 
 
It is also possible, that as water is mostly insoluble in toluene, a vigorous stirring is 
necessary to equally distribute water in the reaction mixture. If the stirring was not sufficient, it 
could also explain why the hydrolysis reaction was not observed. Further experiments with an 
 78 
improved mixing, with other solvents and vessel types would be necessary to draw more 
concrete conclusions.   
5.4.3. Alternative Mechanistic Scenarios 
It should be noted that other mechanistic scenarios are possible for the formation of the 
macrolactones as Hf(OTf)4 is capable of activating different functionalities.
10 The selectivity of 
primary versus secondary alcohols could be explained by the different possible scenarios.  
One of the possibilities is Lewis acid activation of the C-O unit of the carboxylic acid 
(Scheme 5.9). It is important to consider that Hf(OTf)4 has been used to promote Friedel-Crafts 
acylation reactions15 and to promote Fries rearrangement reactions of acylated phenols and 
naphthols,16 where acylium ions have been proposed as intermediates (note that there has been 
no direct observation of discrete acylium ion intermediates in the published examples). Such a 
change in the mechanistic pathway would modify the transition state of the rate-determining 
step and therefore would also modify the rate of both the forward and the reverse reactions, 
although could not explain the selectivity of primary seco acids over secondary seco acids. 
Furthermore, for the acylation reaction between 5.19 and 5.20, Hf(OTf)4 was not the optimal 
catalyst found. Indeed, Er(NTf2)3 was found to be the more productive catalyst
15b and it would 
be informative to test Er(NTf2)3 for the macrolactonization reaction or other Ln(NTf2)3. To the 
best of our knowledge, Hf(NTf2)4 has not been synthesized yet, but testing other strong electron-
withdrawing ligands could also prove to be enlightening.  
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Scheme 5.9. a) Acylation reactions promoted by Hf(OTf)4. b) Possible formation of an acylium 
ion by a hafnium catalyst. 
Another plausible mode of activation could involve bidentate coordination of the 
hafnium to both the carbonyl oxygen and carboxylate oxygen (Scheme 5.10). It has been 
reported that hafnium is able to coordinate up to 8 ligands within its coordination ion spheres.17 
In discussing the coordination sphere of hafnium, it is worth noting that in all of the mechanistic 
scenarios presented, the hydroxyl group does not necessarily need to attack the carbonyl group 
via an outer sphere mechanism, as it could rather come from an inner sphere delivery (Scheme 
5.10, right).  
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Scheme 5.10. Possible bidentate modes of activation on the carboxylic acid by the hafnium 
catalyst. 
At first glance, the steric bulk of the nucleophile could be invoked as a reason for lack of 
macrocyclization with secondary alcohols.  The influence of steric hindrance would be even 
more considerable if one were to consider an inner sphere delivery of the nucleophile.  However, 
it should be noted that increased steric hindrance in the -position of the carboxylic acid was 
not observed to be deleterious to the macrocyclization, as macrocycles 5.24 and 5.25 were 
synthesized in similar yields to less sterically encumbered macrocycles (Figure 5.2).  
 
Figure 5.2. Macrolactones synthesized via Hf(OTf)4 catalysis in which α-substituents are 
present. 
In considering whether the hydroxyl group of the seco acid could bind to the hafnium 
catalyst, we can also imagine an alternative mechanistic scenario: substitution reaction via 
hydroxyl group activation18 (Scheme 5.11) rather than carbonyl or carboxyl activation.  
 
Scheme 5.11. Examples of Hf(OTf)4-catalyzed substitution reaction.  
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When the macrocyclization of seco acids having a secondary alcohol was investigated, 
the formation of alkenyl side-products was observed. Elimination processes (E1 and E2) are 
known to become competitive reactive pathways when leaving groups are bonded to secondary 
carbons. The elimination processes are much slower on primary carbons and therefore SN2 
reactions become favored mechanistic pathways.19 The observation of alkene by-products in 
some macrocyclization attempts with a secondary alcohol-bearing substrate could support a 
mechanism which invokes alcohol activation.  To further explore the alcohol-activation 
hypothesis, typically esterifications are performed on chiral secondary alcohol substrates and 
the products are examined to determine whether the chiral center underwent retention or 
inversion of configuration.  Given the absence of productive reactivity in the Hf-catalyzed 
system with secondary alcohols, an alternative would be to conduct the reaction with a chiral 
deuterated primary alcohol20 as a substrate or to do oxygen-labeling studies in the future. It 
should also be noted that the formation of elimination products may just be due to a background 
reaction becoming competitive when macrocyclization is slow. Other future work could also 
include pKa relationship studies to see the effect on both the alcohol and the carboxylic acid 
functionalities. 
5.5. Summary 
In summary, several mechanistic pathways are available for the Hf(OTf)4-catalyzed 
macrolactonization. While the available data does not point with 100 % certainty to one 
mechanism, it may in fact be that several mechanistic pathways are available and the mechanism 
could change based on the nature of the substrate. Further studies would be necessary to draw 
conclusions as to why the hydrolysis reaction is not observed and to why secondary alcohols do 
not undergo cyclization.  
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6. Alternative Strategies for the Synthesis of 
Macrolactones: Application of the Phase Separation 
Strategy for the Synthesis of Ivorenolide A 
The preceeding chapters of the present thesis outlined new catalytic methods for the 
synthesis of macrolactones via its defining ester functionality. However, analysis of the given 
structure of a macrolactone does not always point to cyclization via its corresponding seco 
acid as the most efficient retrosynthetic disconnection. Indeed, carbon-carbon bond 
formation, particularly via catalysis, can often present new avenues for preparing desired 
macrocycles. Even when catalysis allows for new synthetic routes, both prefunctionalization 
of substrates as well as the ultimate macrocyclization event each present their own 
challenges, the latter of which often limits practicality of eventual large-scale synthesis. As 
a solution to the challenges, our group has developed a phase separation strategy for 
improving macrocyclization reactions that exploits catalysis and unique solvent effects which 
allow cyclization to be conducted at relatively high concentrations. As a demonstration of 
the applicability of the phase separation strategy toward the synthesis of complex 
macrolactones, the formal total synthesis of ivorenolide A (Figure 6.1) was pursued.  
 
Figure 6.1. The macrolactone ivorenolide A. 
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Consequently, the present chapter first provides a brief background on our group's 
previous work involving the phase separation strategy for macrocyclization using the Glaser-
Hay reaction, a catalytic, oxidative coupling of terminal alkynes. Subsequently, background into 
the ivorenolides and previous syntheses will be presented. The following chapter (Chapter 7) 
will describe our results into the formal total synthesis of ivorenolide A via the phase separation 
strategy.    
6.1. The Glaser-Hay Coupling Reaction 
The Glaser-Hay reaction was first introduced in 1962 when Hay discovered that 
TMEDA could serve as a ligand for Cu(I) salts to form soluble, catalytically active species for 
the dimerization of terminal alkynes (Scheme 6.1).1 Since then, the reaction has been widely 
utilized to form symmetrical 1,3-diynes.2 However, heterocoupling is challenging under the 
standard reactions conditions due to differences in the relative rates of coupling for different 
alkynes (aryl alkynes are much more reactive than alkyl alkynes) and because of unfavorable 
statistical probabilities.1b Nonetheless, it is possible to use the standard reaction conditions to 
form unsymmetrical diynes if one of the partners is immobilized onto a solid support.3 However, 
the formation of unsymmetrical 1,3-diynes is most commonly achieved under Cadiot-
Chodkiewicz reaction conditions which require pre-functionalization (halogenation) of one of 
the reaction partners. Other types of catalysis have also been developed for heterocoupling 
where one of the partners is prefunctionalized.4  
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Scheme 6.1. The first Glaser-Hay reaction reported in 1962. 
In 2009, Lei and co-workers developed a co-catalyzed terminal alkyne heterocoupling 
reaction.5 They found that NiCl2∙6H2O and CuI, under an aerobic atmosphere, could efficiently 
catalyze the formation of unsymmetrical 1,3-diynes when using TMEDA as a ligand and Et3N 
as a base. Although five equivalents of the more reactive aryl alkyne were necessary to compete 
with the unwanted homocoupling reactions, good yields were obtained after 20 hours at room 
temperature. The mechanism still remains under investigation to fully understand the co-
catalysis.5 
 
Scheme 6.2. Lei’s synthesis of unsymmetrical diynes. 
The Glaser-Hay reaction is somewhat underutilized in the synthesis of conjugated diyne-
containing small molecules as organic chemists have privileged the Cadiot-Chodkiewicz 
approach, especially for heterocoupling. The main contribution of the Glaser-Hay reaction has 
been found in the synthesis of molecules in materials and supramolecular chemistry. 
Macrocyclic polyynes for instance, such as the cyclic hexamer 6.8, have been synthesized by 
oxidative coupling of terminal alkynes.6 Typical macrocyclic reaction conditions were used; 
superstoichiometric quantities of two Cu salts, slow addition, high dilution and long reaction 
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times provided macrocycle 6.8 in 39 % yield. Such reaction conditions have certainly been a 
drawback for chemists and both more efficient and user-friendly protocols are still needed.  
 
Scheme 6.3. Synthesis of a macrocyclic polyyne under Glaser-Hay conditions. 
6.2. The Phase Separation Strategy for Macrocyclization 
employing the Glaser-Hay Coupling Reaction 
In 2011, our group reported a phase separation strategy that allows for macrocyclic 
Glaser-Hay reactions to be performed at relatively high concentrations.7 The principles behind 
the strategy involve the use of poly(ethylene) glycol (PEG) as a co-solvent and its aggregation 
properties, substrate solubility preferences therein and ability for catalyst inhibition. When 
macrocyclizations of diynes are performed in solvent mixtures of PEG and a hydrophilic solvent 
like MeOH, surface tension measurements show that PEG has a tendency to form aggregates.8 
A survey of solvent effects in the phase separation strategy found that the chain length, end 
groups and branching characteristics of the PEG co-solvent all influenced the aggregation 
properties.9 Furthermore, UV-vis spectroscopy points to PEG preferentially solubilizing 
lipophilic organic compounds, like the diyne precursors for macrocyclization via a Glaser-Hay 
coupling, in preference to the hydrophilic solvent MeOH.10 If a catalytic system is introduced 
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and is exhibiting higher reactivity in the MeOH phase than the PEG phase, then the cyclization 
theoretically occurs preferentially in MeOH, where the catalytic system is active but the diyne 
substrate is only present in a low concentration (Scheme 6.4). In other words, the phase 
separation strategy mimics high dilution conditions without the need for large quantities of 
solvents.  
 
Scheme 6.4. Representation of the phase separation reaction conditions. 
As proof-of-principle for the phase separation strategy, the Glaser-Hay coupling of diyne 
6.9 could be promoted by a Cu/Ni co-catalyst system in a 2:1 mixture of PEG400/MeOH.
10 The 
macrocyclization was performed at a concentration of 30 mM, affording the desired 21-
membered macrocycle 6.10 without producing significant amounts of oligomers (Scheme 6.5 
top). Macrocycle 6.10 could be attained in 93 % yield at concentrations 150 to 500 times the 
concentrations normally reported in the literature (yield of 6.10 was 13 % at 0.2 mM), and some 
betterment in the reaction time could be found when using microwave heating.11 To further 
ameliorate the reaction, the phase separation strategy was transposed for macrocyclization in a 
continuous flow setup.12 As the macrocyclization reaction times under phase separation were 
long under batch conditions (48 h), the improved mixing and heat transfer associated with 
continuous flow could help reduced reaction time.13 Continuous flow is also regarded as an 
industrially viable method to scale up reactions in a safe fashion.14 Impressively, the 
transposition of the batch reaction conditions to continuous flow conditions for the cyclization 
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of 6.9 allowed 6.10 to be formed in 97 % yield while drastically diminishing the reaction time 
(48 h vs. 1.5 h) (Scheme 6.5 bottom). When the reaction (6.9→6.10) was carried on a 1 mmol 
scale, the excellent yield was maintained (93 %). Importantly, the PEG400/MeOH ratio was 
slightly lowered (1:1) due to the viscosity of the PEG in the flow reactor; however, similar yields 
could be achieved, often with reduced catalyst loadings while using an alternative polymeric co-
solvent derived from poly(propylene) glycol (PPG425), which also had a reduced viscosity.
12  
 
Scheme 6.5. Phase separation strategy for macrocyclic Glaser-Hay coupling. Top: Batch 
conditions. Bottom: Continuous flow conditions. a 93 % yield was obtained on a 1 mmol scale. 
While our research group has begun to explore the utility of the phase separation strategy 
in other catalytic transformations such as copper-catalyzed azide-alkyne cycloadditions15 and 
ring-closing olefin metathesis,16 several important avenues remain to be explored within the 
Glaser-Hay variant. The substrate scope that was explored was limited, and did not address the 
influence of racemizable chiral centers, steric hindrance about the alkyne reaction centers or 
tolerance to common protecting groups. In addition, although macrocyclization could be 
adapted for continuous flow applications, no investigation of the feasibility of scale-up of 
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complex macrocycles at the gram scale had been demonstrated. To respond to these questions, 
the formal total synthesis of ivorenolide A 6.1, a rare macrolide bearing a 1,3-diyne unit 
embedded within its macrocyclic framework, was targeted. 
6.3. The Ivorenolide Macrolactones 
Many natural macrolactones possess interesting biological activities such as antibiotic, 
cytotoxic and antiangiogenesis properties, and have an important range of structural diversity.17 
Ivorenolides A 6.1 and B 6.11 are natural macrocycles that have been recently isolated from the 
stem bark of K. ivorensis18 and have shown impressive immunosuppressive properties (Figure 
6.2).19 Ivorenolides A and B possess a conjugated 1,3-diyne moiety, rarely seen in macrocyclic 
natural products, embedded in an 18- and a 17-membered ring macrolactone, respectively. 
Motivated by the need for long-term tolerated immunosuppressive agents with less side 
effects,19 total syntheses of ivorenolides soon followed their reported isolation. 
 
Figure 6.2. Naturally occurring members of the ivorenolide family. 
6.3.1. Total Synthesis of the Unnatural Enantiomer of Ivorenolide A 
The first total synthesis of a member of the ivorenolide family was reported in 2012 by 
Yue and co-workers.18a The key steps of the synthesis of ent-6.1 are an intermolecular Cadiot-
Chodkiewicz reaction to form the conjugated diyne moiety and a Yamaguchi 
macrolactonization reaction as the ring-closing step. The synthesis commenced with the 
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derivatization of (R)-methyl lactate 6.12 into bis-protected diol 6.13 which would serve as one 
of the two Cadiot-Chodkiewicz reaction partners in five steps (Scheme 6.6).  
 
Scheme 6.6. Synthesis of the first Cadiot-Chodkiewicz coupling reaction partner. 
In parallel, the second Cadiot-Chodkiewicz reaction partner 6.17 was synthesized from 
8-bromooctanoic acid (6.14) and propargyl alcohol (6.15) in eight discrete steps in which the Z-
alkene 6.16 was selectively obtained by a Lindlar hydrogenation of the corresponding alkyne 
(Scheme 6.7). Furthermore, differentiation of the two alkynes by bromination of one of the 
cross-coupling partner is necessary in the Cadiot-Chodkiewicz reaction and the required halogen 
was then installed on the long-chained coupling partner 6.17. 
 
Scheme 6.7. Synthesis of the second Cadiot-Chodkiewicz coupling reaction partner. 
Under the Cadiot-Chodkiewicz reaction conditions, diyne 6.18 was prepared from 
alkyne 6.13 and bromoalkyne 6.17 in 70 % yield (Scheme 6.8). Hydroxylamine hydrochloride 
was added in an unspecified amount to maintain the oxidation state of the copper (I) catalyst.20 
A protection and deprotection sequence followed to achieve macrocyclic precursor 6.19. 
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Scheme 6.8. Synthesis of the macrocyclic precursor 6.19. 
The macrocyclization reaction proceeded under the traditional Yamaguchi protocol in 
which slow addition of the in situ formed mixed anhydride is slowly added to a highly diluted 
solution of DMAP in toluene (Scheme 6.9). Although the yield of 6.20 is excellent, the protocol 
was only performed on a very small scale (20 mg, 0.050 mmol of substrate). The total synthesis 
was achieved with two subsequent steps; a double MOM-deprotection allowed the subsequent 
directed epoxidation of the Z-alkene. 
 
 
 
 
 
 
 
Scheme 6.9. Completion of the total synthesis of the unnatural enantiomer of ivorenolide A. 
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6.3.2. Total Synthesis of Ivorenolide A 
 In 2015, Yadav and co-workers provided the first total synthesis of the natural 
enantiomer of ivorenolide A 6.1.3 Their synthetic route involved a base-induced elimination 
reaction for the synthesis of two terminal alkynes, a Sonogashira-type cross-coupling of the two 
alkynes and a MNBA-promoted macrolactonization as key steps. (+)-Diethyl tartrate 6.21 was 
derivatized to the alkyl chloride 6.22 in six steps and the alkyne 6.23 was obtained under strong 
basic elimination conditions in 87 % yield. The completion of the synthesis of the first alkynyl 
reaction partner 6.24 was obtained after a MOM-protection of the secondary alcohol.  
 
Scheme 6.10. Synthesis of the alkynyl reaction partner 6.15. 
 
 The second bromoalkyne fragment was obtained from (S)-methyl lactate 6.25 in nine 
steps, once again by going through the base-induced elimination reaction to form the alkyne 
moiety on 6.27 (Scheme 6.11). Subsequent bromination of the latter formed the coupling 
reaction partner 6.28.  
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Scheme 6.11. Synthesis of the second Sonogashira-type reaction partner. 
A Sonogashira-type coupling between alkyne 6.24 and bromoalkyne 6.28 provided the 
conjugated diyne 6.29 in 74 % yield (Scheme 6.12). Deprotection and oxidation steps followed 
to achieve macrocyclic precursor 6.30. The macrocyclization reaction was effected through the 
formation of a mixed anhydride with MNBA. Slow addition of the substrate in a highly dilute 
medium was necessary and similarly to the previously discussed synthetic route to the 
ivorenolides, the macrocyclization was performed on small scale (15 mg, 0.030 mmol of 
substrate) to form 6.31 in 84 % yield. The completion of the total synthesis of 6.1 was achieved 
after MOM-deprotection and epoxidation reactions.  
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Scheme 6.12. Completion of the total synthesis of ivorenolide A. 
6.3.3. Total Synthesis of Ivorenolide B 
 During the course of our own work in 2015, Fürstner published the first total synthesis 
of ivorenolide B 6.2,21 only a year after its isolation and characterization. Contrary to the 
syntheses of the other members of the family, Fürstner proposed a macrocyclization step using 
catalysis via an alkyne metathesis reaction, thus taking advantage of the presence of the 
conjugated 1,3-diyne moiety. The synthesis began with the construction of diyne 6.36. Starting 
from ethyl (Z)-iodoacrylate 6.32, silylated diyne 6.33 was formed in three steps (Scheme 6.13). 
In parallel, 8-bromooctanoic acid 6.34 was converted to the organozinc intermediate 6.35, which 
could be subsequently subjected to a Pd-catalyzed coupling to afford 6.36 in 68 % yield. The 
authors commented that the moderate yield was in part due to side-reactions between the 
propargyl/allylic position and the palladium catalyst and to the isomerization of the Z-alkene. 
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Scheme 6.13. Construction of the first bis-alkyne unit fragment.  
 The synthesis of the second diyne unit 6.39 was accomplished in three steps from ketone 
6.38, and the product was coupled promptly after the saponification of ester 6.36, as the 
corresponding carboxylic acid 6.37 was highly unstable (Scheme 6.14). The macrocyclization 
to form the core of ivorenolide B was performed using a ring-closing alkyne metathesis reaction. 
As is common in macrocyclic ring-closing metathesis, the ring closure required high catalyst 
loading of the catalyst (2 portions of 20 mol % each of the Mo-based catalyst were added).  Key 
to the successful ring-closing alkyne metathesis was the use of one terminal diyne partner and 
one internal diyne partner. At the current time, it is not known why the particular structural 
requirements are necessary for successful alkyne metathesis of diynes.  In addition, the 
macrocyclization required an inert atmosphere and molecular sieves, but the desired macrocycle 
6.41 was isolated in 82 % yield. Ivorenolide B (6.11) was formed after subsequent epoxidation 
of the Z-alkene and TBS-deprotection of the secondary alcohol functionality. 
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Scheme 6.14. Completion of the total synthesis of ivorenolide B. 
 Although Fürstner and co-workers developed a catalytic process for the macrocyclic 
ring-closing step of ivorenolide B, the installation of the two 1,3-diyne units on the macrocyclic 
precursor required a number of additional synthetic steps. However, taking advantage of the 
conjugated 1,3-diyne moiety found in ivorenolides for the ring-closing step is an alternative 
strategy to synthesize the macrocycles of the family compared to the traditional 
macrolactonization reactions used by Yue and Yadav.  
 Our group would propose a macrocyclic Glaser-Hay reaction in combination with a 
phase separation strategy in continuous flow for the synthesis of ivorenolide A. Advantages of 
such a route include catalysis via a direct oxidative coupling of terminal alkynes, using a 
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relatively high concentration and possible ease of scale-up exploiting continuous flow 
conditions.  
6.4. Application of the Phase Separation Strategy for the 
Synthesis of Ivorenolide A: Retrosynthetic Analysis & 
Conclusion 
 The goal of the project was to further explore the Glaser-Hay/phase separation strategy 
for the synthesis of complex macrolactones through a formal synthesis of ivorenolide A via the 
cyclization of diyne 6.42 (Scheme 6.15) to give the known macrocyclic intermediate 6.31. As 
such, the study would demonstrate tolerance to racemizable stereogenic centers, steric hindrance 
about the alkyne reaction centers and common protecting groups. In addition, macrocyclization 
under continuous flow would be investigated at the gram scale. Retrosynthetic analysis of the 
diyne precursor 6.42 suggested that the synthesis be carried out by a coupling secondary alcohol 
6.43 with carboxylic acid 6.44. Fragment 6.43 would result from the derivatization of cheap and 
commercially available (S)-methyl lactate 6.25. Fragment 6.44, on the other hand, could arise 
from a Z-selective cross olefin metathesis of alkenes 6.45 and 6.46. The retrosynthetic analysis 
using a Glaser-Hay coupling allows for a macrocyclization based on catalysis where 
prefunctionalization of the alkynes is not required. The phase separation strategy would help 
promote macrocyclization at high concentrations in a manner which would be easily scaled. In 
addition, the synthesis of key intermediates would be simplified via a Z-selective cross olefin 
metathesis reaction. 
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Scheme 6.15. Retrosynthetic analysis of ivorenolide A via a macrocyclic Glaser-Hay coupling. 
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7.1. Abstract 
A formal total synthesis of ivorenolide A has been accomplished employing a Z-selective 
olefin cross metathesis and a macrocyclic Glaser-Hay coupling as key steps. The 
macrocyclization protocol employed a phase separation/continuous flow manifold whose 
advantages include catalysis, fast reaction times, high concentrations, and facile scale-up. 
7.2. Introduction 
Macrolides are a family of macrocyclic natural products having a wide array of 
biological activities.1 From a synthetic perspective, several methods have evolved as the most 
popular candidates for macrocyclization. Macrolactonization2 via stoichiometric activation of 
seco-acids, such as the Yamaguchi protocol,3 is without a doubt the most popular method for 
constructing the ester motif of macrolides. Another common synthetic route to form 
macrocycles involves carbon-carbon bond formation involves transition metal catalysis, usually 
via olefin metathesis or cross-coupling strategies.4 Despite the utility displayed by the above-
mentioned transformations, the macrocyclizations are usually performed at low concentration, 
and rely upon slow addition techniques.  Consequently, scale-up of the target macrocycles 
becomes problematic,5 which is disappointing when promising biological activity is observed. 
The ivorenolides A6 and B7 are a unique class of macrolides which possess 1,3-diyne motifs 
isolated from the stem bark of K. ivorensis (Figure 7.1). Their immunosuppressive activities 
make them attractive targets for medicinal chemistry investigations given the need for new 
immunosuppressants with improved therapeutic profiles. Total syntheses of both the natural and 
unnatural enantiomers of ivorenolide A have appeared in the literature, each exploiting a 
macrolactonization employing stoichiometric activation strategies and high dilution and/or slow 
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addition as the key macrocyclization step (Figure 7.1).6,8 As such, the development of alternative 
methods for macrocyclization that would employ catalysis and high concentrations and facilitate 
scale-up would be highly desirable.9  Our group has put forth an alternative strategy for the 
synthesis of macrocycles via Glaser-Hay coupling using a “phase separation” strategy.10  The 
protocol was shown to exploit aggregation effects caused by mixtures of poly(ethylene) glycol 
(PEG) cosolvents.11 During the development of the “phase separation” technology, it was 
apparent that the substrate scope explored to date was limited, and did not address the influence 
of stereogenic centers, steric hindrance about the alkyne reaction centers, or tolerance to 
common protecting groups. In addition, no investigation of the feasibility of scale-up of complex 
macrocycles at the gram scale had been demonstrated. To respond to the aforementioned 
questions, the formal total synthesis of ivorenolide A by application of the “phase separation” 
strategy under continuous flow techniques is described herein (Figure 7.1).   
 
Figure 7.1. Macrocyclization strategies via continuous flow toward ivorenolide A.  
Ring sizes are in red. 
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Results and Discussion 
The retrosynthetic analysis for the development of a phase separation/continuous flow 
macrocyclization toward the synthesis of ivorenolide A aimed to prepare the 18-membered 
macrolactone 1 intermediate, which was previously prepared by Yadav12 and Yue6 as well as a 
simplified model 1a (Figure 7.2). By envisioning the macrocyclization event arising from 
Glaser-Hay coupling of two terminal alkynes, the linear precursor 2 was selected as a target for 
the formation of macrocycle 1, while the macrocyclization of the model 18-membered 
macrolactone 1a was also imagined arising from Glaser-Hay coupling of linear precursor 2a. 
Each ester (2 and 2a) could be prepared from esterification of the alcohol 3 with a corresponding 
carboxylic acid derivative. 
 
Figure 7.2. Retrosynthetic analysis toward the macrocyclic core of ivorenolide A (2→1) and a 
simplified model (2a→1a). 
Ring sizes are indicated in red. 
The synthesis of alkynyl alcohol 3 from (L)-methyl lactate began with protection of the 
hydroxyl group as its t-butyldimethylsilyl (TBS) ether in nearly quantitative yield (Scheme 7.1).  
Reduction of the ester 5 to the corresponding aldehyde 6 using DIBAL-H was achieved in 77 % 
on gram scales. Addition of the organolithium reagent derived from trimethylsilylacetylene 
afforded solely the desired diastereomer.  Subsequent protection of the hydroxyl group as its 
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MOM ether afforded the fully protected alkyne 7 in 52 % yield over two steps. Removal of both 
silyl protecting groups using an excess of TBAF at room temperature unmasked the terminal 
alkyne and secondary alcohol functionality, providing 3 in 94 % yield. Esterification of alcohol 
3 using DCC/DMAP conditions with known carboxylic acid 8 provided the macrocyclization 
precursor 2a in 75 % yield. 
 
Scheme 7.1. Synthesis of Alcohol 3 and Diyne 2a Analysis Toward the Macrocyclic Core of 
Ivorenolide A (2 → 1) and a Simplified Model (2a → 1a) 
The carboxylic alkynyl synthon 1a required for the synthesis of macrocycle 1 was then 
prepared. The cis-olefin was envisioned arising from a Z-selective cross metathesis process.13 
To test the synthetic route, several cross metathesis reactions were evaluated on the racemic, 
MOM-protected secondary alcohol rac-11 (Scheme 7.2).   
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Scheme 7.2. Optimization of a Z-Selective Cross Metathesis to Prepare Racemic 13. 
Cross metathesis was first evaluated with 1.0 equiv of methyl ester 12 at room 
temperature using the Stewart−Grubbs catalyst 14.14 The desired product rac-13 was obtained 
in 47% yield and isolated as the pure E-isomer. Next, two Ru-based Zselective catalysts were 
evaluated, each having a different NHC in which the N-aryl substituent differed.15 After a brief 
survey of reaction conditions,16 it was found that the DIPP-bearing catalyst 15b at 10 mol %, 60 
°C, and [0.5 M] afforded a 59% yield of the desired olefin rac-13, in excellent Z-selectivity (95% 
Z). Cross metathesis using the mesityl catalyst 15a17 was not as selective (75% Z). With 
optimized conditions for the cross metathesis procedure in hand, the synthesis of the 
enantioenriched carboxylic acid 16 was undertaken (Scheme 7.3). First the enantiomerically 
pure alcohol 10 could be obtained via a previously reported CBS reduction, or via 
diastereomeric 
resolution.18 The alcohol 10 was protected as its MOM ether 11 in 94% yield and subsequently 
subjected to Z-selective cross metathesis. To improve reproducibility at larger scales, an 
applied vacuum was used for removing ethylene.19 Consequently, the yield and selectivity of 
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the reaction remained reproducible at 43% (68% based on recovered starting 
material) and >95% Z with a shorter reaction time (6 h vs 18 h). With enantiopure olefin 13 in 
hand, desilylation was performed using TBAF to provide the corresponding terminal 
alkyne in 92% yield (Scheme 7.3). Saponification of the ester afforded the carboxylic acid 16 
in 99% yield. Esterification of acid 16 with secondary alcohol 3 was promoted by reaction 
with DCC and DMAP to provide the desired compound 2 in 62% yield. 
 
Scheme 7.3. Synthesis of linear precursor 1a for macrocyclization to form the macrocyclic core 
of ivorenolide A. 
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Scheme 7.4. Traditional macrocyclizations under slow addition conditions (a) and 
macrocyclizations under phase separation/microwave heating (b) to form macrocycles 1 and 1a. 
Ring sizes are in red. 
With both key linear precursors in hand, macrocyclization was first performed using the 
simplified model 2a (Scheme 7.4). As such, the bis-alkyne 2a was cyclized under slow addition 
conditions, using superstoichiometric amounts of CuCl (12 equiv) and ligand (TMEDA, 20 
equiv) in refluxing toluene. Slow addition was performed over 36 h, and the refluxing reaction 
mixture (final concentration 0.2 mM) was stirred for another 12 h to promote conversion of all 
the starting material 2a. Macrocycle 1a was isolated following silica gel chromatography in 36% 
yield. When identical reaction conditions were used to cyclize the more complex 
macrocyclization precursor 2, the yield of the desired macrocycle 1 was higher at 55%. Next, 
the macrocyclization precursors were subjected to phase separation conditions at ∼120 times 
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the concentration employing reaction conditions previously developed for cyclization under 
microwave heating.20 For the cyclization of 2a, a 40 % yield of macrocycle 1a was isolated. 
Similar yields (30 %) were also observed using the linear precursor 1. Each bis-alkyne was 
observed to be sensitive to the basic conditions of the phase separation/microwave protocol for 
macrocyclization and it was hoped that the precise control over temperature and reaction time 
using continuous flow would be advantageous.21 
Table 7.1. Macrocyclization Using the Phase Seperation Strategy in Continuous Flow 
 
 PEG solvent Ratio 
(PEG:MeOH) 
Temp. (°C) Yield (%)a 
macrocyclization 2a→1a 
1 PEG400 1:1 120 49 (17) 
2 PEG400 2:1 120 26 (<5) 
3 PEG400 4:1 120 19 (24) 
4 PEG400 8:1 120 14 (18)b 
5 PPG425 2:1 120 38-40c 
macrocyclization 2→1 
6 PEG400 1:1 120 52 (0) 
7 PEG400 2:1 120 37 (<5) 
8 PEG400 4:1 100 27 (30) 
a Yields following chromatography. Recovered starting material in parentheses. b 4 h reaction time. c 
Reactions performed at 80 or 100 °C afforded similar yields with small amounts of unreacted 2a. For 
ease of purification, the reaction was kept at 120 °C. Ring sizes in red. 
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For the model precursor 2a, macrocyclizations under continuous flow conditions22 were 
evaluated with different ratios of PEG solvent to MeOH (Table 7.1). Based upon previous 
work,23 residence times of 1−2 h were selected for study. Consequently, a low flow rate (0.167 
mL/min) combined with a 20 mL reactor volume was necessary (two 10 mL reactor coils were 
connected in series). In addition, since higher ratios of PEG400/MeOH typically provide higher 
selectivity for macrocyclization versus oligomerization, albeit with longer reaction times, the 
optimization of the macrocyclization was conducted with a 2 h residence time. When precursor 
2a was cyclized at 120 °C, with a residence time of 2 h in PEG400/MeOH (1:1), a 30% yield of 
macrocycle 1a was isolated. Efforts to boost yields through increasing the ratio of 
PEG400/MeOH to 4:1 resulted in lower yields, and a ratio of PEG400/MeOH (8:1) required 
longer reaction times (4 h). By switching the solvent from PEG400 to PPG425, a 
poly(propylene)glycol solvent, previously demonstrated to be efficient in “phase separation”-
type macrocyclizations, provided the best yield of macrocycle 1a (38−40% yield). To 
demonstrate the feasibility of using the “phase separation” strategy alongside continuous flow 
for large scale preparation of macrolide type macrocycles, the macrocyclization (2a → 1a) was 
repeated at gram scale and provided identical yields to what was observed at smaller scales 
(50−150 mg). Gram scale cyclization of diyne 2a required 120 mL of the PPG425/MeOH (2:1) 
solvent mixture, while the equivalent slow addition experiment would have required >14 L of 
PhMe. When a similar set of conditions were used for the macrocyclization of precursor 2 
possessing the additional Z-olefin and propargylic stereocenter, the best conditions surveyed 
utilized 120 °C, with a residence time of 2 h in PEG400/MeOH (1:1) for a 52% yield of 
macrocycle 1. The higher yield of macrocycle 1 (52%) versus the model macrocycle 1a under 
similar reaction conditions could be explained by the effects of the additional cis-olefin and 
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stereocenter in the respective precursor 2 versus 2a. The addition of the olefin and hydroxyl 
motifs could promote a conformational bias to help bring the alkyne functionalities closer to one 
another.24 Consequently, the use of the phase separation/continuous flow conditions for the 
preparation of the ivorenolide macrocycle 1 provided several advantages to using a traditional 
slow addition type strategy. In addition to providing a similar yield (55 vs 52% of 1), reaction 
under the phase separation/continuous flow manifold was catalytic as opposed to using 
superstoichiometric quantities of ligand and a metal source, the reaction time was significantly 
shortened (48 vs 2 h), and the concentration was greater by more than 2 orders of magnitude 
(0.2 vs 24 mM). 
7.4. Conclusions 
In summary, a formal total synthesis of ivorenolide A has been accomplished using a 
macrocyclic catalytic oxidative coupling of terminal alkynes and a Z-selective cross metathesis 
as key steps. Macrocyclization has been demonstrated employing a phase separation/continuous 
flow method that is applicable to complex macrolides bearing stereogenic centers, steric 
hindrance about the alkynes, and common protecting groups. The macrocyclization also 
described for the first time that continuous flow protocols allow for much more facile scaleup 
which would be highly problematic using high dilution strategies or microwave heating. The 
phase separation strategy produced good yields of the desired macrocycles employing catalysis 
in place of stoichiometric reagents, faster reaction times than the corresponding batch reactions, 
and concentrations ∼120× greater than those used in the stoichiometric slow addition strategy. 
Given the rarity of macrocyclizations performed under continuous flow, and the importance of 
macrocycles in both 
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natural product synthesis and medicinal chemistry, the use of the phase separation/continuous 
flow method would be expected to have significant impact. 
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8. Conclusions and Perspectives 
The present thesis has described efforts to improve the synthesis of macrolactones 
through catalysis. The research projects that have been undertaken aimed to provide alternative 
strategies that could replace the cumbersome slow addition and stoichiometric activating 
reagents that currently dominate the synthetic landscape of macrocylization methods. Below are 
specific conclusions for each of the two major subsections of the thesis, and each summary also 
comments on possible perspectives for future work.  
8.1. Direct Synthesis of Macrolactones and Macrodiolides via 
Hafnium (IV) Catalysis 
8.1.1. Summary of the Results Obtained on the Direct Synthesis of 
Macrolactones and Macrodiolides 
We have developed an efficient hafnium-catalyzed direct macrolactonization between 
carboxylic acid and alcohol functionalities, generating only water as a by-product. In addition 
to forming a variety of macrolactones and benzolactones (25 examples) in moderate to excellent 
yield (55-90 %), intermolecular direct esterifications of carboxylic acids and alcohols were also 
possible and demonstrated compatibility with common carbamate, silyl ether, alkoxymethyl 
ether, and acetal protecting groups.1   
Among these examples include several macrolactones relevant to the perfume industry, 
such as Exaltolide®, isoambrettolide and dihydroambrettolide, as well macrolactones that could 
interest the pharmaceutical industry, such as complex peptide-containing macrocycles. All of 
the macrolactonization and esterification processes developed are operationally simple, “one-
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pot” reactions that exploit a commercially available catalyst without the need for slow addition 
or azeotropic techniques. 
 
Scheme 8.1.Direct synthesis of macrolactones (a) and esters (b) via Hf(IV)-catalysis. 
The protocol was further adapted to the direct synthesis of macrodiolides from equimolar 
mixtures of diols and dicarboxylic acids (8 examples, 58-96 %) by increasing the catalyst 
loading to 10 mol %. To the best of our knowledge, the hafnium-catalyzed method is the first 
catalytic method for forming the head-head-to-tail-tail macrodiolides. By decreasing the catalyst 
loading to 2.5 mol %, selective formation of head-to-tail macrodiolides from 8- to 10-carbon 
long seco acids was demonstrated (4 examples, 72-77 %).2 
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Scheme 8.2. Direct synthesis of macrodiolides via Hf(IV)-catalysis from (a) diol and 
dicarboxylic acids and from (b) selected seco acids. 
 An interesting aspect left to be studied in the methodology is its application to other 
important chemical transformations. Due to its excellent tolerance of functional and protecting 
groups, hafnium-based Lewis acids could potentially catalyze other condensation reactions in 
macrocyclization, such as macrolactamization. Other potential esterifications to study could 
include the formation of boronic esters or phosphonate esters. Interestingly, following our intial 
report on macrolactonization reactions with Hf(OTf)4, Lundberg and Adolfsson
3 published a 
Hf(Cp)2Cl2-catalyzed direct amidation of carboxylic acids with primary amines (Scheme 8.3). 
The adaptation of the protocol to macrocyclization is something worth investigating as the 
lactam moiety is a common feature in biologically active natural and unnatural macrocycles.4  
 
Scheme 8.3. Hf-catalyzed direct amidation. 
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8.1.2. Future work on the Direct Synthesis of Macrolactones and 
Macrodiolides 
One of the limitations described in the thesis is the inability to synthesize macrolactones 
bearing functionalities at the ω-position (i.e. secondary alcohols) via Hf(OTf)4 catalysis. As the 
Hf(OTf)4-catalyzed macrolactonization mechanism is still unknown, mechanistic studies would 
be helpful to understand the selectivity observed between primary and secondary alcohols. Such 
investigations should be conducted in the near future in our research group. 
In the meantime, alternative catalyst systems, including metal-based Lewis acids, 
boronic acids and a Brønsted acid, were evaluated but did not afford the desired reactivity. 
During the aforementioned investigations, another strategy was envisioned which would not 
only promote catalytic macrolactonization of substrates bearing secondary alcohols, but would 
also result in enantioenriched products from racemic starting materials (Scheme 8.4). 
Chemoenzymatic dynamic kinetic resolution (DKR) is a method used for the conversion of 
mixtures of racemic secondary alcohols and amines into enantiopure esters and amides 
respectively.5  
 
Scheme 8.4. Synthesis of ω-substituted macrolactones via a chemoenzymatic DKR 
The concept relies on a dual catalyst system: a racemization catalyst and an 
enantiospecific enzyme-based transesterification catalyst. For example, (±)-1-phenylethanol 
can be treated with the enzyme CALB, which selectively transfers acetate on one enantiomer of 
the alcohol to form (R)-1-phenylethyl acetate. In parallel, the Ru-catalyst 8.3 racemizes the 
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remaining alcohol (S)-8.1. The concerted action of the two catalysts results in the transformation 
of the racemic alcohol 8.1 into is (R)-acetate derivative 8.2 in 92 % yield and 99 % ee (Scheme 
8.5).6 
 
Scheme 8.5. DKR of 1-phenylethanol using a dual catalyst system of an enzyme and transition 
metal catalyst. 
DKR processes are normally used to synthesize small chiral building blocks, and the 
acyl groups that become appended to the final products are often removed following the 
resolution process. To the best of our knowledge, analogous DKR processes have not been 
developed where the acyl donor is a part of the desired product. In addition, no intramolecular 
version of the DKR of secondary alcohols has been reported. To develop a DKR 
macrolactonization process as exemplified in Scheme 8.4, a model intermolecular reaction 
would be investigated where the acyl donors would be adorned with long aliphatic chains to 
resemble intramolecular substrates. In addition, the DKR process requires the installation of a 
leaving group on the carboxylic acid,7 ideally recyclable and non-toxic, but most importantly 
not interfering in the purification process of the desired macrolactone. A wide variety of 
racemization catalysts are commercially available,8 but for preliminary results, Ru-catalyst 8.36 
was chosen due to its wide use in analogous DKR reactions. Enzyme CALB6 was selected as 
the enantiospecific transesterification catalyst and 1-phenylethanol (8.1) was chosen as the 
racemic secondary alcohol.   
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Table 8.1. DKR of 1-phenylethanol with long-chain aliphatic acyl donors. 
 
Entry Acyl donor Temperature 
(°C) 
Time (h) Yield (%) 
1 4-chlorophenyl 
myristate 
22 18 0a 
2 2,2,2-trifluoroethyl 
myristate 
60 18 44 
3 2,2,2-trifluoroethyl 
myristate 
60 48 64 
4 2,2,2-trifluoroethyl 
myristate 
90 18 70 
5 vinyl laurate 22 18 54 
6 vinyl laurate 60 18 76 
a The acyl donor was hydrolyzed under the reaction conditions.  
The DKR of 1-phenylethanol with 4-chlorophenyl myristate as the acyl donor did not 
promote acylation at room temperature (Table 8.1, entry 1); instead 4-chlorophenol and myristic 
acid were isolated after the reaction. However, both 2,2,2-trifluoroethyl myristate (entries 2 to 
4) and vinyl laurate (entries 5 to 6) were found to be compatible acyl donors, although heating 
or long reaction times are necessary to achieve good conversion for the acylation of 8.1. Both 
leaving groups are volatile and simplify the purification of the desired product. A slight 
preference was made for the 2,2,2-trifluoroethyl8 derivative as it is an easier group to install on 
a carboxylic acid than a vinyl group.9 Enantiomeric excess were not calculated on these 
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preliminary results due to time constraints, but a control reaction showed that CALB does not 
catalyze acylation of (S)-1-phenylethanol ((S)-8.1)with vinyl acetate. 
 In parallel, a macrocyclic intramolecular model substrate bearing a racemic secondary 
alcohol such as 8.7 was synthesized. Seco acid 8.4 was esterified with 2,2,2-trifluoroethanol to 
form 8.5  in quantitative yield and the alcohol moiety was oxidized with PCC to form aldehyde 
8.6 in 58 % yield. p-Tolylmagnesium bromide was added at -78 °C to produce the racemic 
secondary alcohol precursor 8.7 in a low 10 % yield. Side-products are formed in the reaction 
and the conditions will be optimized. Intramolecular DKR to form 8.9 will also be investigated 
by a colleague who undertook the project. Full characterization of intermediates 8.5 to 8.7 is 
also in progress.10 
 
Scheme 8.6. Synthesis of a racemic seco acid containing a secondary alcohol for evaluation in 
intramolecular DKR. 
8.2. Application of the Phase Separation Strategy in Complex 
Molecule Synthesis 
8.2.1. Formal Synthesis of Ivorenolide A 
The second subsection of the thesis reported the successful application of the 
macrocyclic Glaser-Hay coupling of terminal alkynes using a phase separation strategy for the 
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synthesis of a complex natural product. The strategy allows for macrocyclizations at high 
concentrations without the need for slow addition5 and was adapted from the protocol developed 
under continuous flow conditions.11 A formal total synthesis of ivorenolide A, an 18-membered 
ring macrolactone, that possesses a conjugated diyne moiety, was accomplished.12 The key 
macrocyclic Glaser-Hay coupling reaction was conducted in continuous flow, employing a 
mixture of 1:1 PEG400 and MeOH at a concentration of 24 mM and afforded the desired 
macrocycle 8.10 in 52 % yield in only two hours (Scheme 8.7a). The key steps also included a 
Z-selective olefin metathesis, a technique that remains underutilized in the total synthesis of 
natural products. Ruthenium complex 8.14 efficiently catalyzed the cross-coupling between 
8.11 and 8.12 to yield 8.13 (68 % brsm, > 95 % Z) with an excellent selectivity on the alkene 
geometry (Scheme 8.7b).  The Glaser-Hay reaction permits direct cross-coupling without 
differentiation of the partners and, consequently, our synthesis of ivorenolide A is the shortest 
achieved so far. The key macrocyclization step could also efficiently be scaled up to gram 
quantities due to the facile adaptation of continuous flow setups. 
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Scheme 8.7. Key steps of the formal total synthesis of ivorenolide A: a) Macrocyclic Glaser-
Hay coupling under continuous flow and b) Z-selective olefin metathesis. 
8.2.2. Future Work in Complex Molecule Synthesis via the Phase Separation 
Strategy 
 Despite the successful synthesis of ivorenolide A via the phase separation strategy in 
continuous flow, several challenges remain to be investigated for the Glaser-Hay methodology.  
The synthesis of macrocycles having basic nitrogen-containing heterocycles is a common 
challenge in drug discovery efforts.  Peptide-containing macrocycles often have amides which 
enforce specific conformations upon macrocyclic precursors and therefore do not always allow 
for facile ring closure.  In addition, the synthesis of peptide macrocycles in industry often targets 
concentrations of approximately 120-200 mM which are not always feasible using the current 
phase separation strategy.13 Consequently, our group is currently investigating the synthesis of 
the macrocyclic core of Vaniprevir 8.15 (Scheme 8.6). The key cyclization would occur to form 
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intermediate 8.16 which contains several different heterocycles, sterically different amides and 
a slightly strained 1,3-diyne unit. Subsequent hydrogenation of macrocycle 8.16 would afford 
the Vaniprevir macrocyclic core. In addition, our group is investigating the use of dendritic 
PEGs as new co-solvents, which typically have enhanced aggregation in hydrophilic media 
compared to analogous linear polymeric PEGs, which could help to promote macrocyclization 
at even higher concentrations.  
 
Scheme 8.8. Retrosynthesis of Vaniprevir.  
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Annexe 1. Supporting Information of Chapter 3 
General:  
 
All reactions that were carried out under anhydrous conditions were performed under an inert 
argon or nitrogen atmosphere in glassware that had previously been dried overnight at 120 oC 
or had been flame dried and cooled under a stream of argon or nitrogen.1 All commercial 
reagents were obtained from Sigma-Aldrich Chemical Company or Strem Chemicals and were 
reagent quality. Technical solvents were obtained from VWR International Co. Methyl 3-
iodobenzoate2, 9-(tert-butyldimethylsilyloxy)non-1-yne3, 11-(tert-
butyldimethylsilyloxy)undec-1-yne4, 20-heneicosan-1-ol5, 8-(triisopropylsilyloxy)octanol6, 8-
(tert-butyldimethylsilyloxy)octanol7, (2,2-dimethyl-1,3-dioxolan-4-yl) methanol8, 15-(tert-
butyldimethylsilyloxy)pentadecanoic acid9, methyl (15-hydroxypentadecyl)-L-phenylalanyl-L-
phenylalaninium trifluoroacetate10, 8-hydroxyoctan-1-ol acetate11 and 12-oxooctadecanoic 
acid12 were prepared according to literature procedure. Anhydrous solvents (CH2Cl2, Et2O, 
THF, DMF, toluene, and n-hexane) were dried and deoxygenated using a GlassContour system 
                                                 
1 Shriver, D. F.; Drezdon, M. A. in The Manipulation of Air-Sensitive Compounds; Wiley-VCH: New York, 1986. 
2 Leatherbarrow, R. J.; Mo, B.; Offermann, D. A.; Sejberg, J. J. P.; Spivey, A. C.; McKendrick, J. E.; Beavil, A. J.; 
Holdom, M. D.; Sutton, B. J.; Helm, B. A. J. Org. Chem. 2012 , 77, 3197-3214. 
3 Keinan, E.; Sinha, S. C.; Yazbak, A. J. Org. Chem. 1998, 63, 5863 – 5868. 
4 Naka, H.; Nishimura, T.; Noyori, R.; Tachinami, T.; Ushimaru, R. J. Am. Chem. Soc. 2013, 135, 50 – 53. 
5 Lumbroso, A.; Abermil, N.; Breit, B. Chem. Sci. 2012, 3, 789. 
6 Delgado, M.; Martin, J. D. J. Org. Chem. 1999, 64, 4798-4816. 
7 Zhu, H.; Wickenden, J. G.; Campbell, N. E.; Leung, J. C. T.; Johnson, K. M.; Sammis, G. M. Org. Lett. 2009, 11, 
2019-2022. 
8 Karmee, S. K. Synth. Comm. 2013, 43, 450-455. 
9 Morales-Serna, J. A.; Sanchez, E.; Velazquez, R.; Bernal, J.; Garcia-Rios, E.; Gavino, R.; Negron-Silva, G.; 
Cardenas, J. Org. Biomol. Chem. 2010, 8, 4940-4948. 
10 Joshi, K. B.; Verma, S. Angew. Chem., Int. Ed. 2008, 47, 2860-2863. 
11 Framis, V.; Camps, F.; Clapes, P. Tetrahedron Lett. 2004, 45, 5031-5033. 
12 Abraham, S.; Lan, Y.; Lam, R. S. H.; Grahame, D. A. S.; Kim, J. J. H.; Weiss, R. G.; Rogers, M. A. Langmuir 
2012, 28, 4955-4964. 
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(Irvine, CA). Isolated yields reflect the mass obtained following flash column silica gel 
chromatography. Organic compounds were purified using the method reported by Still13 and 
using silica gel obtained from Silicycle Chemical division (40-63 nm; 230-240 mesh). 
Analytical thin-layer chromatography (TLC) was performed on glass-backed silica gel 60 
coated with a fluorescent indicator (Silicycle Chemical division, 0.25 mm, F254.). Visualization 
of TLC plates was performed by UV (254 nm), KMnO4 or p-anisaldehyde stains. All mixed 
solvent eluents are reported as v/v solutions. Concentration refers to removal of volatiles at low 
pressure on a rotary evaporator. All reported compounds were homogeneous by thin layer 
chromatography (TLC) and by 1H NMR. NMR spectra were taken in deuterated CDCl3 using 
Bruker AV-300 and AV-400 instruments unless otherwise noted. Signals due to the solvent 
served as the internal standard (CHCl3: δ 7.27 for 1H, δ 77.0 for 13C). The acquisition parameters 
are shown on all spectra. The 1H NMR chemical shifts and coupling constants were determined 
assuming first-order behavior. Multiplicity is indicated by one or more of the following: s 
(singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad); the list of coupling 
constants (J) corresponds to the order of the multiplicity assignment. High resolution mass 
spectroscopy (HRMS) was done by the Centre régional de spectrométrie de masse at the 
Département de Chimie, Université de Montréal from an Agilent LC-MSD TOF system using 
ESI mode of ionization unless otherwise noted.  
                                                 
13 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925.  
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SYNTHESIS OF MACROCYCLE PRECURSORS 
 
 Methyl 3-(9-hydroxynon-1-yl)benzoate (S1) Methyl 3-iodobenzoate (500 mg, 1.91 mmol, 1.0 
equiv.) was dissolved in tetrahydrofuran (10 mL, 0.2 M).   Pd(PPh3)2Cl2 (67 mg, 0.096 mmol, 
0.05 equiv.) and CuI (18.3 mg, 0.096 mmol, 0.05 equiv.) were added to the solution and the 
reaction mixture was purged with N2 for 5 min. Triethylamine (1.59 mL, 11.5 mmol, 6.0 equiv.) 
and the alkyne (592 mg, 2.10 mmol, 1.1 equiv.) were added and the reaction mixture was stirred 
at room temperature for 18 h. Silica (~ 10 mL) was added and the slurry was concentrated under 
reduced pressure and passed through a short pad of silica (20 % EtOAc in hexanes). The crude 
product was dissolved in a mixture of methanol (5 mL) and tetrahydrofuran (5 mL). Pd/C (405 
mg, 5% w/w, 0.191 mmol, 0.100 equiv.) was added and the reaction mixture was purged with 
H2 for 10 min. A balloon filled with H2 equipped with a syringe was put on the septum and the 
reaction mixture was stirred at room temperature for 18 h. The reaction mixture was passed 
through a short pad of Celite® and concentrated under reduced pressure. Purification by flash 
chromatography (10% to 30% EtOAc in hexanes) was performed to afford the desired product 
as a colorless oil (253 mg, 54 %). 1H NMR (400 MHz, CDCl3) δ 7.86 (m, 2H), 7.36 (m, 2H), 
3.92 (s, 3H), 3.64 (t, J = 6.8 Hz), 2.65 (t, J = 8.0 Hz) 1.65-1.55 (m, 4H), 1.38-1.31 (m, 10H) 
ppm; 13C NMR (100 MHz, CDCl3) δ 167.3, 143.2, 133.1, 130.0, 129.5, h128.2, 126.9, 63.0, 
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52.0, 35.7, 32.7, 31.3, 29.4, 29.3, 29.3, 29.1, 25.7 ppm; HRMS (ESI+) for C17H27O3 [M + H]
+ 
calculated: 278.1882 found: 278.1893. 
 
 
3-(9-Hydroxynon-1-yl)benzoic acid (S2) Methyl 3-(9-hydroxynon-1-yl)benzoate (253 mg, 
0.910 mmol, 1.00 equiv.) was dissolved in tetrahydrofuran (4.8 mL). LiOH (87.0 mg, 3.64 
mmol, 4.00 equiv.) was added as an aqueous solution (1.2 mL). The reaction mixture was stirred 
at 65 oC for 6 h. The reaction mixture was cooled to room temperature and HCl 1M was added 
until the mixture was neutralized (pH = 7). Extraction with EtOAc (3 X 5 mL) was performed 
and the combined organic phases were washed with brine (15 mL). The organic phase was dried 
over Na2SO4, filtered and concentrated under reduced pressure to afford the desired product as 
a white solid (145 mg, 61 %).  1H NMR (400 MHz, CDCl3) δ 7.94 (m, 2H), 7.43-7.36 (m, 2H), 
6.78 (br s, 1H (OH)), 3.66 (t, J = 6.4 Hz, 2H), 2.67 (t, J = 7.6 Hz, 2H), 1.66-1.55 (m, 4H), 1.31 
(m, 10H) ppm; 13C NMR (100 MHz, CDCl3) δ 171.8, 143.3, 133.8, 130.0, 129.4, 128.4, 127.5, 
63.0, 35.6, 32.6, 31.2, 29.4, 29.32, 29.29, 29.1, 25.7 ppm; HRMS (ESI+) for C16H25O3 [M + H]
+ 
calculated: 264.1725 found: 264.1738. 
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Methyl 3-(11-hydroxyundec-1-yl)benzoate (S3) Methyl 3-iodobenzoate (300 mg, 1.15 mmol, 
1.0 equiv.) was dissolved in tetrahydrofuran (6 mL, 0.2 M).   Pd(PPh3)2Cl2 (40 mg, 0.057 mmol, 
0.050 equiv.) and CuI (11 mg, 0.057 mmol, 0.050 equiv.) were added to the solution and the 
reaction mixture was purged under N2 for 5 min. Triethylamine (0.95 mL, 6.9 mmol, 6.0 equiv.) 
and the alkyne (355 mg, 1.26 mmol, 1.10 equiv.) were added and the reaction mixture was 
stirred at room temperature for 18 h. Silica (~ 10 mL) was added and the slurry was concentrated 
under reduce pressure and passed through a short padof silica (20 % EtOAc in hexanes). The 
crude was dissolved in a mixture of methanol (5 mL) and tetrahydrofuran (5 mL). Pd/C (244 
mg, 5% w/w, 1.15 mmol, 0.1 equiv.) was added and the reaction mixture was purged with H2 
for 10 min. A balloon filled with H2 equipped with a syringe was put on the septum and the 
reaction mixture was stirred at room temperature for 18 h. The reaction mixture was passed 
through a short pad of Celite® and concentrated under reduced pressure. Purification by flash 
chromatography (10 % to 30 % EtOAc in hexanes) was performed to the desired product as a 
colorless oil (154 mg, 44 %). 1H NMR (400 MHz, CDCl3) δ 7.86 (m, 2H), 7.36 (m, 2H), 3.92 
(s. 3H), 3.64 (t, J = 6.8 Hz, 2H), 2.65 (t, J = 7.2 Hz), 1.65-1.55 (m, 4H), 1.31-1.27 (m, 14H) 
ppm; 13C NMR (100 MHz, CDCl3) δ 167.3, 143.2, 133.1, 130.0, 129.5, 128.2, 126.9, 63.1, 52.0, 
35.7, 32.8, 31.3, 29.55, 29.51, 29.48, 29.42, 29.38, 29.2, 25.7 ppm; HRMS (ESI+) for C19H31O3 
[M + H]+ calculated: 306.2195 found: 306.2207.  
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3-(11-Hydroxyundec-1-yl)benzoic acid (S4) Methyl 3-(11-hydroxyundec-1-yl)benzoate (154 
mg, 0.500 mmol, 1.00 equiv.) was dissolved in tetrahydrofuran (4 mL). LiOH (48 mg, 2.01 
mmol, 4.0 equiv.) was added as an aqueous solution (1 mL). The reaction mixture was stirred 
at 65 oC for 3h. The reaction mixture was cooled down to room temperature and HCl 1M was 
added until the mixture was neutralized (pH = 7). Extraction with EtOAc (3X 5 mL) was 
performed and the combined organic phases were washed with brine (15 mL). The organic phase 
was dried over Na2SO4, filtered and concentrated under reduced pressure to afford the desired 
product acid as a white solid (125 mg, 85 %).1H NMR (400 MHz, CDCl3) δ 7.94 (m, 2H), 7.44-
7.37 (m, 2H), 3.67 (t, J = 6.6 Hz, 2H), 2.68 (t, J = 7.4 Hz, 2H), 1.67-1.55 (m, 4H), 1.33-1.28 
(m, 14H) ppm; 13C NMR (75 MHz, CDCl3) δ 170.9, 143.3, 133.9, 130.1, 129.1, 128.4, 127.5, 
63.1, 35.6, 32.7, 31.2, 29.5, 29.44, 29.42, 29.38, 29.3, 29.0, 25.7 ppm; HRMS (ESI+) for 
C18H29O3 [M + H]
+ calculated: 293.2111 found: 293.2110. 
 
Methyl 3-(11-hydroxyundec-1-yn-1-yl)benzoate (S5) Methyl 3-iodobenzoate (165 mg, 0.629 
mmol, 1.00 equiv.) was dissolved in tetrahydrofuran (3 mL, 0.2 M).   Pd(PPh3)Cl2 (22 mg, 0.032 
mmol, 0.050 equiv.) and CuI (6.1 mg, 0.032 mmol, 0.050 equiv.) were added to the solution and 
the reaction mixture was purged under N2 for 5 min. Triethylamine (0.53 mL, 3.8 mmol, 6.0 
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equiv.) and the alkyne (195 mg, 0.691 mmol, 1.10 equiv.) were added and the reaction mixture 
was stirred at room temperature for 18 h. Silica (~ 10 mL) was added and the slurry was 
concentrated under reduced pressure and passed through a short pad of silica (20 % EtOAc in 
hexanes). The crude was dissolved in THF (12 mL) and TBAF (2.43 mL as 1M solution in THF, 
2.43 mmol, 4.00 equiv.) was added to the solution. The reaction mixture was stirred at room 
temperature for 3 h and was then quenched by adding NH4Cl saturated solution (10 mL). 
Extraction with EtOAc was performed (2 x 10 mL) and the organic phase was washed with 
water (20 mL) and brine (20 mL). The organic phase was then dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude was purified by flash chromatography (20% 
EtOAc in hexanes) to afford the desired product as a colorless oil (74 mg, 39 % over two steps).  
1H NMR (400 MHz, CDCl3) δ 8.07 (s, 1H), 7.93 (d, J = 7.7 Hz, 1H), 7.56 (d, J = 7.4 Hz, 1H), 
7.36 (dd, J = 7.6 Hz, 7.6 Hz, 1H), 3.92 (s, 3H), 3.65 (t, J = 6.6Hz, 2H), 2.42 (t, J = 7.0Hz, 2H), 
1.65-1.55 (m, 4H), 1.50-1.42 (m, 2H), 1.34 (m, 8H) ppm; 13C NMR (100 MHz, CDCl3) δ 166.6, 
135.7, 132.7, 130.2 128.4, 128.3, 124.5, 91.5, 79.6, 63.0, 52.2, 32.8, 29.4, 29.3, 29.0, 28.8, 28.6, 
25.7, 19.3 ppm; HRMS (ESI+) for C19H27O3 [M + H]
+ calculated: 303.1955, found: 303.1965.  
 
3-(11-Hydroxyundec-1-yn-1-yl)benzoic acid (S6) Methyl 3-(11-hydroxyundec-1-yn-1-
yl)benzoate (74 mg, 0.24 mmol, 1.0 eq) was dissolved in tetrahydrofuran (3.2 mL). LiOH (23 
mg, 0.97 mmol, 4.00 eq) was added as an aqueous solution (0.8 mL). The reaction mixture was 
stirred at 65 oC for 3 h. The reaction mixture was cooled down to room temperature and HCl 
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1M was added until the mixture was neutralized (pH = 7). Extraction with EtOAc (3X 5 mL) 
was performed and the combined organic phases were washed with brine (15 mL). The organic 
phase was dried over Na2SO4, filtered and concentrated under reduced pressure to afford the 
desired product as a white solid (39 mg, 56 %) (Note: Seco acid S6 is highly insoluble in CDCl3 
which made it difficult to obtain quality 1H and 13C spectra). 1H NMR (400 MHz, CDCl3) δ 8.14 
(s, 1H), 7.99 (d, J = 7.6 Hz, 1H), 7.61 (d, J = 8.0 Hz, 1H), 7.40 (dd, J = 8.0 Hz, 8.0 Hz, 1H), 
7.49 (br s, 1H (OH)), 3.67 (t, J = 6.4Hz, 2H), 2.42 (t, J = 6.8 Hz, 2H), 1.64-1.58 (4H), 1.50-
1.47 (m, 2H), 1.35 (m, 10H) ppm; 13C NMR (75 MHz, CDCl3) δ 170.8, 136.4, 133.3, 129.0, 
128.4, 124.7, 91.8, 79.6, 63.0, 32.6, 29.4, 29.3, 29.0, 28.8, 28.5, 25.7, 19.3 ppm; HRMS (ESI+) 
for C18H25O3 [M + H]
+ calculated: 289.1798, found: 289.1800. 
 
(±)-erythro-Methyl 16-tert-butyldimethylsilyloxy-9,10-dihydroxyhexadecanoate (S7) (±)-
erythro-aleuritic acid (500 mg, 1.64 mmol, 1.00 equiv.) was dissolved in MeOH (40 mL). 
Concentrated H2SO4 (5-10 drops) was added to the solution. The reaction mixture was heated 
to reflux for 18 h and then brought back to room temperature and quenched by the addition of a 
K2CO3 saturated solution (until pH = 7). Extraction was performed by the addition of EtOAc 
(100 mL) and water (50 mL). The aqueous phase was extracted with EtOAc (2 x 50 mL). The 
combined organic phases were washed with H2O (100 mL) and brine (75 mL), dried over 
Na2SO4, filtered and concentrated under reduced pressure. The crude product was the dissolved 
in CH2Cl2 (15 mL). TBSCl (260 mg, 1.72 mmol, 1.05 equiv.) and imidazole (117 mg, 1.72 
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mmol, 1.05 equiv.) were added to the solution. The reaction mixture was stirred at room 
temperature for 3 h and was quenched by the addition of water (10 mL). Extraction was 
performed with EtOAc (2 x 25 mL) and the combined organic phases were washed with water 
(20 mL) and brine (20 mL). Silica gel was added (10 mL) and the slurry was concentrated under 
reduced pressure. Flash chromatography was performed (25 % EtOAc in hexanes) to afford the 
desired product as a white solid (534 mg, 84 % over two steps). 1H NMR (400 MHz, CDCl3) δ 
3.68 (s, 3H), 3.62 (t, J = 6.8Hz, 2H), 3.42-3.40 (m, 2H), 2.32 (t, J = 7.2Hz, 2H), 2.08-2.04 (br 
s, 2H (OH)), 1.65-1.62 (m, 2H), 1.53-1.34 (m, 20H), 0.92 (s, 9H), 0.06 (s, 6H) ppm; 13C NMR 
(100 MHz, CDCl3) δ 174.3, 74.5, 74.4, 63.2, 51.4, 34.0, 33.6 (2C), 32.8, 29.5, 29.4, 29.1, 29.0, 
26.0, 25.8, 25.6, 25.5, 24.9, 18.4, -5.3 ppm; HRMS (ESI+) for C23H49O5Si [M + H]
+ calculated : 
433.3344 found: 433.3364.  
 
(±)-erythro-Methyl 8-((6-tert-butyldimethylsilyloxy)hexyl-2-thioxo-1,3-dioxolan-4-
yl)octanoate (S8) The diol S7 (200 mg, 0.462 mmol, 1.00 equiv.) was dissolved in PhMe (3.0 
mL) in a sealed tube. TCDI (90.4 mg, 0.508 mmol, 1.10 equiv.) was added and the reaction vial 
was sealed and the mixture was stirred at 130oC for 18 h. The solution was cooled down to room 
temperature and silica gel (10 mL) was added and the slurry was concentrated under reduced 
pressure. Flash chromatography was performed (5-10 % EtOAc in hexanes) to afford the desired 
product (215 mg, 98 %) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 4.46-4.44 (m, 2H), 
3.68 (s, 3H), 3.61 (t, J = 6.4Hz, 2H), 2.32 (t, J =7.2 Hz, 2H), 1.80-1.60 (m, 6H), 1.53-1.50 (m, 
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4H), 1.40-1.30 (m, 12H), 0.90 (s, 9H), 0.05 (s, 6H) ppm; 13C NMR (75 MHz, CDCl3) δ 191,7, 
174.2, 86.8 (2C), 63.0, 51.5, 34.0, 33.25, 33.21, 32.6, 29.0, 28.92 (2C), 28.90, 25.9, 25.6, 24.8, 
24.64, 24.59, 18.4, -5.3 ppm; HRMS (ESI+) for C24H47O5SSi [M + H]
+ calculated: 475.2908 
found: 475.2927.  
 
Methyl (Z)-16-(tert-butyldimethylsilyloxy)hexadec-9-enoate (S9) The thiocarbonate S8 (200 
mg, 0.423 mmol, 1.00 equiv.) was dissolved in trimethylphosphite (10 mL) in a sealed tube. The 
reaction mixture was stirred at 140 °C for 24 h. The solution was cooled to room temperature 
and concentrated under reduced pressure. Flash chromatrography (3 % EtOAc in hexanes) was 
performed to afford the desired product as a colorless oil (101 mg, 62 %) 1H NMR (400 MHz, 
CDCl3) δ 5.39-5.38 (m, 2H), 3.67 (s, 3H), 3.60 (t, J = 6.4Hz, 2H), 2.31 (t, J = 6.8Hz, 2H), 1.94 
(m, 4H), 1.35-1.30 (m, 4H), 1,30 (m, 14H), 0.90 (s, 9H), 0.05 (s, 6H) ppm; 13C NMR (100 MHz, 
CDCl3) δ 174.3, 130.3 (2C), 63.3, 51.4, 34.1, 32.8, 32.54, 32.52, 29.6, 29.5, 29.1 (2C), 28.9(2C), 
26.0, 25.6, 24.9, 18.4, -5.3 ppm; HRMS (ESI+) for C23H47O3Si [M + H]
+ calculated: 399.3289 
found: 399.3301.  
 
Methyl (Z)-16-hydroxyhexadec-9-enoate (S10) Compound S9 (100 mg, 0.263 mmol, 1.00 
equiv.) was dissolved in THF (4 mL). A solution of TBAF (1M in THF) (1.05 mL, 4.00 equiv.) 
was added and the mixture was stirred at room temperature for 3 h. The reaction was quenched 
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by the addition of water (5 mL). Extraction with EtOAc (2 x 10 mL) was performed and the 
combined organic layers were washed with water (20 mL) and brine (20 mL). The organic phase 
was then dried under Na2SO4, filtered and concentrated under reduced pressure. Flash 
chromatography (40 % EtOAc in hexanes) was performed to afford the desired product as a 
colorless oil (41 mg, 58 %). 1H NMR (400 MHz, CDCl3) δ 5.38-5.36 (m, 2H), 3.66 (s, 3H), 3.63 
(t, J = 6.8Hz, 2H), 2.30 (t, J =7.2Hz, 2H), 1.96, (m, 4H), 1.62-1.54 (m, 4H), 1.35-1.28 (m, 14H) 
ppm; 13C NMR (100 MHz, CDCl3) δ 174.3, 130.3, 130.2, 63.0, 51.4, 34.1, 32.7, 32.5, 32.4, 
29.50, 29.48, 29.1 (2C), 28.9, 28.8, 25.6, 24.9 ppm; HRMS (ESI+) for C17H33O3 [M + H]
+ 
calculated: 285.2424 found: 285.2436.  
 
(Z)-16-Hydroxyhexadec-9-enoic acid (S11) The methyl ester S10 (41 mg, 0.15 mmol, 1.0 
equiv.) was dissolved in THF (1.6 mL). LiOH (15 mg, 0.61 mmol, 4.0 equiv.) was dissolved in 
water (0.4 mL) and added to the previous mixture. The solution was stirred at reflux for 18 h. 
The reaction mixture was cooled down to room temperature and HCl 1M was added until the 
mixture was neutralized (pH = 7). Extraction with EtOAc (3 X 5 mL) was performed and the 
combined organic phases were washed with brine (15 mL). The organic phase was dried over 
Na2SO4, filtered and concentrated under reduced pressure to afford the product as a white solid 
(39 mg, 96 %). 1H NMR (400 MHz, CDCl3) δ 5.38-5.37 (m, 2H), 3.65 (t, J = 6.7 Hz, 2H), 2.34 
(t, J = 7.4 Hz, 2H), 1.99-1.96 (m, 4H), 1.63-1.57 (m, 4H), 1.40-1.25 (m, 14H) ppm; 13C NMR 
(75 MHz, CDCl3) δ 178.9, 130.4, 130.3, 63.0, 34.0, 32.6, 32.45, 32.43, 29.5, 29.03, 29.00, 28.8, 
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28.7, 25.6, 24.7 ppm; HRMS (ESI+) for C16H31O3 [M + H]
+ calculated 271.2268 found: 
271.2273. 
 
(±)-erythro-Methyl 16-(tert-butyldimethylsilyloxy)heptadecane-8,9-diyl[bis(2,2-
dimethylpropanoate)]oate (S12) The diol S7 (206 mg, 0.476 mmol, 1.00 equiv.) was dissolved 
in PhMe (5 mL) in a sealed tube. Et3N (0.33 mL, 2.30 mmol, 5.00 equiv.) was added followed 
by PivCl (0.23 mL, 1.9 mmol, 4.0 equiv.). The reaction mixture was stirred at 120 oC for 18 h. 
The reaction was quenched by addition of water (5 mL). Extraction with EtOAc was performed 
(2 x 5 mL) and the combined organic layers were washed with brine (10 mL), dried over 
Na2SO4, filtered and concentrated under reduced pressure. Flash chromatography (10 % EtOAc 
in hexanes) was performed to afford the desired product (252 mg, 88 %) as a colorless oil. 1H 
NMR (400 MHz, CDCl3) δ 4.98 (m, 2H), 3.67 (s, 3H), 3.59 (t, J = 6.8Hz, 2H), 2.30 (t, J = 
7.6Hz, 2H), 1.63-1.48 (m, 8H), 1.30-1.23 (m, 12H), 1.22 (s, 18H) ppm; 13C NMR (75 MHz, 
CDCl3) δ 177.8 (2C), 174.2, 73.3 (2C), 63.1, 51.4, 38.9 (2C), 34.1, 32.7, 30.8, 29.23, 29.20, 
29.02, 29.00, 27.2 (2 x C(CH3)3), 26.0, 25.6, 25.0, 24.9, 18.4, -5.3ppm; HRMS (ESI+) for 
C33H64O7SiNa [M + Na]
+ calculated 623.4314 found: 623.4310. 
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(±)-erythro-Methyl 16-hydroxyheptadecane-9,10-diyl[bis(2,2-dimethylpropanoate)] oate 
(S13) Compound S12 (163 mg, 0.272 mmol, 1.00 equiv.) was dissolved in THF (1.5 mL). A 
solution of TBAF (1M in THF) (1.09 mL, 4.00 equiv.) was added and the mixture was stirred 
at room temperature for 3 h. The reaction was quenched by the addition of water (5 mL). 
Extraction with EtOAc (2 x 10 mL) was performed and the combined organic layers were 
washed with water (20 mL) and brine (20 mL). The organic phase was then dried under Na2SO4, 
filtered and concentrated under reduced pressure. Flash chromatography (40 % EtOAc in 
hexanes) was performed to afford the desired product as a colorless oil (93 mg, 70 %). 1H NMR 
(300 MHz, CDCl3) δ 4.98 (m, 2H), 3.67 (s, 3H), 3.63 (t, J = 6.6Hz, 2H), 2.29 (t, J = 7.8Hz, 2H), 
1.65-1.50 (m, 8H), 1.45-1.30 (m, 16H), 1.22 (s, 18H) ppm; 13C NMR (75 MHz, CDCl3) δ 177.8 
(2C), 174.3, 73.2 (2C), 62.9, 51.4, 38.9 (2C), 34.0, 32.6, 30.8, 30.7, 29.2, 29.1, 29.01, 29.00, 
27.2 (2 x C(CH3)3), 25.5, 25.0, 24.9 ppm; HRMS (ESI+) for C27H51O7 [M + H]
+ calculated 
487.3629 found: 487.3652. 
 
(±)-erythro-16-Hydroxyheptadecane-9,10-diyl[bis(2,2-dimethylpropanoate)]oic acid (S14) 
Compound S13 (93 mg, 0.191 mmol, 1.00 equiv.) was dissolved in THF (2.0 mL). LiOH (16 
mg, 0.38 mmol, 2.0 equiv.) was dissolved in water (0.5 mL) and added to the THF solution of 
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S13. The solution was stirred at 50 °C for 3 h. The reaction mixture was cooled down to room 
temperature and HCl 1M was added until the mixture was neutralized (pH = 7). Extraction with 
EtOAc (3 X 5 mL) was performed and the combined organic phases were washed with brine 
(15 mL). The organic phase was dried over Na2SO4, filtered and concentrated under reduced 
pressure to afford the desired product as a colorless oil (52 mg, 58 %). 1H NMR (300 MHz, 
CDCl3) δ 4.99-4.96 (m, 2H), 3.63 (t, J = 6.5 Hz, 2H), 2.33 (t, J = 7.2 Hz, 2H), 1.64-1.23 (m, 
24H), 1.21 (s, 18H) ppm; 13C NMR (75 MHz, CDCl3) δ 178.9, 177.9 (2C), 73.2 (2C), 62.8, 38.9 
(2C), 33.9, 32.4, 30.7, 30.6, 29.0 (2C), 28.9, 28.8, 27.2 (2 x C(CH3)3), 25.4, 24.9, 24.6 ppm; 
HRMS (ESI+) for C26H48O7Na
 [M + Na]+ calculated 495.3292 found: 495.3306. 
 
Methyl 3-(21-hydroxyheneicosan-1-yn-1-yl)benzoate (S15) Methyl 3-iodobenzoate (218 mg, 
0.832 mmol, 1.00 equiv.) was dissolved in tetrahydrofuran (5 mL, 0.2 M).   Pd(PPh3)2Cl2 (29 
mg, 0.042 mmol, 0.050 equiv.) and CuI (8.0 mg, 0.042 mmol, 0.050 equiv.) were added to the 
solution and the reaction mixture was purged under N2 for 5 min. Triethylamine (0.69 mL, 4.99 
mmol, 6.00 equiv.) and the alkyne (256 mg, 0.832 mmol, 1.00 eq) were added and the reaction 
mixture was stirred at room temperature for 18 h. Silica (~ 5 mL) was added and the slurry was 
concentrated under reduced pressure. Flash chromatography (5 to 20 % EtOAc in hexanes) was 
performed to afford the desired product (261 mg, 71 %) as a yellow solid. 1H NMR (400 MHz, 
CDCl3) δ 8.07 (dd, J = 1.6 Hz, 1.6 Hz, 1H), 7.93 (dd, J = 7.6 Hz, 7.6Hz, 1.6 Hz, 1H), 7.56 (ddd, 
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J = 7.6 Hz, 7.6 Hz, 1.6 Hz, 1H), 7.36 (dd, J = 7.6 Hz, 7.6 Hz, 1H), 3.92 (s, 3H), 3.64 (t, J = 6.4 
Hz, 2H), 2.41 (t, J = 6.8 Hz, 2H), 1.65-1.52 (m, 4H), 1.48-1.35 (m, 2H), 1.26 (m, 28H) ppm ; 
13C NMR (75 MHz, CDCl3) δ 166.6, 135.7, 132.7, 130.2, 128.4, 128.3, 124.5, 91.6, 79.6, 63.1, 
52.2, 32.8, 29.7 (4C), 29.62, 29.59, 29.58, 29.5, 29.4, 29.1, 28.9, 28.6, 25.7, 19.4 ppm; HRMS 
(ESI+) for C29H47O3
 [M + H]+ calculated: 443.3520 found: 443.3520. 
 
3-(21-Hydroxyheneicosan-1-yn-1-yl)benzoic acid (S16) The methyl ester S15 (100 mg, 0.226 
mmol, 1.00 equiv.) was dissolved in THF (4.0 mL). LiOH (38 mg, 0.90 mmol, 4.0 equiv.) was 
dissolved in water (1.0 mL) and added to the previous mixture. The solution was stirred at reflux 
for 4 h. The reaction mixture was cooled down to room temperature and HCl 1M was added 
until the mixture was neutralized (pH = 7). Extraction with EtOAc (3 X 5 mL) was performed 
and the combined organic phases were washed with brine (15 mL). The organic phase was dried 
over Na2SO4, filtered and concentrated under reduced pressure to afford the desired product as 
white solid (94 mg, 97 %).(Note: Seco acid S16 is highly insoluble in CDCl3 which made it 
difficult to obtain quality 1H and 13C spectra). 1H NMR (400 MHz, CDCl3) δ 8.12 (s, 1H), 7.98 
(d, J = 7.7 Hz, 1H), 7.61 (d, J = 7.7 Hz, 1H), 7.39 (dd, J = 7.7 Hz, 7.7 Hz, 1H), 3.67 (t, J = 6.3 
Hz, 2H), 2.42 (t, J = 7.0 Hz, 2H), 1.64-1.58 (m, 4H), 1.52-1.42 (m, 2H), 1.40-1.22 (m, 26H); 
13C NMR (175 MHz, CDCl3) δ 168.4, 136.3, 133.2, 129.2, 129.0, 128.4, 124.7, 91.8, 79.5, 63.2, 
32.7, 29.64, 29.63, 29.62, 29.61, 29.60 (2C), 29.58 (2C) 29.6, 29.55, 29.47, 29.4, 29.1, 28.9, 
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28.6, 25.7, 19.4 ppm; HRMS (ESI+) for C28H44O3Na
 [M + Na]+ calculated: 451.3191 found: 
451.3183. 
 
20-Hydroxyicosa-10,12-diynoic acid (S17) The macrolactone14 (150 mg, 0.47 mmol, 1.00 
equiv) was dissolved in tetrahydrofuran (8.0 mL). LiOH (79 mg, 1.88 mmol, 4.00 equiv.) was 
added as dissolved in water (2.0 mL) and added to the previous mixture. The solution was stirred 
at reflux for 18 h. The reaction mixture was cooled down to room temperature and HCl 1M was 
added until the mixture was neutralized (pH = 7). Extraction with EtOAc (3 x 10 mL) was 
performed and the combined organic phases were washed with brine (25 mL). The organic phase 
was dried over Na2SO4, filtered and concentrated under reduced pressure to afford the desired 
product as a white solid (130 mg, 86 %). (Note: Seco acid S17 is highly insoluble in CDCl3 
which made it difficult to obtain quality 1H and 13C spectra). 1H NMR (400 MHz, CDCl3) δ 6.46 
(bs, OH), 3.66 (t, J = 5.0 Hz, 2H), 2.45-2.32 (m, 2H), 2.25 (t, J = 5.6 Hz, 4H), 1.72-1.46 (m, 
6H), 1.43-1.22 (m, 16H) ppm; 13C NMR (100 MHz, CDCl3) δ  179.6, 77.42 (2C), 65.3 (2C), 
63.0, 33.9, 32.6, 29.7, 29.0 (2C), 28.9, 28.8, 28.7, 28.2 (2C), 25.5, 24.6, 24.5, 19.2 ppm; HRMS 
(ESI+) for C20H33O3 [M + H]
+ calculated: 321.2426 found: 321.2424.  
 
 
                                                 
14 Bédard, A.-C.; Collins, S. K. J. Am. Chem. Soc 2011, 133, 19976-19981. 
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Methyl (15-hydroxypentadecanoyl)-L-isoleucinate (S18) The isoleucine salt (500 mg, 2.75 
mmol, 1.20 equiv.) and Et3N (0.86 mL, 6.18 mmol, 2.70 equiv.) were added in CH2Cl2 (10 mL) 
and the mixture was stirred at room temperature upon complete dissolution. 15-(tert-
butyldimethylsilyloxy)pentadecanoic acid was added (854 mg, 2.29 mmol, 1.00 equiv.) to the 
solution followed by HOBt (464 mg, 3.44 mmol, 1.5 equiv.) and EDC●HCl (660 mg, 3.44 
mmol, 1.5 equiv.) and the mixture was stirred at room temperature for 18 h. The mixture was 
diluted with CH2Cl2 (5 mL) and washed with a 5 % w/w citric acid aqueous solution (10 mL) 
and a NaHCO3 saturated aqueous solution (10 mL). The organic phase was dried over Na2SO4, 
filtered and concentrated under reduced pressure. Flash chromatography (10 to 40 % EtOAc in 
hexanes) was performed to afford the in-situ TBS-deprotected product (640 mg, 73 %) as a 
white solid. 1H NMR (400 MHz, CDCl3) δ 6.08 (d, J = 8.4 Hz, 1H (NH)), 4.59 (dd, J = 8.7 Hz, 
5.0 Hz, 1H), 3.70 (s, 3H), 3.60 (t, J = 6.6 Hz, 2H), 2.20 (t, J = 7.3 Hz, 2H), 1.90 (br, s, 1H (OH)), 
1.89-1.80 (m, 1H), 1.65-1.50 (m, 4H), 1.48-1.35 (m, 1H), 1.34-1.20 (m, 20H), 1.19-1.05 (m, 
1H), 0.92-0.86 (m, 6H) ppm; 13C NMR (100 MHz, CDCl3) δ 172.9, 172.7, 62.8, 56.1, 51.9, 
37.9, 36.6, 32.7, 29.5 (2C), 29.4 (3C), 29.35, 29.33, 29.2, 29.1, 25.7, 25.6, 25.1., 15.3, 11.4 ppm; 
HRMS (ESI+) for C22H44NO4 [M + H]
+ calculated 386.3265 found: 386.3282. 
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(15-Hydroxypentadecanoyl)-L-isoleucine (S19) The methyl ester S18 (527 mg, 1.37 mmol, 
1.00 equiv.) was dissolved in THF (20 mL). LiOH (230 mg, 548 mmol, 4.00 equiv.) was 
dissolved in H2O (5 mL) and was added to the previous solution. The reaction mixture was 
stirred at 50 oC for 18 h and was then cooled down to room temperature. HCl 1M was added 
until the mixture was neutralized (pH = 7). Extraction with EtOAc (3 x 25 mL) was performed 
and the combined organic phases were washed with brine (100 mL). The organic phase was 
dried over Na2SO4, filtered and concentrated under reduced pressure to afford the desired 
product as a white solid (421 mg, 83 %). 1H NMR (400 MHz, CDCl3) δ 6.17 (d, J = 8.5 Hz, 1H 
(NH)), 5.64 (br s, 1H (OH), 4.61 (dd, J = 8.5 Hz, 4.8 Hz, 1H), 3.66 (t, J = 6.7 Hz, 2H), 2.25 (t, 
J = 7.4 Hz, 2H), 1.97-1.87 (m, 1H), 1.68-1.45 (m, 5H), 1.40-1.12 (m, 21H), 0.95-0.92 (m, 6H) 
ppm; 13C NMR (100 MHz, CDCl3) δ 174.8, 173.8, 63.0, 56.4, 37.6, 36.6, 32.6, 29.5, 29.43 (2C), 
29.41 (2C), 29.32, 29.30, 29.1, 29.1, 25.6 (2C), 25.1, 15.4, 11.6 ppm; HRMS (ESI+) for 
C21H40NO4 [M + H]
+ calculated 370.2963 found: 370.2962. 
 
Methyl (15-hydroxypendecyl)-L-phenylalanyl-L-phenylalaninate (S20) Phe-Phe methyl 
ester TFA salt (343 mg, 0.780 mmol, 1.00 equiv.) was dissolved in CH2Cl2 (8 mL). 15-(tert-
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butyldimethylsilyloxy)pentadecanoic acid was added (290 mg, 0.780 mmol, 1.0 equiv.) to the 
solution followed by HOBt (158 mg, 1.17 mmol, 1.5 equiv.), EDC●HCl (225 mg, 1.17 mmol, 
1.5 equiv.) and Et3N (0.33 mL, 2.3 mmol, 3.0 equiv.) and the mixture was stirred at room 
temperature for 18 h. The mixture was diluted with CH2Cl2 (5 mL) and washed with a 5 % w/w 
citric acid aqueous solution (10 mL) and a NaHCO3 saturated aqueous solution (10 mL). The 
organic phase was dried over Na2SO4, filtered and concentrated under reduced pressure. Flash 
chromatography (30 % to 100 % EtOAc in hexanes) was performed to afford the desired product 
(237 mg, 54 %) as a white solid. 1H NMR (CDCl3, 400 MHz) δ 7.29-7.18 (m, 8H), 7.02-7.00 
(m, 2H), 6.39 (d, J = 7.4 Hz, 1H), 6.11 (d, J = 7.6 Hz, 1H), 4.74 (ddd, J = 7.4 Hz, 7.4 Hz, 6.3 
Hz, 1H), 4.66 (ddd, J = 7.6 Hz, 7.6Hz, 7.1 Hz, 1H), 3.68 (s, 3H), 3.63 (t, J = 6.6 Hz, 2H), 3.10-
2.94 (m, 4H), 2.11 (t, J = 7.0 Hz, 2H), 1.60-1.48 (m, 4H), 1.37-1.20 (m, 20H) ppm; 13C NMR 
(CDCl3, 100 MHz) δ 173.0, 171.2, 170.6, 136.4, 135.6, 129.3, 129.1, 128.54, 128.50, 127.1, 
126.9, 63.0, 54.0, 53.4, 52.2, 38.0, 37.8, 36.5, 32.8, 29.51 (2C), 29.49 (2C), 29.37, 29.35, 29.2, 
29.1, 25.7, 25.5 ppm; HRMS (ESI +) for C34H51N2O5 (M + H
+) calculated mass : 567.3793, 
found 567.3805. 
 
(15-Hydroxypentadecyl)-L-phenylalanyl-L-phenylalanine (S21) The methyl ester S20 (210 
mg, 0.371 mmol, 1.0 equiv.) was dissolved in THF (6 mL). LiOH (62 mg, 1.5 mmol, 4.0 equiv.) 
was dissolved in H2O (1.5 mL) and was added to the previous solution. The reaction mixture 
was stirred at 50 oC for 18 h and was then cooled down to room temperature. HCl 1M was added 
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until the mixture was neutralized (pH = 7). Extraction with EtOAc (3 x 10 mL) was performed 
and the combined organic phases were washed with brine (20 mL). The organic phase was dried 
over Na2SO4, filtered and concentrated under reduced pressure to afford the desired product as 
a white solid (120 mg, 59 %). 1H NMR (DMSO-d6, 400 MHz) δ 12.71 (br s, 1H), 8.19 (d, J =7.8 
Hz, 1H), 7.92 (d, J = 8.7 Hz, 1H), 7.27-7.15 (m, 10H), 4.55 (ddd, J = 7.8 Hz, 5.2 Hz, 4.0 Hz, 
1H), 4.44 (ddd, J = 10.4 Hz, 8.7 Hz, 8.4 Hz, 1H), 4.33 (br s, 1H), 3.37 (t, J = 6.6 Hz, 2H), 3.08 
(dd, J = 13.9 Hz, 5.2 Hz, 1H), 2.98 (dd, J = 14.0 Hz, 4.0 Hz, 1H), 2.93 (dd, J = 13.6 Hz, 8.4 Hz, 
1H), 2.68 (dd, J = 13.9 Hz, 10.4 Hz, 1H), 1.96 (t, J = 6.8 Hz, 2H), 1.41-1.02 (m, 24 H) ppm; 13C 
NMR (DMSO-d6, 100 MHz) δ 172.7, 171.9, 171.5, 138.0, 137.4, 129.1 (2C), 128.1, 127.8, 
126.4, 126.1, 60.7, 53.4, 37.4, 36.6, 35.2, 32.5, 29.11, 29.06 (2C), 29.04 (3C), 28.97, 28.89, 
28.8, 28.4, 25.5, 25.2 ppm; HRMS (ESI +) for C33H48N2O5Na (M + Na
+) calculated mass : 
575.3455, found 575.3460. 
SYNTHESIS OF MACROLACTONES 
 
1-Oxacyclohexadecan-2-one (2) 15-Hydroxypentadecanoic acid (26 mg, 0.10 mmol, 1.0 
equiv.) was dissolved in toluene (20 mL, 5 mM).   Hf(OTf)4 (3.9 mg, 0.0050 mmol, 0.05 equiv.) 
was added to the solution and the reaction mixture heated to 110 oC. The reaction mixture was 
stirred at this temperature for 24 h. After cooling down to room temperature, silica gel (~ 1 mL) 
was added and the slurry was concentrated under reduced pressure and purified by flash 
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chromatography (3 % Et2O in hexanes) to the desired product as a white solid (20 mg, 83 %). 
Spectral data were in accordance with those previously reported in the literature.9 
 
1-Oxacyclotridecan-2-one (4) 12-Hydroxypentadecanoic acid (22 mg, 0.10 mmol, 1.0 equiv.) 
was dissolved in toluene (20 mL, 5 mM).   Hf(OTf)4 (3.9 mg, 0.0050 mmol, 0.05equiv.) was 
added to the solution and the reaction mixture heated to 110 oC. The reaction mixture was stirred 
at this temperature for 24 h. After cooling down to room temperature, silica gel ( ~ 1 mL) was 
added and the slurry was concentrated under reduced pressure and purified by flash 
chromatography (3 % Et2O in hexanes) to afford the desired product as a colorless oil (11 mg, 
56 %). Spectral data were in accordance with those previously reported in the literature.9 
 
1-Oxacycloheptadecan-2-one (5): 16-Hydroxypentadecanoic acid (27 mg, 0.10 mmol, 1.0 
equiv.) was dissolved in toluene (20 mL, 5 mM).   Hf(OTf)4 (3.9 mg, 0.0050 mmol, 0.05equiv.) 
was added to the solution and the reaction mixture heated to 110 oC. The reaction mixture was 
stirred at this temperature for 24 h. After cooling down to room temperature, silica gel (~ 1 mL) 
was added and the slurry was concentrated under reduced pressure and purified by flash 
chromatography (3 % Et2O in hexanes) to afford the desired product as a white solid (22 mg, 87 
%). Spectral data were in accordance with those previously reported in the literature.9  
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3-Oxabiclyclo[11.3.1]heptadeca-1(17),13,15-trien-2-one (6): 3-(9-Hydroxynon-1-yl)benzoic 
acid (26 mg, 0.10 mmol, 1.0 equiv.) was dissolved in toluene (20 mL, 5 mM).   Hf(OTf)4 (3.9 
mg, 0.0050 mmol, 0.05 equiv.) was added to the solution and the reaction mixture heated to 110 
oC. The reaction mixture was stirred at this temperature for 24 h. After cooling down to room 
temperature, silica gel (~ 1 mL) was added and the slurry was concentrated under reduced 
pressure and purified by flash chromatography (3 % EtOAc in hexanes) to the desired product 
as a white solid (22 mg, 90 %).  1H NMR (400 MHz, CDCl3) δ 8.02 (s, 1H), 7.85 (d, J =6.7 Hz, 
1H), 7.39-7.35 (m, 2H), 4.38 (t, J = 5.0 Hz, 2H), 2.81(t, J = 5.5 Hz, 2H), 1.82-1.78 (m, 4H), 
1.66-1.62 (m, 2H), 1.52 (m, 6H), 1.38-1.36 (m, 2H) ppm; 13C NMR (75 MHz, CDCl3) δ 168.7, 
141.2, 133.8, 130.4, 128.6, 128.4, 126.5, 66.3, 31.8, 28.5, 27.9, 27.5, 26.7, 26.6, 25.1, 24.3 ppm; 
HRMS (ESI+) for C16H23O2 [M + H]
+ calculated: 247.1693 found: 247.1693. 
 
3-Oxabicyclo[13.3.1]nonadeca-1(19),15,17-trien-2-one (7) : 3-(11-Hydroxyundec-1-
yl)benzoic acid (29 mg, 0.10 mmol, 1.0 equiv.) was dissolved in toluene (20 mL, 5 mM).   
Hf(OTf)4 (3.9 mg, 0.0050 mmol, 0.05equiv.) was added to the solution and the reaction mixture 
heated to 110 oC. The reaction mixture was stirred at this temperature for 24 h. After cooling 
down to room temperature, silica gel (~ 1 mL) was added and the slurry was concentrated under 
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reduced pressure and purified by flash chromatography (3 % EtOAc in hexanes) to afford the 
desired product  (23 mg, 84 %).  1H NMR (400 MHz, CDCl3) δ 7.92-7.90 (m, 2H), 7.39-7.35 
(m, 2H), 4.38 (t, J = 5.4 Hz, 2H), 2.75 (t, J = 6.2Hz, 2H), 1.80-1.68 (m, 4H), 1.58-1.52 (m, 2H), 
1.31-1.24 (m, 12H) ppm; 13C NMR (100 MHz, CDCl3) δ 166.8, 142.1, 133.6, 130.3, 129.1, 
128.5, 127.2, 65.0, 33.4, 28.5, 27.51, 27.48, 27.45, 27.37, 27.3, 26.9, 25.6, 25.4 ppm; HRMS 
(ESI+) for C18H27O2 [M + H]
+ calculated: 275.2006 found: 275.2005. 
 
3-Oxobicyclo[13.3.1]nonadeca-1(19)-15,17-trien-13-yn-2-one (8) The hydroxyacid S6 (29 
mg, 0.10 mmol, 1.0 equiv.) was dissolved in toluene (20 mL, 5 mM).   Hf(OTf)4 (3.9 mg, 0.0050 
mmol, 0.05 equiv.) was added to the solution and the reaction mixture heated to 110 oC. The 
reaction mixture was stirred at this temperature for 24 h. After cooling down to room 
temperature, silica gel (~ 1 mL) was added and the slurry was concentrated under reduced 
pressure and purified by flash chromatography (3 % EtOAc in hexanes) to afford the desired 
product (15 mg, 56 %) as a white solid. 1H NMR (400 MHz, CDCl3) δ = 8.30 (dd, J = 1.5 Hz, 
1.5 Hz 1H), 7.92 (dd, J = 7.7 Hz, 7.7 Hz, 1.5 Hz, 1H), 7.42 - 7.49 (m, 1H), 7.34-7.42 (m, 1H), 
4.34 - 4.41 (m, 2H), 2.41 - 2.48 (m, 2H), 1.82-1.80 (m, 2H), 1.77 -1.65 (m, 8H), 1.57-1.41 (m, 
4H) ppm; 13C NMR (100 MHz, CDCl3) δ = 165.8, 136.2, 132.5, 130.6, 128.6, 128.1, 124.5, 
93.6, 82.1, 66.4, 30.6, 30.1, 29.9, 28.8, 28.4, 28.2, 27.7, 19.2 ppm; HRMS (ESI) m/z calculated 
for C18H23O2 [M+H]
+ 271.1693; found 271.1693. 
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3-Oxobicyclo[23.3.1]nonacosa-1(29)-25,27-trien-23-yn-2-one (9) The hydroxyacid S16 (43 
mg, 0.10 mmol, 1.0 equiv.) was dissolved in toluene (20 mL, 5 mM).   Hf(OTf)4 (3.9 mg, 0.0050 
mmol, 0.05 equiv.) was added to the solution and the reaction mixture heated to 110 oC. The 
reaction mixture was stirred at this temperature for 24 h. After cooling down to room 
temperature, silica gel (~ 1 mL) was added and the slurry was concentrated under reduced 
pressure and purified by flash chromatography (3 % EtOAc in hexanes) to afford the desired 
product as a white solid (26 mg, 63 %). 1H NMR (400 MHz, CDCl3) δ 8.06 (dd, J = 1.6 Hz, 1.6 
Hz, 1H), 7.96 (ddd, J = 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.57 (ddd, J = 8.4 Hz, 8.4 Hz, 1.6 Hz, 1H), 
7.37 (dd, J = 8.0 Hz, 8.0 Hz, 1H), 4.34 (t, J = 6.4 Hz, 2H), 2.44 (t, J = 7.2 Hz, 2H), 1.82-1.62 
(m, 2 H), 1.66-1.60 (m, 2H), 1.51-1.35 (m, 4H), 1.27 (m, 26H) ppm; 13C NMR (75 MHz, CDCl3) 
δ 166.2, 135.5, 132.5, 130.7, 128.7, 128.3, 124.4, 91.5, 79.9, 65.3, 29.6, 28.96, 28.91, 28.84, 
28.82, 28.80, 28.79, 28.77, 28.74, 28.72 (2C), 28.70, 28.65, 28.60, 28.4, 28.3, 26.0, 19.3 ppm; 
HRMS (ESI+) for C28H42O2 [M +H]
+ calculated: 411.3258 found: 411.3249. 
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(9Z)-Isoambrettolide (10) (Z)-16-Hydroxyhexadec-9-enoic acid (27 mg, 0.10 mmol, 1.0 
equiv.) was dissolved in toluene (20 mL, 5 mM).   Hf(OTf)4 (3.9 mg, 0.0050 mmol, 0.05 equiv.) 
was added to the solution and the reaction mixture heated to 110 oC. The reaction mixture was 
stirred at this temperature for 24 h. After cooling down to room temperature, silica gel (~ 1 mL) 
was added and the slurry was concentrated under reduced pressure and purified by flash 
chromatography (3 % Et2O in hexanes) to afford the desired product as a white solid (18 mg, 72 
%). Spectral data were in accordance with those previously reported in the literature15. 
 
(±)-erythro-10,11-Bis[2,2-(dimethyl)propanoate]oxaheptadecan-2-one (11) The 
hydroxyacid S14 (47 mg, 0.10 mmol, 1.0 equiv.) was dissolved in toluene (20 mL, 5 mM).   
Hf(OTf)4 (3.9 mg, 0.0050 mmol, 0.05 equiv.) was added to the solution and the reaction mixture 
heated to 110 oC. The reaction mixture was stirred at this temperature for 24 h. After cooling 
down to room temperature, silica gel (~ 1 mL) was added and the slurry was concentrated under 
reduced pressure and purified by flash chromatography (10 % Et2O in hexanes) to afford the 
                                                 
15 Delphis, C. Cis-isoambrettolide of High Degree of Isomer Purity and Use Thereof  2001, Patent No.: US 
6,284,900  B1. 
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desired product as a colorless oil (33 mg, 73 %). 1H NMR (400 MHz, CDCl3) δ 5.10-5.05 (m, 
1H), 5.03-4.98 (m, 1H), 4.18-4.10 (m, 2H), 2.34 (t, J = 6.4 Hz, 2H), 1.75-1.25 (m, 22H), 1.19 
(s, 9H), 1.18 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 177.8, 177.7, 174.0, 73.2, 72.3, 64.1, 38.8, 
34.6, 30.0, 29.2, 28.6, 28.1, 28.0, 27.7, 27.5, 27.22, 27.20, 25.6, 25.0, 23.7, 22.7 ppm; HRMS 
(ESI+) for C26H46O6Na
 [M +Na]+ calculated: 477.3187 found: 477.3166. 
 
Oxacycloicosa-10,12-diyne-2-one (12) The hydroxyacid S17 (32 mg, 0.10 mmol, 1.0 equiv.) 
was dissolved in toluene (20 mL, 5 mM).   Hf(OTf)4 (3.9 mg, 0.0050 mmol, 0.05 equiv.) was 
added to the solution and the reaction mixture heated to 110 oC. The reaction mixture was stirred 
at this temperature for 24 h. After cooling down to room temperature, silica gel (~ 1 mL) was 
added and the slurry was concentrated under reduced pressure and purified by flash 
chromatography (10 % EtOAc in hexanes) to afford the macrocycle as a white solid (26 mg, 86 
%). Spectral data were in accordance with those previously reported in the literature14. 
 
(S)-3-((S)-sec-Butyl)-1-oxa-4-azacyclononadecane-2,5-dione (13)The hydroxyacid S19 (64 
mg, 0.17 mmol, 1.0 equiv.) was dissolved in toluene (35 mL, 5 mM).   Hf(OTf)4 (6.7 mg, 0.0087 
mmol, 0.05 equiv.) was added to the solution and the reaction mixture heated to 110 oC. The 
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reaction mixture was stirred at this temperature for 24 h. After cooling down to room 
temperature, silica gel (~ 2 mL) was added and the slurry was concentrated under reduced 
pressure and purified by flash chromatography (10 to 50 % EtOAc in hexanes) to afford the 
macrocycle as a white solid (45 mg, 74 %). 1H NMR (400 MHz, CDCl3) δ 5.90 (d, J = 8.5 Hz, 
1H (NH)), 4.61 (dd, J = 8.7 Hz, 5.2 Hz, 1H), 4.40-4.34 (m, 1H), 3.99 (dt, J = 10.7 Hz, 5.7 Hz, 
1H), 2.33 (dt, J = 14.6 Hz, 6.4 Hz, 1H), 2.19-2.12 (m, 1H), 1.92-1.86 (m, 1H), 1.80-1.50 (m, 
4H), 1.49-1.38 (m, 1H), 1.37-1.20 (m, 20H), 1.20-1.10 (m, 1H), 0.95-0.91 (m, 6H) ppm; 13C 
NMR (100 MHz, CDCl3) δ 172.7, 171.8, 64.9, 56.6, 38.0, 36.5, 28.5, 28.09, 28.07, 28.04, 28.01, 
27.9, 27.5, 27.1, 27.0, 25.20, 25.19, 25.0, 15.4, 11.5 ppm; HRMS (ESI+) for C21H40NO3 [M + 
H]+ calculated: 354.3003 found: 354.3008. 
 
(3S, 6S)-3,6-Dibenzyl-1-oxa-4,7-diazacyclodocosane-2,5-dione (14) The hydroxyacid (S21) 
(65 mg, 0.11 mmol, 1.0 equiv.) was dissolved in toluene (24 mL, 5 mM).   Hf(OTf)4 (4.6 mg, 
0.0056 mmol, 0.05 equiv.) was added to the solution and the reaction mixture heated to 110 oC. 
The reaction mixture was stirred at this temperature for 24 h. After cooling down to room 
temperature, silica gel (~ 2 mL) was added and the slurry was concentrated under reduced 
pressure and purified by flash chromatography (10 to 60 % EtOAc in hexanes) to afford the 
macrocycle as a white solid (37 mg, 57 %). 1H NMR (CDCl3, 300 MHz) δ 7.37-7.19 (m, 8H), 
6.92-6.89 (m, 2H), 6.26 (d, J = 6.8 Hz, 1H), 5.83 (d, J = 7.1 Hz, 1H), 4.67-4.58 (m, 2H), 4.23-
4.15 (m, 1H), 4.12-4.05 (m, 1H), 3.22-2.90 (m, 4H), 2.20-2.05 (m, 6H), 1.63-1.54 (m, 8 H), 
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1.28-1.25 (m, 16 H) ppm; 13C NMR (CDCl3, 75 MHz) δ 173.3, 170.8, 170.2, 136.8, 135.8, 
129.5, 129.2, 128.8, 128.4, 127.2, 127.1, 65.4, 54.1, 53.9, 37.6, 37.4, 36.3, 28.09 (3C), 28.05 
(2C), 28.01 (3C), 27.96, 27.91, 25.1 (2C) ppm; ; HRMS (ESI +) for C33H47N2O4 (M + H
+) 
calculated mass : 535.3530, found 535.3529. 
SYNTHESIS OF ESTERIFICATION PRECURSORS 
 
8-(Methoxymethoxy)octanol (S22) 1,8-octanediol (1.00 g, 6.84 mmol, 1.00 equiv.) was 
dissolved in CH2Cl2 (34 mL). iPr2NEt (2.38 mL, 13.7 mmol, 2.00 equiv.) was added followed 
by MOMCl (0.52 mL, 6.8 mmol, 1.0 equiv.). The reaction mixture was stirred at room 
temperature for 24 h and was subsequently quenched by the addition of a saturated solution of 
NH4Cl (25 mL). Extraction with CH2Cl2 (2 x 30 mL) was performed and the combined organic 
layers were washed with water (30 mL) and brine (30 mL) and dried over Na2SO4, filtered and 
concentrated under reduced pressure. Flash chromatography (20 % EtOAc in hexanes) was 
performed to afford the product as a colorless oil (775 mg, 60 %). 1H NMR (400 MHz, CDCl3) 
δ 4.61 (s, 2H), 3.62 (t, J = 6.6 Hz, 2H), 3.51 (t, J = 6.6 Hz, 2H), 3.35 (s, 3H), 1.75 (br s, 1H 
(OH)), 1.70-1.50 (m, 4H), 1.35-1.25 (m, 8H) ppm; 13C NMR (100 MHz, CDCl3) δ 96.3, 67.8, 
62.9, 55.0, 32.7, 29.6, 29.32, 29.30, 26.1, 25.6 ppm; HRMS (ESI+) for C10H22O3Na
 [M + Na]+ 
calculated 213.1461 found: 213.1469. 
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SYNTHESIS OF ESTERS 
General procedure A: An open oven-dried sealable tube was charged with the carboxylic acid 
(1.00 mmol, 1.00 equiv.) and dissolved in toluene (1 mL, 1M). Hf(OTf)4 (38 mg, 0.050 mmol, 
0.050 equiv.) and the alcohol (1.0 mmol, 1.0 equiv.) were then added to the mixture and the tube 
was sealed. The reaction mixture was stirred at 110 oC for 24 h and then cooled down to room 
temperature. The tube was opened and silica gel (~ 5 mL) was added.  The slurry was 
concentrated under reduced pressure and purified by flash chromatography. 
General procedure B: An open oven-dried sealable tube was charged with the carboxylic acid 
(1.00 mmol, 1.00 equiv.), iPr2NEt (0.087 mL, 0.50 mmol, 0.5 equiv.) and dissolved toluene (1 
mL, 1M). Hf(OTf)4 (38 mg, 0.050 mmol, 0.050 equiv.) and the alcohol (1.0 mmol, 1.0 equiv.) 
were then added to the mixture and the tube was sealed. The reaction mixture was stirred at 110 
oC for 24 h and then cooled down to room temperature. The tube was opened and silica gel (~ 5 
mL) was added. The slurry was concentrated under reduced pressure and purified by flash 
chromatography. 
 
Pentyl pentanoate (15) Following general procedure A, flash chromatography (5 % EtOAc in 
hexanes) afforded the product as a colorless oil (171 mg, >99 %). Spectral data were in 
accordance with those previously reported in the literature.16 
                                                 
16 Solvhoj, A; Madsen, R. Organometallics 2011, 30, 6044-6048. 
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Pentyl ((tert-butyloxy)carbonyl)glycinate (16) Following general procedure A, flash 
chromatography (15 % EtOAc in hexanes) was performed to afford the product as a colorless 
oil (176 mg, 72 %). 1H NMR (400 MHz, CDCl3) δ 5.09 (br s, 1H (NH)), 4.11 (t, J = 6.7 Hz, 
2H), 3.87 (d, J = 5.4 Hz, 2H), 1.65-1.57 (m, 2H), 1.44-1.40 (m, 11H), 1.35-1.28 (m, 4H), 0.88 
(t, J = 6.4 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 170.4, 155.7, 79.8, 65.4, 42.3, 28.2, 
28.1, 27.8, 22.2, 13.8 ppm; HRMS (ESI+) for C12H23NO4Na
 [M + Na]+ calculated 268.1519 
found: 268.1525. 
 
Pentyl N-(p-tosyl)glycinate (17) Following general procedure A, flash chromatography (10 % 
EtOAc in hexanes) was performed to afford the product as a white solid (224 mg, 75 %). 1H 
NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.1 Hz, 2H), 7.30 (d, J = 8.1 Hz, 2H), 5.23 (br s, 1H 
(NH)), 4.01 (t, J = 6.9 Hz, 2H), 3.77 (d, J = 5.5 Hz, 2H), 2.42 (s, 3H), 1.55-1.50 (m, 2H), 1.30-
1.22 (m, 4H), 0.88 (t, J = 6.8 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 168.8, 143.7, 136.2, 
129.7, 127.2, 65.9, 44.1, 28.0, 27.7, 22.1, 21.4, 13.8 ppm; HRMS (ESI+) for C14H22NO4S
 [M + 
H]+ calculated 300.1264 found: 300.1278. 
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Pentyl ((benzyloxy)carbonyl)glycinate (18) Following general procedure A, flash 
chromatography (10 % EtOAc in hexanes) was performed to afford the product as a colorless 
oil (220 mg, 79 %). 1H NMR (400 MHz, CDCl3) δ 7.33-7.28 (m, 5H), 5.64 (br s, 1H (NH)), 
5.10 (s, 2H), 4.11 (t, J = 6.8 Hz), 3.92 (d, J = 7.0 Hz, 2H), 1.65-1.55 (m, 2H), 1.35-1.25 (m, 
4H), 0.90 (t, J = 6.9 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 170.0, 156.2, 136.1, 128.2, 
127.85, 127.79, 66.7, 65.3, 42.5, 27.9, 27.7, 22.0, 13.7 ppm; C15H22NO4
 [M + H]+ calculated 
280.1543 found: 280.1551. 
 
8-(tert-Butyldimethylsilyloxy)octyl pentanoate (19) Following general procedure B, flash 
chromatography (5 % EtOAc in hexanes) afforded the product as a colorless oil (178 mg, 66 
%). 1H NMR (400 MHz, CDCl3) δ 4.,06 (t, J = 6.7Hz, 2H), 3.61 (t, J = 6.5Hz, 2H), 2.31 (t, J = 
7.3 Hz, 2H), 1.64-1.60 (m, 2H), 1.55-1.48 (m, 2H), 1.40-1.30 (m, 8H), 0.94-0.90 (m, 12H), 0.05 
(s, 6H) ppm; 13C NMR (100 MHz, CDCl3) δ 173.9, 64.3, 63.2, 34.1, 32.8, 29.3, 29.2, 28.6, 27.1, 
26.0, 25.9, 25.7, 22.2, 18.3, 13.7, -5.3 ppm; HRMS (ESI+) for C19H41O3Si
 [M + H]+ calculated 
345.2820 found: 345.2831. 
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8-(Triisopropylsilyloxy)octyl pentanoate (20) Following general procedure B, flash 
chromatography (5 % EtOAc in hexanes) afforded the product as a colorless oil (217 mg, 62 
%). 1H NMR (400 MHz, CDCl3) δ 4.06 (t, J = 6.8 Hz, 2H), 3.68 (t, J = 6.7 Hz, 2H), 2.30 (t, J 
= 7.4 Hz, 2H), 1.65-1.50 (m, 6H), 1.35-1.25 (m, 10H), 1.09-1.06 (m, 21 H), 0.92 (t, J = 7.3 Hz, 
3H) ppm; 13C NMR (100 MHz, CDCl3) δ 173.9, 64.3, 63.4, 34.1, 33.0, 29.3, 29.2, 28.6, 27.1, 
25.9, 25.7, 22.2, 17.9, 13.6, 12.0 ppm; HRMS (ESI+) for C22H46O3SiNa
 [M + Na]+ calculated 
409.3108 found: 409.3128. 
 
8-(Methoxymethoxy)octyl pentanoate (21) Following general procedure B, flash 
chromatography (10 % EtOAc in hexanes) afforded the product as a colorless oil (210 mg, 77 
%). 1H NMR (400 MHz, CDCl3) δ 4.58 (s, 2H), 4.02 (t, J = 6.8Hz, 2H), 3.48 (t, J = 6.6Hz, 2H), 
3.32 (s, 3H), 2.26 (t, J = 7.5 Hz, 2H), 1.60-1.50 (m, 6H), 1.35-1.25 (m, 10H), 0.88 (t, J = 7.3 
Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 173.8, 96.3, 67.7, 64.2, 54.9, 34.0, 29.6, 29.2, 
29.1, 28.5, 27.0, 26.0, 25.8, 22.2, 13.6 ppm; HRMS (ESI+) for C15H30O4Na
 [M + Na]+ calculated 
297.2036 found: 297.2047. 
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8-acetoxyoctyl pentanoate (22) Following general procedure B, flash chromatography (5 % 
EtOAc in hexanes) afforded the product as a colorless oil (129 mg, 89 %). 1H NMR (400 MHz, 
CDCl3) δ 4.035 (t, J = 6.7 Hz, 2H), 4.030 (t, J = 6.8 Hz, 2H), 2.28 (t, J = 7.4 Hz, 2H), 2.02 (s, 
3H), 1.63-1.55 (m, 6H), 1.35-1.25 (m, 10H), 0.89 (t, J = 7.3 Hz, 3H) ppm; 13C NMR (100 MHz, 
CDCl3) δ 173.9, 171.1, 64.5, 64.2, 34.0, 29.03, 29.02, 28.53, 28,49, 27.0, 25.8, 25.7, 22.2, 20.9, 
13.6 ppm; HRMS (ESI+) for C15H29O4 (M + H
+) calculated mass: 273.2060, found 273.2059. 
 
Pentyl 12-oxooctadecanoate (23) Following general procedure A, flash chromatography (5 % 
EtOAc in hexanes) afforded the product as a colorless solid (170 mg, 89 %). 1H NMR (400 
MHz, CDCl3) δ 4.04 (t, J = 6.6 Hz, 2H), 2.38-2.34 (m, 4H), 2.27 (t, J = 7.3 Hz, 2H), 1.70-1.50 
(m, 8 H), 1.45-1.20 (m, 22H), 0.90-0.84 (m, 6H) ppm; 13C NMR (100 MHz, CDCl3) δ 211.6, 
173.9, 64.3, 42.7, 34.3, 31.6, 29.3 (4C), 29.2 (2C), 29.1, 28.9, 28.3, 28.0, 24.9, 23.81, 28.78, 
22.4, 22.3, 13.95, 13.89 ppm;  HRMS (ESI+) for C23H45O3 (M + H
+) calculated mass: 369.3363, 
found 369.3369. 
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(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl pentanoate (24) Following general procedure B, 
flash chromatography (15 % EtOAc in hexanes) afforded the product as a colorless oil (130 mg, 
61 %). 1H NMR (400 MHz, CDCl3) δ 4.35-4.27 (m, 1H), 4.19-4.05 (m, 3H), 3.74 (dd, J = 8.4 
Hz, 6.2 Hz, 1H), 2.35 (t, J = 7.4 Hz, 2H), 1.66-1.58 (m, 2H), 1.43 (s, 3H), 1.40-1.30 (m, 5H), 
0.91 (t, J = 7.3 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 173.6, 109.8, 73.6, 66.3, 64.5, 
33.8, 26.9, 29.6, 25.4, 22.2, 13.6 ppm; HRMS (ESI+) for C11H20O4Na
 [M + Na]+ calculated 
239.1254 found: 239.1255.  
 
2-propargyl benzoate (25) Following general procedure A, flash chromatography (10 % 
EtOAc in hexanes) afforded the product as a colorless oil (124 mg, 78 %). Spectral data were in 
accordance with those previously reported in the literature.17 
 
 
                                                 
17 Pereira, G. R.; Brandao, G. C.; Arantes, L. M.; de Oliveira Jr., H. A.; de Paula, R. C.; do Nascimento, M. F. A.; 
dos Santos, F. M.; da Rocha, R. K.; Lopez, J. C. D.; de Oliveira, A. B. Eur. J. Med. Chem. 2014, 73, 295-309.  
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Pentyl furan-3-carboxylate (26) Following general procedure A, flash chromatography (10 % 
EtOAc in hexanes) afforded the product as a colorless oil (144 mg, 75 %). 1H NMR (400 MHz, 
CDCl3) δ 7.99 (s, 1H), 7.40 (d, J = 1.2 Hz, 1H), 6.73 (d, J = 1.2 Hz, 1H), 4.23 (t, J = 6.8 Hz, 
2H), 1.70-1.65 (m, 2H), 1.40-1.30 (m, 4H), 0.90 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (100 MHz, 
CDCl3) δ 163.1, 147.5, 143.6, 119.6, 109.8, 64.5, 28.3, 28.1, 22.3, 13.9 ppm; HRMS (ESI+) for 
C10H15O3[M + H]
+ calculated 183.1016 found: 183.1015. 
 
 
Pentyl thiophen-3-carboxylate (27) Following general procedure A, flash chromatography (10 
% EtOAc in hexanes) afforded the product as a colorless oil (177 mg, 89 %). 1H NMR (400 
MHz, CDCl3) δ 8.10 (dd, J = 3.1, 1.2 Hz, 1H), 7.53 (dd, J = 5.0, 1.2 Hz, 1H), 7.29 (dd, J = 5.0, 
3.1 Hz, 1H), 4.27 (t, J = 6.7 Hz, 2H), 1.77-1.73 (m, 2H), 1.45-1.30 (m, 4H), 0.93 (t, J = 7.0 Hz, 
3H) ppm; 13C NMR (100 MHz, CDCl3) δ 162.8, 134.0, 132.4, 127.9, 125.8, 64.8, 28.4, 28.1, 
22.3, 13.9 ppm; HRMS (ESI+) for C10H15O2S
 [M + H]+ calculated 199.0787 found: 199.0790. 
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Pentan-3-yl pentanoate (36) Following general procedure A using Dy(OTf)3 (30.5 mg, 0.050 
mmol, 0.05 equiv.), flash chromatography (5 % EtOAc in hexanes) afforded the product as a 
colorless oil (103 mg, 60 %). Spectral data were in accordance with those previously reported 
in the literature.18 
 
 
Nonyl benzoate (37) An open oven-dried sealable tube was charged with the benzamide acid 
(121 mg mL, 1.00 mmol, 1.00 equiv.) and dissolved in toluene (1 mL, 1M). Hf(OTf)4 (38 mg, 
0.050 mmol, 0.050 equiv.) and nonanol (0.174 mL, 1.0 mmol, 1.0 equiv.) were then added to 
the mixture and the tube was sealed. The reaction mixture was stirred at 110 oC for 24 h and 
then cooled down to room temperature. The tube was opened and silica gel (~ 5 mL) was added.  
The slurry was concentrated under reduced pressure and purified by flash chromatography (5% 
EtOAc in hexanes) to afford the product as a colorless oil (145 mg, 58 %). Spectral data were 
in accordance with those previously reported in the literature.19 
 
 
 
                                                 
18 Srimani, D.; Balarama, E.; Gnanaprakasam, B.; Ben-David, Y.; Milstein, D. Adv. Synth. Cat. 2012, 354 (13), 
2403-2406. 
19 Ahmad, I.; Malik, A.; Afza, N.; Anis, I.; Fatima, I.; Nawaz, S. A.; Tareen, R. B.; Iqbal, C. ZNB  2005, 60, 2403-
2406. 
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TABULAR DATA 
 
Table S1: Optimization of a Lewis acid catalyzed macrolactonization process. 
 
 Catalyst Yield 2 (%)  Catalyst 
Yield 2 
(%) 
1 AlCl3 0 16 ZrCl4(THF)2 13 
2 MgBr2 ·OEt2 0 17 Zr(tfacac)3 0 
3 BF3·OEt2 36 18 CuBr2 0 
4 B(OH)3 0 19 CuCl2 0 
5 TiCp2Cl2 0 20 Cu(OAc)2 25 
6 TiCl4 0 21 Cu(OTf)2 54 
7 Fe(acac)3 0 22 Sc(OTf)3 45 
8 FeCl3 0 23 Sm(OTf)3 21 
9 Fe(OTf)2 0 24 Dy(OTf)3 13 
10 Fe(OTf)3 0 25 Yb(OTf)3 38 
11 Pd(TFA)3 0 26 Hf(OTf)4 83 
12 Ni(acac)2 0 26 HfCl4(THF)2 17 
13 AgOTf 22 27 Hf(On-Bu)4 12 
14 Zn(OTf)2 0    
15 Co(OAc)2 0    
a Isolated yields following silica gel chromatography.  Remaining mass balance is unreacted 1 unless otherwise 
noted. b No trace of 1 was isolated.  c Polymerization of  1 is observed.  d Lower catalyst loadings provided lower 
yields.  When 2.5 mol % Hf(OTf)4 was  used 72 % of 2 and 27 % re-isolated 1 were obtained. 
 
 
 
 
Table S2: Macrolactonization in the presence of excess water. 
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 Catalyst 
Yield 2 
(%)a 
 Catalyst Yield 2 (%)a 
1 BF3·OEt2 17 7 Sm(OTf)3 0 
2 AgOTf 4 8 Yb(OTf)3 0 
3 Cu(OAc)2 0 9 HfCl4(THF)2 0 
4 ZrCl4(THF)2 13 10 Hf(On-Bu)4 0 
5 Cu(OTf)2 <5 11 Hf(OTf)4 83b 
6 Sc(OTf)3 0 12 Dy(OTf)3 0 
a Isolated yields following silica gel chromatography. b Increasing the water content to 400 
equiv. resulted in a decrease in yield to 23 % of 2. 
 
Table S3: Ring-opening (hydrolysis) of macrolactone 2 under Lewis acid conditions. 
 
 Catalyst 2 (%)a  Catalyst 2 (%)a 
1 BF3·OEt2 99 7 Sm(OTf)3 96 
2 AgOTf 83 8 Yb(OTf)3 83 
3 Cu(OAc)2 67 9 HfCl4(THF)2 50 
4 ZrCl4(THF)2 99 10 Hf(On-Bu)4 99 
5 Cu(OTf)2 67 11 Hf(OTf)4 88b 
6 Sc(OTf)3 58 12 Dy(OTf)3 99 
 
a Yields of recovered 2 following silica gel chromatography. b The re-isolated yield of 2 
remained high (>80 %) even when using 1000 equiv. of added H2O. 
 
COMPETITION EXPERIMENTS 
 
 A39 
Competition experiments confirmed selectivity for primary alcohols over secondary 
alcohols and amines. 
 
Forcing conditions with secondary or tertiary alcohols did not afford the desired esters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SPECTRAL DATA 
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Compound S1 
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Compound S2 
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Annexe 2. Supporting Information of Chapter 4 
General:  
 
All reactions that were carried out under anhydrous conditions were performed under an inert 
argon or nitrogen atmosphere in glassware that had previously been dried overnight at 120 oC 
or had been flame dried and cooled under a stream of argon or nitrogen.1 All commercial 
reagents were obtained from Sigma-Aldrich Chemical Company or Strem Chemicals and were 
reagent quality. Technical solvents were obtained from VWR International Co. Methyl 3-
iodobenzoate2 and methyl 4-iodobenzoate2 were prepared according to literature procedures. 
Anhydrous solvents (CH2Cl2, Et2O, THF, DMF, toluene, and n-hexane) were dried and 
deoxygenated using a GlassContour system (Irvine, CA). Isolated yields reflect the mass 
obtained following flash column silica gel chromatography. Organic compounds were purified 
using the method reported by Still3 and using silica gel obtained from Silicycle Chemical 
division (40-63 nm; 230-240 mesh). Analytical thin-layer chromatography (TLC) was 
performed on glass-backed silica gel 60 coated with a fluorescent indicator (Silicycle Chemical 
division, 0.25 mm, F254.). Visualization of TLC plates was performed by UV (254 nm), KMnO4 
or p-anisaldehyde stains. All mixed solvent eluents are reported as v/v solutions. Concentration 
refers to removal of volatiles at low pressure on a rotary evaporator. All reported compounds 
were homogeneous by thin layer chromatography (TLC) and by 1H NMR. NMR spectra were 
taken in deuterated CDCl3 using Bruker AV-300 and AV-400 instruments unless otherwise 
                                                 
1 Shriver, D. F.; Drezdon, M. A. in The Manipulation of Air-Sensitive Compounds; Wiley-VCH: New York, 1986. 
2 Leatherbarrow, R. J.; Mo, B.; Offermann, D. A.; Sejberg, J. J. P.; Spivey, A. C.; McKendrick, J. E.; Beavil, A. J.; 
Holdom, M. D.; Sutton, B. J.; Helm, B. A. J. Org. Chem. 2012 , 77, 3197-3214 
3 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925.  
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noted. Signals due to the solvent served as the internal standard (CHCl3: δ 7.27 for 1H, δ 77.0 
for 13C). The acquisition parameters are shown on all spectra. The 1H NMR chemical shifts and 
coupling constants were determined assuming first-order behavior. Multiplicity is indicated by 
one or more of the following: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br 
(broad); the list of couplings constants (J) corresponds to the order of the multiplicity 
assignment. High resolution mass spectroscopy (HRMS) was done by the Centre régional de 
spectrométrie de masse at the Département de Chimie, Université de Montréal using an Agilent 
LC-MSD TOF system with the ESI mode of ionization unless otherwise noted.  
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SYNTHESIS OF MACROCYCLE PRECURSORS 
 
Docosa-10,12-diyne-1,22-diol (S1) CuCl2 (55 mg, 0.41 mmol, 0.25 equiv.) and Ni(NO3)2 
. 6H2O 
(120 mg, 0.413 mmol, 0.25 equiv.) were dissolved in MeOH (15 mL). Then Et3N (0.69 mL, 5.0 
mmol, 3.0 equiv.) and pyridine (0.67 mL, 8.3 mmol, 5.0 equiv.) were added to the solution 
followed by 9-undecyn-1-ol (277 mg, 1.65 mmol, 1.0 equiv.). The reaction mixture was purged 
with O2 and was stirred at 60 
oC for 48 h (The reaction mixture was purged O2 every 12 h). The 
mixture was then cooled down to room temperature and silica gel was added. The slurry was 
concentrated under reduced pressure and flash chromatography (30 % EtOAc in hexanes) was 
performed to afford the desired product (130 mg, 47 %) as a white solid.   1H NMR (400 MHz, 
CDCl3) δ 3.65 (t, J = 6.8 Hz, 4H), 2.25 (t, J = 6.8 Hz, 4H), 1.60-1.50 (m, 8H), 1.45-1.26 (m, 
22H) ppm; 13C NMR (75 MHz, CDCl3) δ 77.2, 65.3, 63.1, 32.8, 29.4, 29.0, 28.8, 28.3, 25.73, 
25.70, 19.2 ppm; HRMS (ESI+) for C22H39O2 [M + H]
+ calculated 335.2945 found: 335.2945. 
 
Methyl 3-(5-hydroxypent-1-yn-1-yl)benzoate (S2) Methyl 3-iodobenzoate (1.00 g, 3.82 
mmol, 1.0 equiv.) was dissolved in tetrahydrofuran (20 mL, 0.2 M).  Then  Pd(PPh3)2Cl2 (134 
mg, 0.191 mmol, 0.05 equiv.) and CuI (36 mg, 0.19 mmol, 0.05 equiv.) were added to the 
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solution and the reaction mixture was purged under N2 for 5 min. Triethylamine (3.19 mL, 22.9 
mmol, 6.0 equiv.) and the alkyne (0.35 mL, 3.8 mmol, 1.0 equiv.) were added and the reaction 
mixture was stirred at room temperature for 18 h. Silica gel (~ 5 mL) was added and the slurry 
was concentrated under reduced pressure and flash chromatography (20-40 % EtOAc in 
hexanes) was performed to afford the desired product as a colorless oil (796 mg, 96 %). 1H 
NMR (400 MHz, CDCl3) δ 8.07 (s, 1H), 7.94 (d, J = 7.9 Hz, 1H), 7.56 (d, J = 7.7 Hz, 1H), 7.36 
(dd, J = 7.8, 7.7 Hz, 1H), 3.92 (s, 3H), 3.83 (t, J = 6.2 Hz, 2H), 2.56 (t, J = 7.0 Hz, 2H), 1.91-
1.84 (m, 2H), 1.59 (br s, 1H) ppm; 13C NMR (100 MHz, CDCl3) δ 166.5, 135.7, 132.7, 130.3, 
128.6, 128.3, 124.2, 90.4, 80.1, 61.7, 52.2, 31.3, 15.9 ppm; HRMS (ESI+) for C13H15O3 [M + 
H]+ calculated: 219.1016 found: 219.1018. 
 
Methyl 3-(5-hydroxypent-1-yl)benzoate (S3) The alkyne (218 mg, 1.00 mmol) was dissolved 
in ethyl acetate (5 mL) under N2. Then Pd/C (212 mg, 5% w/w, 0.100 mmol, 0.1 equiv.) was 
added and the reaction mixture was purged with H2 for 10 min. A balloon, filled with H2 and 
equipped with a syringe, was pierced into the septum and the reaction mixture was stirred at 
room temperature for 18 h. The reaction mixture was passed through a short pad of Celite® after 
being purged by bubbling with N2
 for 10 min and concentrated under reduced pressure. 
Purification by flash chromatography (30% EtOAc in hexanes) was performed to afford the 
desired product as a colorless oil (212 mg, 95 %). 1H NMR (400 MHz, CDCl3) δ 7.89-7.88 (m, 
2H), 7.39-7.37 (m, 2H), 3.94 (s, 3H), 3.67 (t, J = 6.5 Hz, 2H), 2.70 (t, J = 8.6 Hz, 2H), 1.74-
1.60 (m, 4H), 1.46-1.41 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3) δ 167.3, 142.8, 133.0, 130.1, 
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129.5, 128.3, 127.0, 62.8, 52.0, 35.6, 32.6, 31.1, 25.3 ppm; HRMS (ESI+) for C13H18O3Na [M 
+ Na]+ calculated: 245.1148 found: 245.1146. 
 
3-(5-Hydroxypent-1-yl)benzoic acid (S4) Methyl 3-(5-hydroxypent-1-yl)benzoate (200 mg, 
0.901 mmol, 1.0 equiv.) was dissolved in tetrahydrofuran (8 mL). Then LiOH (87 mg, 3.6 mmol, 
4.0 equiv.) was added as an aqueous solution (2 mL). The reaction mixture was stirred at 65 oC 
for 18 h. The reaction mixture was cooled to room temperature and HCl (1 M) was added until 
the pH was neutralized (pH = 7). Extraction with EtOAc (3 X 5 mL) was performed and the 
combined organic phases were washed with brine (15 mL). The organic phase was dried over 
Na2SO4, filtered and concentrated under reduced pressure to afford the desired product as a 
white solid (187 mg, 99 %). 1H NMR (400 MHz, CDCl3) δ 7.95-7.94 (m, 2H), 7.44-7.36 (m, 
2H), 3.67 (t, J = 6.6 Hz, 2H), 2.71 (t, J = 7.5 Hz, 2 H), 1.73-1.59 (m, 4H), 1.46-1.38 (m, 2H) 
ppm; 13C NMR (100 MHz, CDCl3) δ 171.5, 142.9, 133.7, 129.9, 129.5, 128.4, 127.6, 62.7, 35.6, 
32.3, 31.0, 25.3 ppm;  HRMS (ESI+) for C12H16O3Na [M + Na]
+ calculated: 231.0992 found: 
231.0986. 
 
Methyl 4-(5-hydroxypent-1-yn-1-yl)benzoate (S5) Methyl 3-iodobenzoate (1.00 g, 3.82 
mmol, 1.0 equiv.) was dissolved in tetrahydrofuran (20 mL, 0.2 M).  Then Pd(PPh3)2Cl2 (134 
 A85 
mg, 0.191 mmol, 0.05 equiv.) and CuI (36 mg, 0.19 mmol, 0.05 equiv.) were added to the 
solution and the reaction mixture was purged under N2 for 5 min. Triethylamine (3.19 mL, 22.9 
mmol, 6.0 equiv.) and the alkyne (0.35 mL, 3.8 mmol, 1.0 equiv.) were added and the reaction 
mixture was stirred at room temperature for 18 h. Silica gel (~ 5 mL) was added and the slurry 
was concentrated under reduced pressure and flash chromatography (20-40 % EtOAc in 
hexanes) was performed to afford the desired product as a white solid (563 mg, 68 %). 1H NMR 
(400 MHz, CDCl3) δ 7.96 (d, J = 8.6 Hz, 2H), 7.45 (d, J = 8.4 Hz, 2H), 3.92 (s, 3H), 3.84 (m, 
2H), 2.58 (t, J = 7.0 Hz, 2H), 1.91-1.87 (m, 2H), 1.50 (br s, 1H) ppm; 13C NMR (100 MHz, 
CDCl3) δ 166.6, 131.5, 129.4, 129.0, 128.6, 92.8, 80.6, 61.7, 52.2, 31.2, 16.1 ppm; HRMS 
(ESI+) for C13H15O3 [M + H]
+ calculated: 219.1016 found: 219.1018. 
 
Methyl 4-(5-hydroxypent-1-yl)benzoate (S6) The alkyne (250 mg, 1.15 mmol, 1.00 equiv.) 
was dissolved in ethyl acetate (6 mL) under N2. Then Pd/C (243 mg, 5% w/w, 0.115 mmol, 0.1 
equiv.) was added and the reaction mixture was purged with H2 for 10 min. A balloon filled with 
H2 and equipped with a syringe and a needle and the needle was pierced into the septum and the 
reaction mixture was stirred at room temperature for 18 h. The reaction mixture was passed 
through a short pad of Celite® after being purged by bubbling with N2
 for 10 min and 
concentrated under reduced pressure. Purification by flash chromatography (30% EtOAc in 
hexanes) was performed to afford the desired product as a white solid (212 mg, 95 %). 1H NMR 
(400 MHz, CDCl3) δ 7.95 (d, J = 8.2 Hz, 2H), 7.24 (d, J = 8.0 Hz, 2H), 3.90 (s, 3H), 3.64 (t, J 
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= 6.6 Hz, 2H), 2.68 (t, J = 7.7 Hz, 2H), 1.72-1.57 (m, 4H), 1.45-1.37 (m, 2H) ppm; 13C NMR 
(100 MHz, CDCl3) δ 167.2, 148.1, 129.6, 128.4, 127.7, 62.8, 51.9, 35.9, 32.5, 30.9, 25.4 ppm; 
HRMS (ESI+) for C13H19O3 [M + H]
+ calculated: 223.1329 found: 223.1321. 
 
4-(5-Hydroxypent-1-yl)benzoic acid (S7) Methyl 4-(5-hydroxypent-1-yl)benzoate (200 mg, 
0.900 mmol, 1.0 equiv.) was dissolved in tetrahydrofuran (7.2 mL). Then LiOH (86 mg, 3.6 
mmol, 4.0 equiv.) was added as an aqueous solution (1.8 mL). The reaction mixture was stirred 
at 65 oC for 18 h. The reaction mixture was cooled to room temperature and HCl (1 M) was 
added until the pH of the mixture was neutralized (pH = 7). Extraction with EtOAc (3 X 5 mL) 
was performed and the combined organic phases were washed with brine (15 mL). The organic 
phase was dried over Na2SO4, filtered and concentrated under reduced pressure to afford the 
desired product as a white solid (130 mg, 70 %). 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = 8.1 
Hz, 2H), 7.29 (d, J = 8.2 Hz, 2H), 3.67 (t, J = 6.6 Hz, 2H), 2.71 (t, J = 7.5 Hz, 2H), 1.72-1.60 
(m, 4H), 1.47-1.40 (m, 2H) ppm; 13C NMR (75 MHz, CDCl3) δ 171.2, 149.1, 130.3, 128.6, 
126.8, 62.8, 36.0, 32.5, 30.9, 25.4 ppm; HRMS (ESI+) for C12H16O3Na [M + Na]
+ calculated: 
231.0992 found: 231.0988. 
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SYNTHESIS OF MACROCYCLES 
 
1,6-Dioxapentadecane-7,15-dione (4): 1,4-Butanediol (0.017 mL, 0.20 mmol, 1.0 equiv.) and 
1,9-nonanedioic acid (38 mg, 0.20 mmol, 1.0 equiv.) were dissolved in toluene (40 mL, 5 mM).   
Then Hf(OTf)4 (15.5 mg, 0.0200 mmol, 0.1equiv.) was added to the solution and the reaction 
mixture heated to 110 oC. The reaction mixture was stirred at this temperature for 48 h. After 
cooling to room temperature, silica gel (~ 1 mL) was added and the slurry was concentrated 
under reduced pressure and purified by flash chromatography (5 % EtOAc in hexanes) to afford 
the desired product as a white solid (28 mg, 58 %).  1H NMR (400 MHz, CDCl3) δ 4.21 (m, 
4H), 2.34 (m, 4H), 1.77 (m, 4H), 1.64 (m, 4H), 1.37-1.34 (m 6H) ppm; 13C NMR (100 MHz, 
CDCl3) δ 173.7, 63.6, 34.6, 27.8, 27.5, 26.5, 24.6 ppm; HRMS (ESI+) for C13H23O4 [M + H]+ 
calculated: 243.1591 found: 243.1599.  
 
1,7-Dioxahexadecane-8,16-dione (5): 1,4-Pentanediol (0.021 mL, 0.20 mmol, 1.0 equiv.) and 
1,9-nonanedioic acid (38 mg, 0.20 mmol, 1.0 equiv.) were dissolved in toluene (40 mL, 5 mM).   
Then Hf(OTf)4 (15.5 mg, 0.0200 mmol, 0.1equiv.) was added to the solution and the reaction 
mixture heated to 110 oC. The reaction mixture was stirred at this temperature for 48 h. After 
cooling to room temperature, silica gel (~ 1 mL) was added and the slurry was concentrated 
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under reduced pressure and purified by flash chromatography (5 % EtOAc in hexanes) to afford 
the desired product as a white solid (30 mg, 60 %).  1H NMR (400MHz, CDCl3) δ 4.14 (t, J = 
5.4 Hz, 4H), 2.36 (t, J = 6.5 Hz, 4H), 1.71-1.62 (m, 8H), 1.57-1.48 (m, 2H), 1.37-1.30 (m, 6H) 
ppm; 13C NMR (100 MHz, CDCl3) δ 173.8, 64.1, 34.3, 28.7, 28.3, 27.7, 24.9, 23.9 ppm; HRMS 
(ESI+) for C14H25O4 [M + H]
+ calculated: 257.1756 found: 257.1747. 
 
1,9-Dioxaoctadecane-10,18-dione (6): 1,7-Heptanediol (0.030 mL, 0.20 mmol, 1.0 equiv.) and 
1,9-nonanedioic acid (38 mg, 0.20 mmol, 1.0 equiv.) were dissolved in toluene (40 mL, 5 mM).   
Then Hf(OTf)4 (15.5 mg, 0.0200 mmol, 0.1 equiv.) was added to the solution and the reaction 
mixture heated to 110 oC. The reaction mixture was stirred at this temperature for 48 h. After 
cooling to room temperature, silica gel (~ 1 mL) was added and the slurry was concentrated 
under reduced pressure and purified by flash chromatography (5 % EtOAc in hexanes) to afford 
the desired product as a white solid (55 mg, 96 %).  1H NMR (400 MHz, CDCl3) δ 4.13 (t, J = 
5.6 Hz, 4H), 2.32 (t, J = 6.4 Hz, 4H), 1.65-1.59 (m, 8H), 1.41-1.30 (m, 12H) ppm; 13C NMR 
(100 MHz, CDCl3) δ 173.8, 63.7, 34.9, 29.2, 28.8, 28.4, 28.0, 25.6, 25.5 ppm; HRMS (ESI+) 
for C16H29O4 [M + H]
+ calculated: 285.2060 found: 285.2051.  
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1,10-Dioxanonadecane-11,19-dione (3): 1,8-Octanediol (29, 0.20 mmol, 1.0 equiv.) and 1,9-
nonanedioic acid (38 mg, 0.20 mmol 1.0 equiv.) were dissolved in toluene (40 mL, 5 mM).  
Then Hf(OTf)4 (7.8 mg, 0.010 mmol, 0.1 equiv.) was added to the solution and the reaction 
mixture heated to 110 oC. The reaction mixture was stirred at this temperature for 48 h. After 
cooling to room temperature, silica gel (~ 1 mL) was added and the slurry was concentrated 
under reduced pressure and purified by flash chromatography (5 % EtOAc in hexanes) to the 
desired product as a white solid (55 mg, 92 %).   1H NMR (400 MHz, CDCl3) δ 4.12 (t, J = 6.0 
Hz, 4H), 2.32 (t, J = 6.8 Hz, 4H), 1.65-1.60 (m, 8H), 1.40-1.30 (m, 14H) ppm; 13C NMR (100 
MHz, CDCl3) δ 174.0, 64.3, 34.8, 29.3, 29.1, 28.9, 28.7, 26., 25.3 ppm; HRMS (ESI+) for 
C17H31O4 [M + H]
+ calculated: 299.2217 found: 299.2226.  
 
 
1,11-Dioxacyclotritriaconta-21,23-diyne-2,10-dione (7) The diol S1 (33 mg, 0.10 mmol, 1.0 
eq) and the diacid (19 mg, 0.10 mmol 1.0 eq) were dissolved in toluene (20 mL, 5 mM). Then 
Hf(OTf)4 (7.8 mg, 0.010 mmol, 0.1 equiv.) was added to the solution and the reaction mixture 
heated to 110 oC. The reaction mixture was stirred at this temperature for 48 h. After cooling to 
room temperature, silica gel (~ 2 mL) was added and the slurry was concentrated under reduced 
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pressure and purified by flash chromatography (5 % EtOAc in hexanes) to afford the desired 
product as a yellow solid (30 mg, 62 %). 1H NMR (400 MHz, CDCl3) δ 4.08 (t, J = 6.0 Hz, 4H), 
2.30 (t, J =7.4 Hz, 4H), 2.26 (t, J =6.5 Hz, 4H), 1.65-1.60 (m, 8H), 1.55-1.48 (m, 4H), 1.40-
1.30 (m, 26H) ppm 13C NMR (100 MHz, CDCl3) δ 173.9, 77.4, 65.4, 64.3, 34.4, 29.1, 29.0, 
28.9, 28.7, 28.6, 28.5, 28.0, 25.9, 24.9, 19.1 ppm; HRMS (ESI+) for C31H50O4Na
 [M + Na]+ 
calculated 509.3601 found: 509.3596.  
 
1,5-Dioxacycloheptacosa-15,17-diyne-2,4-dione (8) The diol S1 (33 mg, 0.10 mmol, 1.0 
equiv.) and the diacid (11 mg, 0.10 mmol 1.0 equiv.) were dissolved in toluene (20 mL, 5 mM). 
Then Hf(OTf)4 (7.8 mg, 0.010 mmol, 0.1 equiv.) was added to the solution and the reaction 
mixture heated to 110 oC. The reaction mixture was stirred at this temperature for 48 h. After 
cooling to room temperature, silica gel (~ 2 mL) was added and the slurry was concentrated 
under reduced pressure and purified by flash chromatography (5 % EtOAc in hexanes) to afford 
the desired product as a white solid (26 mg, 64 %). 1H NMR (400 MHz, CDCl3) δ 4.15 (t, J = 
6.8 Hz, 4H), 3.38 (s, 2H), 2.28 (t, J =6.0 Hz, 4H), 2.26 (t, J =6.5 Hz, 4H), 1.70-1.60 (m, 4H), 
1.53-1.30 (m, 24H) ppm; 13C NMR (100 MHz, CDCl3) δ 166.6, 77.4, 65.6, 41.8, 29.2, 28.8, 
28.7, 27.8, 25.8, 19.1 ppm; HRMS (ESI+) for C25H38O4Na
 [M + Na]+ calculated 425.2662 
found: 425.2672.  
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3,13-Dioxa-1(1,13)-benzenacyclotetradecaphane-2,14-dione (9) 1,9-Nonanediol (16 mg, 0.1 
mmol, 1.0 equiv.) and isophthalic acid (17 mg, 0.1 mmol 1.0 equiv.) were dissolved in toluene 
(20 mL, 5 mM). Then Hf(OTf)4 (7.8 mg, 0.01 mmol, 0.1 equiv.) was added to the solution and 
the reaction mixture heated to 110 oC. The reaction mixture was stirred at this temperature for 
48 h. After cooling to room temperature, silica gel (~ 2 mL) was added and the slurry was 
concentrated under reduced pressure and purified by flash chromatography (10 % EtOAc in 
hexanes) to afford the desired product as a white solid (23 mg, 79 %). 1H NMR (400 MHz, 
CDCl3) δ 8.76 (s, 1H), 8.26-8.23 (m, 2H), 7.57 (t, J = 7.8 Hz, 1H), 4.39 (t, J = 5.2 Hz, 4H), 
1.82-1.20 (m, 14H) ppm; 13C NMR (100 MHz, CDCl3) δ 165.5, 133.7, 130.91, 130.89, 128.8, 
65.3, 28.9, 28.4, 28.1, 26.2 ppm; HRMS (ESI+) for C17H23O4
 [M + H]+ calculated 291.1591 
found: 291.1592.  
 
3,13-Dioxa-1(2,5)-furanacyclotetradecaphane-2,14-dione (10) 1,9-Nonanediol (16 mg, 0.1  
mmol, 1.0 equiv.) and 2,5-furandicarboxylic acid (15 mg, 0.10 mmol 1.0 equiv.) were dissolved 
in toluene (20 mL, 5 mM).  Then Hf(OTf)4 (7.8 mg, 0.010 mmol, 0.1 equiv.) was added to the 
solution and the reaction mixture heated to 110 oC. The reaction mixture was stirred at this 
temperature for 48 h. After cooling to room temperature, silica gel (~ 2 mL) was added and the 
slurry was concentrated under reduced pressure and purified by flash chromatography (10 % 
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EtOAc in hexanes) to afford the desired product as a white solid (22 mg, 79 %). 1H NMR (400 
MHz, CDCl3) δ 7.25 (s, 2H), 4.37 (t, J = 5.5 Hz, 4H), 1.80-1.75 (m, 4H), 1.63-1.35 (m, 10H) 
ppm; 13C NMR (100 MHz, CDCl3) δ 158.1, 146.5, 118.0, 65.8, 29.1, 28.4, 27.7, 26.2 ppm; 
HRMS (ESI+) for C15H20O5Na
 [M + Na]+ calculated 303.1203 found: 303.1205.  
 
(3R, 4R)-2,5-Dioxo-1,6-dioxacyclopentadecane-3,4-diyl dibenzoate (11) 1,9-Nonanediol (32 
mg, 0.20 mmol, 1.0 equiv.) and dibenzoyl-L-tartaric acid (71 mg, 0.20 mmol 1.0 equiv.) were 
dissolved in toluene (40 mL, 5 mM).  Then Hf(OTf)4 (15.5 mg, 0.020 mmol, 0.1 equiv.) was 
added to the solution and the reaction mixture heated to 110 oC. The reaction mixture was stirred 
at this temperature for 48 h. After cooling to room temperature, silica gel (~ 2 mL) was added 
and the slurry was concentrated under reduced pressure and purified by flash chromatography 
(10-20 % EtOAc in hexanes) to afford the desired product as a colorless oil (56 mg, 58 %). 1H 
NMR (400 MHz, CDCl3) δ 8.06 (d, J = 7.9 Hz, 4H), 7.57 (t, J = 7.2 Hz, 2H), 7.43 (t, J = 7.6 
Hz, 4H), 5.88 (s, 2H), 4.36-4.32 (m, 4H), 1.75-1.65 (m, 4H), 1.43-1.38 (m, 10H) ppm; 13C NMR 
(100 MHz, CDCl3) δ 166.6, 165.1, 133.7, 130.1, 128.6, 128.5, 70.6, 65.6, 27.8, 26.4, 25.6, 23.5 
ppm; HRMS (ESI+) for C30H36O8Na
 [M + Na]+ calculated 547.2302 found: 547.2322. 
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(3R, 4R)-2,5-Dioxo-1,6-dioxacyclooctadecane-3,4-diyl dibenzoate (12) 1,12-Dodecanediol 
(40 mg, 0.2 mmol, 1.0 equiv.) and dibenzoyl-L-tartaric acid (71 mg, 0.20 mmol 1.0 equiv.) were 
dissolved in toluene (40 mL, 5 mM). Then Hf(OTf)4 (15.5 mg, 0.020 mmol, 0.1 equiv.) was 
added to the solution and the reaction mixture heated to 110 oC. The reaction mixture was stirred 
at this temperature for 48 h. After cooling to room temperature, silica gel (~ 2 mL) was added 
and the slurry was concentrated under reduced pressure and purified by flash chromatography 
(10-20 % EtOAc in hexanes) to afford the desired product as a colorless oil (68 mg, 65 %). 1H 
NMR (400 MHz, CDCl3) δ 8.15 (d, J = 7.8 Hz, 4H), 7.62 (t, J = 7.4 Hz, 2H), 7.49 (t, J = 7.7 
Hz, 4H), 5.95 (s, 2H), 4.40-4.35 (m, 2H), 4.16-4.10 (m, 4H), 1.73-1.64 (m, 2H), 1.52-1.43 (m, 
8H), 1.43-1.38 (m, 10H) ppm; 13C NMR (100 MHz, CDCl3) δ 165.5, 165.3, 133.7, 130.2, 128.7, 
128.5, 71.4, 66.9, 28.5, 27.9, 27.8, 27.4, 25.9 ppm; HRMS (ESI+) for C27H30O8Na
 [M + Na]+ 
calculated 505.1833 found: 3505.1848. 
 
Nonane-1,9-diyl norbornene-2-endo,3-exo-dicarboxylate (13) 1,9-Nonanediol (32 mg, 0.20 
mmol, 1.0 equiv.) and norbornane-2-endo,3-exo-dicarboxylic acid (37 mg, 0.20 mmol 1.0 
equiv.) were dissolved in toluene (40 mL, 5 mM).  Then Hf(OTf)4 (15.5 mg, 0.0200 mmol, 0.1 
equiv.) was added to the solution and the reaction mixture heated to 110 oC. The reaction mixture 
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was stirred at this temperature for 48 h. After cooling to room temperature, silica gel (~ 2 mL) 
was added and the slurry was concentrated under reduced pressure and purified by flash 
chromatography (5% Et2O in hexanes) to afford the desired product as a colorless oil (42 mg, 
68 %). 1H NMR (400 MHz, CDCl3) δ 4.42 (ddd, J = 12, 9.1, 3.0 Hz, 1H), 4.33 (ddd, J = 12, 
8.4, 3.0 Hz, 1H), 3.98-3.89 (m, 2H), 3.05-3.01 (m, 1H), 2.75 (dd, J = 6.1, 1.4 Hz, 1H), 2.63-
2.60 (m, 2H), 1.78-1.52 (m, 6H), 1.50-1.28 (m, 14H) ppm; 13C NMR (100 MHz, CDCl3) δ 174.7, 
173.2, 63.8, 63.7, 51.1, 49.2, 40.5, 39.8, 38.7, 29.0, 28.0, 27.8, 26.7, 25.9, 25.6, 23.9, 23.7, 23.6 
ppm; HRMS (ESI+) for C18H29O4
 [M + H]+ calculated 309.2060 found: 309.2064. 
 
Dodecane-1,12-diyl norbornene-2-endo,3-exo-dicarboxylate (14) 1,12-Dodecanediol (40 
mg, 0.20 mmol, 1.0 equiv.) and norbornane-2-endo,3-exo-dicarboxylic acid (37 mg, 0.20 mmol 
1.0 equiv.) were dissolved in toluene (40 mL, 5 mM).  Then Hf(OTf)4 (15.5 mg, 0.0200 mmol, 
0.1 equiv.) was added to the solution and the reaction mixture heated to 110 oC. The reaction 
mixture was stirred at this temperature for 48 h. After cooling down to room temperature, silica 
gel (~ 2 mL) was added and the slurry was concentrated under reduced pressure and purified by 
flash chromatography (5% Et2O in hexanes) to afford the desired product as a colorless oil (42 
mg, 68 %).1H NMR (400 MHz, CDCl3) δ 4.35 (ddd, J = 18, 8.2, 4.2 Hz, 1H), 4.27 (ddd, J = 18, 
8.2, 4.2 Hz, 1H), 3.98-3.93 (m, 2H), 3.15-3.12 (m, 1H), 2.83 (d, J = 5.3 Hz, 1H), 2.64-2.60 (m, 
2H), 1.70-1.57 (m, 6H), 1.48-1.27 (m, 20H) ppm; 13C NMR (100 MHz, CDCl3) δ 174.7, 173.4, 
64.7, 64.5, 50.1, 48.9, 41.4, 40.4, 38.3, 28.7, 28.5, 28.4, 28.1, 27.9, 27.6, 27.2, 27.0, 26.9, 25.5, 
25.3, 24.2 ppm; HRMS (ESI+) for C21H34O4Na
 [M + Na]+ calculated 373.2349 found: 373.2353. 
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1,12-Dioxacyclodocosane-2,13-dione (16) 10-Hydroxydecanoic acid (38.8 mg, 0.200 mmol 
1.0 equiv.) was dissolved in toluene (40 mL, 5 mM).  Then Hf(OTf)4 (3.9  mg, 0.0050 mmol, 
0.025 equiv.) was added to the solution and the reaction mixture heated to 110 oC. The reaction 
mixture was stirred at this temperature for 48 h. After cooling to room temperature, silica gel (~ 
2 mL) was added and the slurry was concentrated under reduced pressure and purified by flash 
chromatography (10 % EtOAc in hexanes) to afford the desired product as a white solid (26 mg, 
74 %).1H NMR (400 MHz, CDCl3) δ 4.12 (t, J = 5.9 Hz, 4H), 2.32 (t, J = 7.0 Hz, 4H), 1.65-
1.60 (m, 4H), 1.40-1.28 (m, 20H) ppm; 13C NMR (100 MHz, CDCl3) δ 173.9, 64.0, 34.8, 29.4, 
29.1, 29.0, 28.9, 28.6, 26.0, 25.4 ppm; HRMS (ESI+) forC20H37O4 [M + H]
+ calculated: 
341.2686 found: 341.2700. 
 
1,10-Dioxacyclooctadecane-2,11-dione (17) 8-Hydroxydecanoic acid (32.0 mg, 0.200 mmol 
1.0 equiv.) was dissolved in toluene (40 mL, 5 mM).  Then Hf(OTf)4 (3.9  mg, 0.0050 mmol, 
0.025 equiv.) was added to the solution and the reaction mixture heated to 110 oC. The reaction 
mixture was stirred at this temperature for 48 h. After cooling to room temperature, silica gel (~ 
2 mL) was added and the slurry was concentrated under reduced pressure and purified by flash 
chromatography (10 % EtOAc in hexanes) to afford the desired product as a white solid (22 mg, 
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77 %).1H NMR (400 MHz, CDCl3) δ 4.12 (t, J = 5.9 Hz, 4H), 2.32 (t, J = 6.9 Hz, 4H), 1.67-1.57 
(m, 8 H), 1.45-1.30 (m, 12 H) ppm; 13C NMR (100 MHz, CDCl3) δ 173.7, 63.8, 34.9, 28.7, 
28.60, 28.56, 25.7, 25.2 ppm; HRMS (ESI+) for C16H29O4 [M + H]
+ calculated: 285.2060 found: 
285.2069. 
 
3,11-Dioxa-1,9(1,3)-dibenzenacyclohexadecaphane-2,10-dione (18) The hydroxyacid (67 
mg, 0.32 mmol 1.0 equiv.) was dissolved in toluene (60 mL, 5 mM).  Then Hf(OTf)4 (6.2  mg, 
0.0080 mmol, 0.025 equiv.) was added to the solution and the reaction mixture heated to 110 
oC. The reaction mixture was stirred at this temperature for 48 h. After cooling to room 
temperature, silica gel (~ 2 mL) was added and the slurry was concentrated under reduced 
pressure and purified by flash chromatography (10 % EtOAc in hexanes) to afford the desired 
product as a white solid (44 mg, 72 %).1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 7.0 Hz, 2H), 
7.70 (s, 2 H), 7.35-7.30 (m, 4H), 4.32 (t, J = 5.3 Hz, 4H), 2.69 (t, J = 6.7 Hz, 4H), 1.77-1.68 
(m, 8H), 1.43-1.40 (m, 4H) ppm; 13C NMR (100 MHz, CDCl3) δ 166.7, 142.3, 133.1, 130.2, 
129.4, 128.3, 127.2, 64.7, 35.8, 30.4, 28.4, 25.5 ppm; HRMS (ESI+) for C24H28O4 [M + H]
+ 
calculated: 381.2060 found: 381.2049.  
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3,11-Dioxa-1,9(1,4)-dibenzenacyclohexadecaphane-2,10-dione (19) The hydroxyacid (42 
mg, 0.20 mmol 1.0 equiv.) was dissolved in toluene (40 mL, 5 mM).  Then Hf(OTf)4 (3.9  mg, 
0.0050mmol, 0.025 equiv.) was added to the solution and the reaction mixture heated to 110 oC. 
The reaction mixture was stirred at this temperature for 48 h. After cooling to room temperature, 
silica gel (~ 2 mL) was added and the slurry was concentrated under reduced pressure and 
purified by flash chromatography (10 % EtOAc in hexanes) to afford the desired product as a 
white solid (28 mg, 74 %).1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 8.3 Hz, 4H), 7.15 (d, J = 
8.2 Hz, 4H), 4.35 (t, J = 5.3 Hz, 4H), 2.74 (t, J = 6.0 Hz, 4H), 1.80-1.70 (m, 8 H), 1.37-1.32 
(m, 2H) ppm; 13C NMR (100 MHz, CDCl3) δ 166.5, 147.0, 129.4, 128.7, 127.8, 63.5, 34.1, 28.4, 
27.7, 22.9 ppm; HRMS (ESI+) for C24H28O4 [M + H]
+ calculated: 381.2060 found: 381.2061. 
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9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
ity
10.104.013.881.904.012.024.06
8
.0
7
8
3
8
.0
5
8
6
8
.0
5
5
1
7
.5
9
2
5
7
.5
7
4
4
7
.5
5
8
1
7
.5
5
5
4
7
.4
4
5
4
7
.4
2
5
6
7
.4
0
6
9
7
.2
7
0
0
5
.8
7
5
6
4
.3
6
0
4
4
.3
4
9
6
4
.3
4
2
9
4
.3
3
2
4
4
.3
2
6
9
4
.3
1
6
1
1
.7
3
2
9
1
.7
1
3
0
1
.7
0
5
9
1
.6
8
7
5
1
.4
1
2
2
1
.3
9
7
5
 
180 160 140 120 100 80 60 40 20 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
N
o
rm
a
liz
e
d
 I
n
te
n
s
ity
1
6
6
.6
1
5
8
1
6
5
.0
9
1
2
1
3
3
.6
6
4
0
1
3
0
.0
5
5
5
1
2
8
.6
0
7
5
1
2
8
.4
5
4
2
7
7
.3
1
4
1
7
7
.0
0
0
0
7
6
.6
8
5
9
7
0
.6
0
2
7
6
5
.6
4
5
8
2
7
.8
5
1
9
2
6
.4
1
9
2
2
5
.5
6
8
8
2
3
.4
5
4
2
 
 
 
 A114 
 
 
Compound 12 
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Compound 18 
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Compound 19 
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Annexe 3. Supporting Information of Chapter 5 
GENERAL 
All reactions that were carried out under anhydrous conditions were performed under an 
inert argon or nitrogen atmosphere in glassware that had previously been dried overnight at 120 
oC or had been flame dried and cooled under a stream of argon or nitrogen.1 All commercial 
reagents were obtained from Sigma-Aldrich Chemical Company or Strem Chemicals and were 
reagent quality. Technical solvents were obtained from VWR International Co. Methyl 15-
hydroxypentadecanoate2 and methyl 15-oxopentadecanoate3 were prepared according to 
literature procedure. Anhydrous solvents (CH2Cl2, Et2O, THF, DMF, toluene, and n-hexane) 
were dried and deoxygenated using a GlassContour system (Irvine, CA). Isolated yields reflect 
the mass obtained following flash column silica gel chromatography. Organic compounds were 
purified using the method reported by Still4 and using silica gel obtained from Silicycle 
Chemical division (40-63 nm; 230-240 mesh). Analytical thin-layer chromatography (TLC) was 
performed on glass-backed silica gel 60 coated with a fluorescent indicator (Silicycle Chemical 
division, 0.25 mm, F254.). Visualization of TLC plates was performed by UV (254 nm), KMnO4 
or p-anisaldehyde stains. All mixed solvent eluents are reported as v/v solutions. Concentration 
refers to removal of volatiles at low pressure on a rotary evaporator. All reported compounds 
were homogeneous by thin layer chromatography (TLC) and by 1H NMR. NMR spectra were 
                                                 
1 Shriver, D. F.; Drezdon, M. A. in The Manipulation of Air-Sensitive Compounds; Wiley-VCH: New York, 1986. 
2 Yamashita, Y.; Mutoh, Y.; Yamasaki, R.; Kasama, T.; Saito, S. Chem. Eur. J. 2015, 21, 2139-2145. 
3 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925. 
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taken in deuterated CDCl3 using Bruker AV-300 and AV-400 instruments unless otherwise 
noted. Signals due to the solvent served as the internal standard (CHCl3: δ 7.27 for 1H, δ 77.0 
for 13C). The 1H NMR chemical shifts and coupling constants were determined assuming first-
order behavior. Multiplicity is indicated by one or more of the following: s (singlet), d (doublet), 
t (triplet), q (quartet), m (multiplet), br (broad); the list of couplings constants (J) corresponds 
to the order of the multiplicity assignment. High resolution mass spectroscopy (HRMS) was 
done by the Centre régional de spectrométrie de masse at the Département de Chimie, Université 
de Montréal using an Agilent LC-MSD TOF system with the ESI mode of ionization unless 
otherwise noted. 
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GENERAL PROCEDURES 
A. General Procedure for the Synthesis of 5.3 via Lewis Acid Activation 
 
Pentan-3-yl pentanoate (5.3) 3-Pentanol (0.11 mL, 1.0 mmol, 1.0 equiv.) and valeric acid (0.11 
mL, 1.0 mmol 1.0 equiv.) were dissolved in toluene (1.0 mL, 1.0 M).  The Lewis acid catalyst 
(see Table 5.1) was added to the solution and the reaction mixture was stirred at 110 oC for 24 
h. After cooling down to room temperature, silica gel (~ 5 mL) was added and the slurry was 
concentrated under reduced pressure and purified by flash chromatography (10 to 40 % EtOAc 
in hexanes) to afford the desired product as a colorless oil. Spectral data were in accordance 
with those previously reported in the literature.5 
 
B. General Procedure for the Synthesis of 5.5 via Lewis Acid Activation 
 
                                                 
5 Srimani, D.; Balaraman, E.; Gnanaprakasam, B.; Ben-David, Y.; Milstein, D. Adv.. Syn. Cat. 2012, 354 (13), 
2403-2406. 
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15-Heptadecanolide (5.5) 15-Hydroxyheptadecanoic acid (28 mg, 0.1 mmol, 1.0 equiv.) was 
dissolved in toluene (20.0 mL, 5.0 mM). The Lewis acid catalyst (see Table 5.2) was added to 
the solution and the reaction mixture heated to 110 oC. The reaction mixture was stirred at this 
temperature for 24 h. After cooling down to room temperature, silica gel (~ 2 mL) was added 
and the slurry was concentrated under reduced pressure and purified by flash chromatography 
(5 to 40 % EtOAc in hexanes) to afford the desired product as a white solid. Spectral data were 
in accordance with those previously reported in the literature.6 
 
PROCEDURES FOR THE MACROCYCLIC PRECURSOR 5.7 
 
Methyl 15-hydroxyheptadecanoate 5.6 Et2O (16 mL, 0.1 M) was added to a round-bottom 
flask under N2. Methyl 15-oxopentadecanoate (437 mg, 1.60 mmol, 1.00 equiv.) was added and 
the mixture was allowed to cool down to -78 °C. A solution of ethylmagnesium bromide in THF 
(1.12 mL, 1.68 mmol, 1.5 M) was added dropwise and the reaction mixture was stirred at -78 
°C for 2 h. The reaction was quenched by the addition of a saturated solution of NH4Cl (5 mL) 
and extracted with EtOAc (10 mL). The organic phase was washed with water (20 mL) and 
brine (20 mL), dried over Na2SO4, filtered and concentrated under reduced pressure. Flash 
chromatography (10 % EtOAc in hexanes) was performed to afford 5.6 as a white solid (193 
mg, 40%). 1H NMR (400 MHz, CDCl3) δ 3.67 (s, 3H), 3.55-3.50 (m, 1H), 2.30 (t, J = 7.6 Hz, 
2H), 1.65-1.60 (m, 2H), 1.55-1.35 (m, 6H), 1.30-1.25 (m, 18H), 0.94 (t, J = 7.4 Hz, 3H) ppm; 
                                                 
6 Bollbuck, B.; Tochtermann, W. Tetrahedron 1999, 55 (23), 7209-7220. 
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13C NMR (75 MHz, CDCl3) δ 174.4, 73.3, 36.9, 34.1, 30.1, 29.7, 29.6 (4C), 29.5, 29.4, 29.2, 
29.1, 25.6, 24.9, 9.9 ppm; HRMS (ESI+) for C18H37O3 [M + H]
+ calculated: 301.2698 found: 
301.2711. 
 
15-hydroxyheptadecanoic acid 5.7 Methyl 15-hydroxyheptadecanoate (403 mg, 1.34 mmol, 
1.00 equiv.) was dissolved in THF (11 mL). LiOH (225 mg, 5.36 mmol, 4.00 equiv.) was added 
as a solution in water (3 mL). The reaction mixture was stirred at reflux for 18 h. The mixture 
was cooled down to room temperature and HCl 1M was added until the mixture was neutralized 
(pH = 7). Extraction with EtOAc (3 X 15 mL) was performed and the combined organic phases 
were washed with brine (45 mL). The organic phase was dried over Na2SO4, filtered and 
concentrated under reduced pressure to afford 5.7 as a white solid (326 mg, 86 %). 1H NMR 
(400 MHz, CDCl3) δ 3.60-3.52 (m, 1H), 2.34 (t, J = 7.5 Hz, 2H), 1.68-1.60 (m, 2H), 1.54-1.40 
(m, 6H), 1.35-1.23 (m, 18H), 0.94 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 179.2, 
73.4, 36.9, 34.0, 30.0, 29.7, 29.6 (2C), 29.5 (2C), 29.4, 29.3, 29.2, 29.0 25.6, 24.7, 9.8 ppm; 
HRMS (ESI+) for C17H35O3 [M + H]
+ calculated: 287.2541 found: 287.2573.  
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Spectral Data 
Compound 5.6 
9 8 7 6 5 4 3 2 1
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
ity
2.9018.536.472.602.000.952.76
3
.6
6
8
2
3
.5
5
1
7
3
.5
1
8
3
3
.5
0
7
3
2
.3
2
2
6
2
.3
0
3
8
2
.2
8
4
6
1
.6
4
8
6
1
.6
1
9
3
1
.4
4
3
3
1
.4
2
5
4
1
.4
0
8
5
1
.3
6
0
5
1
.2
8
4
6
1
.2
5
9
0
0
.9
6
1
8
0
.9
4
3
5
0
.9
2
4
8
 
 A127 
180 160 140 120 100 80 60 40 20
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
 I
n
te
n
s
ity
1
7
4
.3
6
0
2
7
7
.4
2
3
1
7
7
.0
0
0
0
7
6
.5
7
6
9
7
3
.3
0
9
2
5
1
.4
2
8
9
3
6
.9
3
7
3
3
4
.0
9
6
1
3
0
.1
1
2
8
2
9
.6
8
9
8
2
9
.6
0
2
0
2
9
.5
4
8
7
2
9
.4
1
4
6
2
9
.1
2
3
9
2
5
.6
3
9
5
2
4
.9
3
2
6
9
.8
6
3
1
 
Compound 5.7 
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Annexe 4. Supporting Information of Chapter 7 
GENERAL:  
 
All reactions that were carried out under anhydrous conditions were performed under an inert 
argon or nitrogen atmosphere in glassware that had previously been dried overnight at 120 oC 
or had been flame dried and cooled under a stream of argon or nitrogen.1 All chemical products 
were obtained from Sigma-Aldrich Chemical Company or Strem Chemicals and were reagent 
quality. Technical solvents were obtained from VWR International Co. Tridec-12-ynoic acid2, 
(±)-3-hydroxy-5-(triisopropylsilyl)pent-1-en-4-yne,3 (3S)-3-hydroxy-5-(triisopropylsilyl)pent-
1-en-4-yne3 and methyl dec-9-enoate4 were prepared according to literature procedure. 
Anhydrous solvents (CH2Cl2, Et2O, THF, DMF, toluene, and n-hexane) were dried and 
deoxygenated using a GlassContour system (Irvine, CA). Isolated yields reflect the mass 
obtained following flash column silica gel chromatography. Organic compounds were purified 
using the method reported by W. C. Still5 and using silica gel obtained from Silicycle Chemical 
division (40-63 nm; 230-240 mesh). Analytical thin-layer chromatography (TLC) was 
performed on glass-backed silica gel 60 coated with a fluorescence indicator (Silicycle 
Chemical division, 0.25 mm, F254.). Visualization of TLC plate was performed by UV (254 nm), 
KMnO4 or p-anisaldehyde stains. All mixed solvent eluents are reported as v/v solutions. 
Concentration refers to removal of volatiles at low pressure on a rotary evaporator. All reported 
                                                 
1 Shriver, D. F.; Drezdon, M. A. in The Manipulation of Air-Sensitive Compounds; Wiley-VCH: New York, 1986. 
2 Lumbroso, A.; Abermil, N.; Breit, B. Chem. Sci., 2012, 3, 789. 
3 Mann, T. J.; Speed, Alexander W. H.; Schrock, R. R.; Hoveyda, A. H. Angew. Chem., Int.Ed. 2013 ,  52, 8395. 
An alternative synthesis, via diastereomeric resolution, can be used. See page S6.  
4 Ranganathan, D.; Ranganathan, S.; Mehrotra, M. M. Tetrahedron 1980, 36, 1869. 
5 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925.  
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compounds were homogeneous by thin layer chromatography (TLC) and by 1H NMR. NMR 
spectra were taken in deuterated CDCl3 using Bruker AV-300 and AV-400 instruments unless 
otherwise noted. Signals due to the solvent served as the internal standard (CHCl3: δ 7.27 for 
1H, δ 77.0 for 13C). The acquisition parameters are shown on all spectra. The 1H NMR chemical 
shifts and coupling constants were determined assuming first-order behavior. Multiplicity is 
indicated by one or more of the following: s (singlet), d (doublet), t (triplet), q (quartet), appquin 
(apparent quintet), m (multiplet), br (broad); the list of couplings constants (J) corresponds to 
the order of the multiplicity assignment. High resolution mass spectroscopy (HRMS) was done 
by the Centre régional de spectrométrie de masse at the Département de Chimie, Université de 
Montréal from an Agilent LC-MSD TOF system using ESI mode of ionization unless otherwise 
noted. The microwave used is a Biotage Initiator Sixty®. 
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SYNTHESIS OF MACROCYCLE PRECURSORS 
 
Methyl (S)-2-((tert-butyldimethylsilyl)oxy)propanoate (5) TBSCl (8.68 g, 57.6 mmol, 1.2 
equiv.) and imidazole (3.92 g, 57.6 mmol, 1.2 equiv.) were added to a solution of Methyl (S)-2-
hydroxypropanoate (4) (4.6 mL, 48.0 mmol, 1.0 equiv.) in CH2Cl2 (120 mL) at 0 °C. The 
solution was stirred for 3 h at room temperature. Brine was then added and the organic and 
aqueous layers were separated. The aqueous phase was extracted with CH2Cl2 (3X) and the 
combined organic phases were washed with brine, dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. Flash chromatography (6% EtOAc in hexanes) was 
performed to afford the product as a colorless oil (10.27 g, 98 %). Spectral data were in 
accordance with those previously reported in the literature.6 
 
(S)-2-((tert-butyldimethylsilyl)oxy)propanal (6) DIBAL-H 1 M in hexanes (20.0 mL, 20.0 
mmol, 1.5 equiv.) was added dropwise to a solution of methyl (S)-2-((tert-
butyldimethylsilyl)oxy)propanoate (5) (2.92 g, 13.35 mmol, 1.0 equiv.) in anhydrous Et2O (45 
mL) at -78 °C and stirred for 3 h. The solution was then quenched with a solution of sodium and 
potassium tartrate and the organic and aqueous layers were separated. The aqueous layer was 
extracted with Et2O (3X). The combined organic layers were washed with brine, dried over 
anhydrous Na2SO4, filtered and concentrated under reduced pressure. Flash chromatography 
                                                 
6 Massad, S. K.; Hawkins, L. D.; Baker, D. C.  J. Org. Chem., 1983, 48, 5180. 
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(10% Et2O in hexanes) was performed to afford the product as a colorless oil (1.92 g, 77 %). 
Spectral data were in accordance with those previously reported in the literature.6 
 
(3R,4S)-4-((tert-butyldimethylsilyl)oxy)-1-(trimethylsilyl)pent-1-yn-3-ol (S1) n-BuLi 1.35 
M in THF (11.5 mL, 15.6 mmol, 1.5 equiv.) was added dropwise to a solution of 
ethynyltrimethylsilane (2.2 mL, 15.6 mmol, 1.5 equiv.) in anhydrous THF (23 mL) at -78 °C. 
The solution was stirred for 2 h at 0 °C. (S)-2-((tert-butyldimethylsilyl)oxy)propanal (6) (1.96 
g, 10.4 mmol, 1.0 equiv.) was added to the solution at -78 °C and stirred for an additional hour. 
The solution was then quenched with a solution of sodium and potassium tartrate. The resulting 
mixture was vigorously stirred for 2 h before Et2O (30 mL) was added to the mixture. The 
organic and aqueous layers were separated. The aqueous layer was extracted with Et2O (3X). 
The combined organic layers were washed with brine, dried over anhydrous Na2SO4, filtered 
and concentrated under reduced pressure. Flash chromatography (100 % Hexanes to 4 % EtOAc 
in hexanes) was performed to afford exclusively the desired diastereoisomer as a white solid 
(1.55 g, 52 %). Spectral data were in accordance with those previously reported in the literature.7 
 
(5R,6S)-6,8,8,9,9-pentamethyl-5-((trimethylsilyl)ethynyl)-2,4,7-trioxa-8-siladecane (7)   In 
a sealable tube, NaI (135 mg, 0,89 mmol, 10 mol%) was added to a solution of (3R,4S)-4-((tert-
butyldimethylsilyl)oxy)-1-(trimethylsilyl)pent-1-yn-3-ol (S1) (2.58 g, 8.9 mmol, 1.0 equiv.) in 
                                                 
7 Marshall, J. A.; Bourbeau, M. P. Org. Lett., 2003, 5, 3197. 
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CH2Cl2 (90 mL). The solution was cooled to 0 °C and iPr2NEt (3.13 mL, 17.9 mmol, 2.0 equiv.) 
and MOMCl (2.05 mL, 26.9 mmol, 3.0 equiv.) were added. The mixture was stirred for 18 h at 
60 °C then quenched with water and the organic and aqueous layers were separated. The aqueous 
layer was extracted with CH2Cl2 (3X). The combined organic layers were washed with brine, 
dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. Flash 
chromatography (100 % Hexanes to 5 % EtOAc in hexanes) was performed to afford the product 
as a yellow oil (2.97 g, 99 %). Spectral data were in accordance with those previously reported 
in the literature.8  
 
(2S,3R)-3-(methoxymethoxy)pent-4-yn-2-ol (3)   TBAF (1 M in THF) (53.9 mL, 53.9 mmol, 
6 equiv.) was added to a solution of (5R,6S)-6,8,8,9,9-pentamethyl-5-((trimethylsilyl)ethynyl)-
2,4,7-trioxa-8-siladecane (7) (2.97 g, 9.0 mmol, 1.0 equiv.) in anhydrous THF (45 mL) and 
stirred for 3 h at room temperature. The solution was then quenched with water and the organic 
and aqueous layers were separated. The aqueous layer was extracted with EtOAc (3X). The 
combined organic layers were washed with brine, dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. Flash chromatography (30 % EtOAc in hexanes) was 
performed to afford the product as a yellow oil (1.22 g, 94 %). 1H NMR (400 MHz, CDCl3) δ 
4.96 (d, J = 8 Hz, 1H), 4.70 (d, J = 8 Hz, 1H), 4.31-4.29 (m, 1H), 3.98-3.95 (m, 1H), 3.42 (s, 
3H), 2.50 (d, J = 2 Hz, 1H), 2.38 (bs, 1H) 1.31 (d, J = 4 Hz, 3H) ppm. 13C NMR (75 MHz, 
                                                 
8 Zhang, B.; Wang, Y.; Yang, S. P.; Zhou, Y.; Wu, W. B.; Tang, W.; Zuo, J. P.; Li, Y.; Yue, J. M. J. Am. Chem. 
Soc., 2012, 134, 20605. 
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CDCl3) δ 94.4, 79.0, 75.8, 70.8, 69.1, 55.9, 18.1 ppm. HRMS (ESI+) m/z calculated for 
C7H12NaO3 [M+Na]
+: 167.0679; found: 167.0675.  
 
(2S,3R)-3-(methoxymethoxy)pent-4-yn-2-yl tridec-12-ynoate (2a) DCC (946 mg, 4.6 mmol, 
2 equiv.), DMAP (840 mg, 6.9 mmol, 3 equiv.) and (2S,3R)-3-(methoxymethoxy)pent-4-yn-2-
ol (3) (331 mg, 2.3 mmol, 1 equiv.) were added to a solution of tridec-12-ynoic acid (8) (723 
mg, 3.4 mmol, 1.5 equiv.) in CH2Cl2 (10 mL) and stirred for 18 h at room temperature. The 
solution was then placed in the freezer for 12 h and the precipitated urea was filtered. Silica gel 
was added to the filtrate and the slurry was concentrated under reduced pressure. Flash 
chromatography (100 % hexanes to 10 % EtOAc in hexanes) was performed  to afford the 
product as a colorless oil (579 mg, 75 %). 1H NMR (400 MHz, CDCl3) δ 5.1-5.10 (m, 1H), 
4.92 (d, J = 6.8 Hz, 1H), 4.64 (d, J = 6.9 Hz, 1H), 4.42 (dd, J = 4 Hz, J = 2.1 Hz, 1H), 3.40 (s, 
3H), 2.45 (d, J = 2.2 Hz, 1H), 2.33 (t, J = 7.5 Hz, 2H), 2.19 (td, J = 7.1 Hz, J = 2.7 Hz, 2H), 
1.95 (t, J = 2.7 Hz, 1H), 1.65-1.61 (m, 2H), 1.56-1.49 (m, 2H), 1.40-1.28 (m, 15H) ppm. 13C 
NMR (75 MHz, CDCl3) δ 173.1, 94.2, 84.8, 79.1, 75.0, 70.8, 68.0, 67.4, 55.7, 34.4, 29.40, 
29.36, 29.2, 29.0 (2C), 28.7, 28.5, 24.9, 18.4, 15.1 ppm. HRMS (ESI+) m/z calculated for 
C20H36NO4 [M+NH4]
+: 354.2639; found: 354.2648. 
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(3S)-3-(N-Boc-L-phenylalanine)-5-(triisopropylsilyl)pent-1-en-4-yne (S2) DCC (2.74 g, 
13.3 mmol, 2 equiv.), DMAP (2.43 g, 19.9 mmol, 3 equiv.) and (±)-3-hydroxy-5-
(triisopropylsilyl)pent-1-en-4-yne (rac-10) (1.58 g, 6.64 mmol, 1 equiv.) were added to a 
solution of N-Boc-L-phenylalanine (2.64 g, 9.96 mmol, 1.5 equiv.) in CH2Cl2 (10 mL) and 
stirred for 18 h at room temperature. The solution was then placed in the freezer for 12 h and 
the precipitated urea was filtered. Silica gel was added to the filtrate and the slurry was 
concentrated under reduced pressure. Flash chromatography (100 % hexanes to 7 % Et2O in 
hexanes) was performed to separate the diastereomers and isolate S2 as a colorless oil (923 mg, 
29 %). 1H NMR (400 MHz, CDCl3) δ 7.29-7.15 (m, 5H), 5.92 (d, J = 4.4Hz, 1H), 5.98-5.81 
(m, 1H), 5.61 (d, J = 13.7 Hz, 1H), 5.34 (d, J = 9.8Hz, 1H), 4.96 (d, J = 6.8 Hz, 1H), 4.63 (d, J 
= 5.8 Hz, 1H), 3.13-3.06 (m, 2H), 1.42 (s, 9H), 1.10-1.09 (m, 21 H) ppm. 13C NMR (100 MHz, 
CDCl3) δ 170.5, 155.0, 135.8, 132.5, 129.5, 129.4, 128.5, 127.0, 119.6, 119.4, 101.4, 89.7, 79.9, 
65.6, 54.2, 37.9, 54.2, 37.9, 28.3, 18.5, 11.1 ppm. HRMS (ESI+) m/z calculated for 
C28H43NO4SiNa [M+Na]
+: 508.2854; found: 508.2865. 
 
(±)-3-hydroxy-5-(triisopropylsilyl)pent-1-en-4-yne (10) The amino acid adduct (S3) (960 mg, 
1.98 mmol, 1.0 equiv.) was dissolved in tetrahydrofuran (16 mL). Then LiOH (190 mg, 7.92 
mmol, 4.0 equiv.) was added as an aqueous solution (4 mL). The reaction mixture was stirred 
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at 65 oC for 18 h. The reaction was then cooled to room temperature and HCl (1 M) was added 
until the mixture was neutralized (pH = 7). Extraction with EtOAc (3 X 5 mL) was performed 
and the combined organic phases were washed with brine (15 mL). The organic phase was dried 
over Na2SO4, filtered and concentrated under reduced pressure to afford the desired product as 
a white solid (421 mg, 89 %). Spectral data were in accordance with those previously reported 
in the literature.3 
 
(3S)-3-(methoxymethoxy)-5-(triisopropylsilyl)pent-1-en-4-yne (11) The alcohol (10) (1.50 g, 
6.30 mmol, 1.00 equiv.) was dissolved in CH2Cl2  (31 mL). iPr2NEt (2.19 mL, 12.6 mmol, 2.00 
equiv.) was added to the solution. MOMCl (0.96 mL, 12.6 mmol, 2.00 equiv.) was carefully 
added at 0 °C and the reaction mixture was stirred at room temperature for 18 h. The reaction 
was quenched by addition of water (20 mL) and extracted with CH2Cl2 (2 x 15 mL). The 
combined organic phases were washed with brine, dried over Na2SO4, filtered and concentrated 
under reduced pressure. Flash chromatography (5 % Et2O in hexanes) was performed to obtain 
the product as a colorless oil (1.42 g, 80 %). 1H NMR (CDCl3, 400 MHz) δ = 5.94 (ddd, J = 
17.0 Hz, 10.2 Hz, 5.5 Hz, 1H), 5.56 (dt, J = 17.0 Hz, 1.2 Hz, 1H), 5.28 (dt, J = 10.2 Hz, 1.2 Hz, 
1H), 4.98 (d, J = 6.7 Hz, 1H), 4.90 (dt, J = 5.5 Hz, 1.2 Hz, 1H), 4.68 (d, J = 6.7 Hz, 1H), 3.41 
(s, 3H), 1.10-1.03 (m, 21H) ppm;  13C NMR (CDCl3, 75 MHz) δ = 134.9, 117.7, 103.6, 93.7, 
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88.4, 66.7, 5.7, 18.6, 11.1 ppm; HRMS (ESI+) calculated for C16H30O2SiNa [M + Na]
+ 
305.1907, found 305.1907.9 
 
Methyl (11S, 9Z)-11-(methoxymethoxy)-13-(triisopropylsilyl)tridec-9-en-12-ynoate (13) A 
flame-dried sealable tube was charged with CH2Cl2 (2.75 mL), Methyl dec-9-enoate (254 mg, 
1.38 mmol, 1.00 equiv.) and ther ester (12) (390 mg, 1.38 mmol, 1.00 equiv.). The catalyst (15b) 
(47 mg, 0.069 mmol, 0.05 equiv.) was added and the tube was sealed. The reaction mixture was 
allowed to stir for 3 h at 60 °C. A second equivalent of Methyl dec-9-enoate (12) (254 mg, 1.38 
mmol, 1.00 equiv.) was added and the reaction mixture was allowed to stir for an additional 3 
h. During the reaction time, the mixture was put under vacuum for 5 seconds every hour to 
eliminate the ethylene formed. After being cooled down to room temperature, silica was added 
and the slurry was concentrated under reduced pressure. Flash chromatography (5 to 10 % Et2O 
in hexanes) was performed to afford the product as a colorless oil (258 mg, 43 % (68 % BRSM), 
>95:5 Z : E).  1H NMR (CDCl3, 400 MHz) δ = 5.64-5.52 (m, 2H), 5.14 (d, J = 8.2 Hz, 1H), 4.95 
(d, J = 6.8 Hz, 1H), 4.63 (d, J = 6.8 Hz, 1H), 3.67 (s, 3H), 3.40 (s, 3H), 2.30 (t, J = 7.5 Hz, 2H), 
2.17-2.11 (m, 2H), 1.66-1.60 (m, 2H), 1.42-1.29 (m, 8 H), 1.11-1.05 (m, 21 H) ppm; 13C 
NMR (CDCl3, 100 MHz) δ = 174.2, 133.9, 127.1, 105.2, 93.3, 86.6 61.5, 55.6, 51.4, 34.1, 29.3, 
                                                 
9 The same procedure was used for the synthesis of (±)-3-(methoxymethoxy)-5-(triisopropylsilyl)pent-1-en-4-
yne (rac-11). The product was obtained as a colorless oil (1.70 g, 80 %). 
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29.11, 29.05, 29.03, 27.7, 24.9, 18.6. 11.1 ppm; HRMS (ESI+) calculated for C25H46O4SiNa [M 
+ Na]+ 461.3058, found 461.3063.10 
 
Methyl (11S, 9Z)-11-(methoxymethoxy)tridec-9-en-12-ynoate (S3) The protected alkyne 
(13) (390 mg, 0.890 mmol, 1.00 equiv.) and THF (2.67 mL) was added to a flame-dried round-
bottom flask under N2. TBAF (1 M in THF, 1.78 mL, 1.78 mmol, 2.0 equiv.) was slowly added 
and the reaction mixture was stirred at room temperature for 3 h. The reaction was quenched by 
addition of H2O (2 mL) and extracted with Et2O (2 x 5 mL). The combined organic phases were 
washed with H2O (10 mL), dried over Na2SO4, filtered and concentrated under reduced pressure. 
Flash chromatography (5 % to 10 % EtOAc in hexanes) was performed to afford the product as 
a colorless oil (230 mg, 92 %). 1H NMR (CDCl3, 400 MHz) δ = 5.69-5.62 (m, 1H), 5.54-5.48 
(m, 1H), 5.13 (ddd, J = 8.8 Hz, 2.1 Hz, 0.9 Hz, 1H), 4.85 (d, J = 6.9 Hz, 1H), 4.63 (d, J = 6.9 
Hz, 1H), 3.67 (s, 3H), 3.40 (s, 3H), 2.48 (d, J = 2.1 Hz, 1H), 2.30 (t, J = 7.5 Hz, 2H), 2.16-2.10 
(m, 2H), 1.66-1.58 (m, 2H), 1.43-1.29 (m, 8H) ppm; 13C NMR (CDCl3, 100 MHz) δ = 174.2, 
134.7, 126.4, 93.2, 81.8, 73.5, 60.5, 55.6, 51.4, 34.1, 29.2, 29.0 (2C), 28.9, 27.5, 24.9 ppm; 
HRMS (ESI+) calculated for C16H26O4Na [M + Na]
+ 305.1723, found 302.1715. 
                                                 
10 A similar procedure was used for the synthesis of Methyl (±, 9Z)-11-(methoxymethoxy)-13-
(triisopropylsilyl)tridec-9-en-12-ynoate (rac-13). The modifications were: the reaction was run for 18 h, there 
was no second equivalent of ester added, no vacuum was performed and 10 mol% catalyst was used. The product 
was obtained as a colorless oil (250 mg, 59 %). 
 A139 
 
(9Z, 11S)-11-(methoxymethoxy)tridec-9-en-12-ynoic acid (16) Methyl ester (S3) (251 mg, 
0.890 mmol, 1.0 equiv.) was dissolved in tetrahydrofuran (4 mL). Then LiOH (85 mg, 3.56 
mmol, 4.0 equiv.) was added as an aqueous solution (1 mL). The reaction mixture was stirred 
at 65 oC for 18 h. The reaction was then cooled to room temperature and HCl (1 M) was added 
until the mixture was neutralized (pH = 7). Extraction with EtOAc (3 X 5 mL) was performed 
and the combined organic phases were washed with brine (15 mL). The organic phase was dried 
over Na2SO4, filtered and concentrated under reduced pressure to afford the desired product as 
a white solid (238 mg, 99 %). 1H NMR (CDCl3, 400 MHz) δ =  5.66 (dt, J = 10.6, 7.5 Hz, 1H), 
5.52 (m, 1H), 5.13 (dd, J = 8.8, 2.2 Hz, 1H), 4.86 (d, J = 6.9 Hz, 1H), 4.64 (d, J = 6.9 Hz, 1H), 
3.41 (s, 3H), 2.48 (d, J = 2.2 Hz, 1H), 2.36 (t, J = 7.5 Hz, 2H), 2.16-2.11 (m, 2H), 1.64-1.62 (m, 
2H), 1.42-1.33 (m, 8H) ppm; 13C NMR (CDCl3, 100 MHz) δ = 179.8, 134.6, 126.3, 93.1, 81.6, 
73.5, 60.5, 55.5, 33.9, 29.1, 28.9, 28.8 (2C), 27.4, 24.5 ppm; HRMS (ESI+) calculated for 
C15H23O4 [M+H]
+:  267.1602, found 267.1609. 
 
(2S, 3R)-3-(methoxymethoxy)pent-4-yn-2-yl (S, Z)-11-(methoxymethoxy)tridec-12-ynoate 
(2) DCC (472 mg, 2.29 mmol, 2 equiv.), DMAP (419 mg, 3.44 mmol, 3 equiv.) and (2S,3R)-3-
(methoxymethoxy)pent-4-yn-2-ol (3) (165 mg, 1.15 mmol, 1 equiv.) were added to a solution 
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of (9Z, 11S)-11-(methoxymethoxy)tridec-9-en-12-ynoic acid (307 mg, 1.15mmol, 1 equiv.) in 
CH2Cl2 (4 mL) and stirred for 18 h at room temperature. The solution was then placed in the 
freezer for 12 h and the precipitated urea was filtered. Silica gel was added to the filtrate and the 
slurry was concentrated under reduced pressure. Flash chromatography (100 % hexanes to 20 
% EtOAc in hexanes) was performed  to afford the product as a colorless oil (282 mg, 62 %).1H 
NMR (CDCl3, 400 MHz) δ = 5.65 (dt, J = 11 Hz, 7.3 Hz, 1H), 5.51 (t, J = 8.9 Hz, 1H), 5.14-
5.09 (m, 2H), 4.92 (d, J = 6.9 Hz, 1H), 4.85 (d, J = 6.9 Hz, 1H), 4.63 (d, J = 6.9 Hz, 2H), 4.42 
(dd, J = 3.8 Hz, 2.1 Hz, 1H), 3.40 (s, 3H), 3.39 (s, 3H), 2.47 (dd, J = 9.9 Hz, 2.1 Hz, 2H), 2.33 
(t, J = 7.5 Hz, 2H), 2.17-2.10 (m, 2H), 1.66-1.60 (m, 2H), 1.39-1.29 (m, 11H) ppm; 13C NMR 
(CDCl3, 100 MHz) δ = 173.0, 134.7, 126.4, 94.2, 93.3, 81.8, 79.1, 75.0, 73.5, 70.8, 67.4, 55.6, 
34.4, 29.2, 29.1, 29.0, 27.5, 24.9, 15.1 ppm; HRMS (ESI+) m/z calculated for C22H34NaO6 
[M+Na]+: 417.2248; found: 417.2260. 
SYNTHESIS OF MACROCYCLES 
 
(17R,18S)-17-(methoxymethoxy)-18-methyloxacyclooctadeca-13,15-diyn-2-one (1a) 
Slow Addition Procedure: To a triple-neck round-bottom flask equipped with a stirring bar 
and a condenser, CuCl (154 mg, 1.56 mmol, 12 equiv.) and TMEDA (0.4 mL, 2.6 mmol, 20 
equiv.) was added to PhMe (550 mL). The mixture was stirred and warmed at 110 °C. To the 
mixture, a solution of 2a (44 mg, 0.13 mmol, 1 equiv.) in PhMe (50 mL) was slowly added over 
36 h (0.023 mL/min) with a syringe pump. The mixture was stirred and heated for an additional 
12 h. The reaction was then cooled down to room temperature and concentrated under reduced 
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pressure. Flash chromatography was performed (5 % to 20 % EtOAc in hexanes) to afford the 
desire product as a colorless oil (15.6 mg, 36 %). [α]D 25 = −0.221 (c = 0.0044, MeOH); 1H 
NMR (300 MHz, CDCl3) δ 5.04 (appquint, J = 6 Hz, 1H), 4.93 (d, J = 9 Hz, 1H), 4.61 (d, J = 
6 Hz, 1H), 4.30 (d, J = 6 Hz, 1H), 3.38 (s, 3H), 2.36-2.31 (m, 4H), 1.74-1.67 (m, 4H), 1.37-1.26 
(m, 15H) ppm. 13C NMR (75 MHz, CDCl3) δ 172.8, 94.2, 81.0, 71.4, 71.0, 70.7, 69.0, 65.1, 
55.9, 35.3, 29.7, 29.2, 28.4, 27.5, 26.8, 26.3, 25.7, 24.9, 18.8, 17.4 ppm. HRMS (ESI+) m/z 
calculated for C20H30NaO4 [M+Na]
+: 357.2036; found: 357.2029. 
Microwave Procedure: To a microwave vial equipped with a stirring bar was dissolved the 
diyne (41 mg, 0.12 mmol, 1 equiv.) in MeOH. To the mixture was added polyethylene glycol 
400 (3.75 mL), CuCl2·2H2O (5 mg, 0.03 mmol, 25 mol %) and Ni(NO3)2·6H2O (8.7 mg, 0.03 
mmol, 25 mol %) and the mixture was stirred at room temperature for 30 seconds or until the 
metals were solubilized. Oxygen was bubbled in the solution for 5 min then TMEDA (0.09 mL, 
0.6 mmol, 5 equiv.) and Et3N (0.05 mL, 0.36 mmol, 3 equiv.) were added and the mixture was 
stirred at room temperature for an additional 30 seconds. The vial was then sealed with a 
microwave cap. The reaction was warmed to 100 °C for 3 h. The crude mixture was loaded 
directly onto silica gel for purification by chromatography (10 % to 20 % EtOAc in hexanes) to 
afford the desire product as a colorless oil (16 mg, 40 %). 
Continuous Flow Procedure: To a 200 mL pear-shaped flask equipped with a stirring bar, 
CuCl2·2H2O (118 mg, 0.70 mmol, 25 mol%), Ni(NO3)2·6H2O (204 mg, 0.70 mmol, 25 mol%),  
TMEDA (2.07 mL, 13.9 mmol, 5 equiv.) and Et3N (1.16 mL, 8.34 mmol, 3 equiv.) was dissolved 
in MeOH (20 mL) and the mixture was stirred at room temperature for 30 seconds or until the 
metals were solubilized. Poly(propylene glycol) 425 (77.2 mL) was added and the mixture was 
stirred at room temperature for an additional 30 seconds. 2a (935 mg, 2.78 mmol, 1 equiv.) was 
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dissolved in 18.6 mL of MeOH then added to the solution. The reaction mixture was pumped 
into the flow reactor for a reaction time of 120 min (2 x 10 mL Stainless Steel reactors) at a flow 
rate of 0.167 mL/min at 120 °C. The flow reaction was conducted in a VapourTec R4 reactor 
and a R2+ pumping module. The continuous flow setup is ended with two in-line back pressures 
regulators (VapourTec 8 bar + IDEX 17 bar). Upon completion, the mixture was extracted with 
EtOAc, washed with water and the combined organic phases were washed with brine. The 
organic phase was dried over Na2SO4, filtered and concentrated under reduced pressure. The 
crude mixture was purified by chromatography (5 to 10 % EtOAc in hexanes) to afford the 
desire product as a yellowish oil (353 mg, 38 %). 
 
 (10Z,12S,17R,18S)-12,17-di(methoxymethoxy)-18-methyloxacyclooctadec-10-ene-13,15-
diyn-2-one (1) 
Slow Addition Procedure: To a triple-neck round-bottom flask equipped with a stirring bar 
and a condenser, CuCl (119 mg, 1.2 mmol, 12 equiv.) and TMEDA (0.3 mL, 2.0 mmol, 20 
equiv.) was added to PhMe (405 mL). The mixture was stirred and warmed at 110 °C. To the 
mixture, a solution of 2 (40 mg, 0.10 mmol, 1 equiv.) in PhMe (50 mL) was slowly added over 
24 h (0.035 mL/min) with a syringe pump. The mixture was stirred and heated for an additional 
24 h. The reaction was then cooled down to room temperature and concentrated under reduced 
pressure. Flash chromatography was performed (5 % to 20 % EtOAc in hexanes) to afford the 
desire product as a colorless oil (21.4 mg, 55 %). [α]D 25 = −62.1(c = 0.00145, MeOH); 1H NMR 
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(400 MHz, CDCl3) δ 5.63−5.56 (td, J = 10.8, 5.5 Hz, 1H), 5.49 (app t, J = 10.9 Hz, 1H), 5.20 
(d, J = 8 Hz, 1H) 5.06−5.01 (m, 1H), 4.91 (d, J = 6.9 Hz, 1H), 4.81 (d, J = 6.7 Hz, 1H), 4.61 (t, 
J = 5.5 Hz, 1H), 4.28 (d, J = 7.7 Hz, 1H), 3.38 (s, 3H), 3.38 (s, 3H), 2.38−2.29 (m, 2H), 2.20− 
2.06 (m, 2H), 1.73−1.57 (m, 4H), 1.39−1.29 (m, 9H) ppm. 13C NMR (75 MHz, CDCl3) δ 172.8, 
134.3, 126.5, 94.4, 93.6, 75.7, 70.6, 70.5, 69.5, 68.9, 61.5, 56.0, 55.7, 35.2, 29.7, 29.5, 29.4, 
28.6, 28.5, 27.7, 25.4, 17.6 ppm 
Microwave Procedure: To a microwave vial equipped with a stirring bar was dissolved 2 (38 
mg, 0.10 mmol, 1 equiv.) in MeOH (1.05 mL). To the mixture was added polyethylene glycol 
400 (3.15 mL), CuCl2·2H2O (4.2 mg, 0.025 mmol, 25 mol %) and Ni(NO3)2·6H2O (7 mg, 0.025 
mmol, 25 mol %) and the mixture was stirred at room temperature for 30 seconds or until the 
metals were solubilized. Oxygen was bubbled in the solution for 5 min then TMEDA (0.07 mL, 
0.5 mmol, 5 equiv.) and Et3N (0.04 mL, 0.3 mmol, 3 equiv.) were added and the mixture was 
stirred at room temperature for an additional 30 seconds. The vial was then sealed with a 
microwave cap. The reaction was warmed to 100 °C for 3 h. The crude mixture was loaded 
directly onto silica gel for purification by chromatography (10 % EtOAc in hexanes) to afford 
the desire product as a colorless oil (11.5 mg, 30 %). 
Continuous Flow Procedure: To a 20mL-reaction vial equipped with a stirring bar, 
CuCl2·2H2O (3 mg, 0.018 mmol) and Ni(NO3)2·6H2O (5.2 mg, 0.018 mmol) was dissolved in 
MeOH (1.5 mL) and the mixture was stirred at room temperature for 30 seconds or until the 
metals were solubilized. Polyethylene glycol 400 (1.5 mL), TMEDA (0.05 mL, 0.33 mmol) and 
Et3N (0.03 mL, 0.22 mmol) were added and the mixture was stirred at room temperature for an 
additional 30 seconds. 2 (19.9 mg, 0.051 mmol, 1 equiv.) was mixed 2 mL of the previous 
solution. The mixture was stirred at room temperature until everything was soluble then taken 
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into a syringe. The reaction mixture was injected using a 2 mL injection loop into the flow 
reactor for a reaction time of 120 min (2 x 10 mL Stainless Steel reactors) at a flow rate of 0.167 
mL/min at 120 °C. The flow reaction was conducted in a VapourTec R4 reactor and a R2+ 
pumping module. The continuous flow setup is ended with two in-line back pressures regulators 
(VapourTec 8 bar + IDEX 17 bar). Upon completion, silica gel was added to the collection flask 
and the volatiles were removed under vacuum. The crude mixture was purified by 
chromatography (20 % EtOAc in hexanes) to afford the desire product as a colorless oil (10.2 
mg, 52 %). 
 
Figure 1. Continuous flow setup. 
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OPTIMIZATION OF A Z-SELECTIVE CROSS METATHESIS 
Table S1 Optimization of a Z-selective cross metathesis to prepare racemic 13. 
 
 
Catalyst  
(mol %) 
[M] 
Tem
p. 
(°C) 
Yiel
d 
(%)a 
 % Z 
b 
1 14 (2) 0.1 21 47 < 1 
2 14 (2) 0.1 40 40 < 1 
3 15b (2) 0.1 21 0 - 
4 15b (5) 0.5 60 40 ~98 
5 15b (10) 0.5 60 59 95 
6 15a (10) 0.5 60 16 75 
a Yields following chromatography. b Determined by 1H NMR Mes = 2,4,6-trimethylphenyl, 
DIPP = 2,6-di-iso-propylphenyl.  
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SPECTRAL DATA FOR KNOWN COMPOUNDS 
Compound 5 
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
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1
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1
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0
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0
 
Compound 6 
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
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9
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1
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4
.1
1
0
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9
6
4
.0
9
3
4
.0
7
9
1
.2
9
6
1
.2
7
8
0
.9
3
0
0
.1
1
4
0
.1
0
2
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Compound S1 
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
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Compound 7 
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Compound 10 
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
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Annexe 5. Supporting Information of Chapter 8 
General:  
 
All reactions that were carried out under anhydrous conditions were performed under an inert 
argon or nitrogen atmosphere in glassware that had previously been dried overnight at 120 oC 
or had been flame dried and cooled under a stream of argon or nitrogen.1 All commercial 
reagents were obtained from Sigma-Aldrich Chemical Company or Strem Chemicals and were 
reagent quality. Technical solvents were obtained from VWR International Co. Anhydrous 
solvents were dried and deoxygenated using a GlassContour system (Irvine, CA). Isolated yields 
reflect the mass obtained following flash column silica gel chromatography. Organic 
compounds were purified using the method reported by Still2 and using silica gel obtained from 
Silicycle Chemical division (40-63 nm; 230-240 mesh). Analytical thin-layer chromatography 
(TLC) was performed on glass-backed silica gel 60 coated with a fluorescent indicator (Silicycle 
Chemical division, 0.25 mm, F254.). Visualization of TLC plates was performed by UV (254 
nm), KMnO4 or p-anisaldehyde stains. All mixed solvent eluents are reported as v/v solutions. 
Concentration refers to removal of volatiles at low pressure on a rotary evaporator. All reported 
compounds were homogeneous by thin layer chromatography (TLC) and by 1H NMR.  
  
                                                 
1 Shriver, D. F.; Drezdon, M. A. in The Manipulation of Air-Sensitive Compounds; Wiley-VCH: New York, 1986. 
2 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925.  
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General Procedure for the DKR of 1-phenylethanol 
 
(R)-1-phenylethyl myristate 8.2a and (R)-1-phenylethyl laurate 8.2b In a glove-box, 8.3 (25 
mg, 0.040 mmol, 4.0 mol %) and NaOtBu (4.8 mg, 0.050 mmol, 5 mol %) were added to a 
round-bottom flask. The flask was removed from the glove-box and kept under an N2 
atmosphere. CALB3 (6 mg), Na2CO3 (106 mg, 1.00 mmol, 1.0 equiv.) were quickly added and 
the mixture was dissolved with PhMe (2 mL, 0.5 M) and stirred for 5 min. 8.1 (0.12 mL, 1.00 
mmol, 1.00 equiv.) was added and the reaction mixture was stirred for another 5 min. The acyl 
donor (See Table 5.3, 1.50 mmol, 1.50 equiv.) was added and the reaction mixture was stirred 
at the temperature and for the time specified in Table 5.3. The reaction mixture was then filtered 
and concentrated under reduced pressure. Purification by flash chromatography (5 to 10 % 
EtOAc in hexanes) afforded the desired esters 8.2a or 8.2b. Spectral data were in accordance 
with those previously reported in the literature.4 
 
 
 
 
                                                 
3 Immobilized and commercially available as Novozyme-435. 
4 Monteiro, C. M.; Lourenco, N. M. T.; Afonso, C. A. M. Tet. Asymmetry 2010, 21, 952-956. 
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2,2,2-trifluoroethyl 15-hydroxypentadecanoate 8.4  15-hydroxypentadecanoic acid (5.00 g, 
19.4 mmol) was dissolved in 2,2,2-trifluoroethanol (70 mL). Drops (15-20) of concentrated 
H2SO4 were added and the mixture was stirred at reflux. After 18 h, the mixture was cooled 
down and neutralized (pH = 7) with a saturated solution of K2CO3. The mixture was extracted 
with EtOAc (3 x 50 mL). The combined organic phases were washed with water (2 x 100 mL) 
and brine (1 x 100 mL), dried over Na2SO4, filtered and concentrated under reduced pressure to 
afford 5.20 as a white solid (6.00 g, 99 %) which was used without any further purification. 
 
2,2,2-trifluoroethyl 15-oxopentadecanoate 8.6 Compound 8.5 (943 mg, 2.91 mmol) was 
dissolved in CH2Cl2 (15 mL) and PCC (754 mg, 3.49 mmol) was added. The reaction mixture 
was stirred for 3 h at room temperature. Silica gel was added and the slurry was concentrated 
under reduced pressure and flash chromatography (5 to 10 % EtOAc in hexanes) was performed 
to afford 5.21 as a colorless oil (545 mg, 58 %). 
 
2,2,2-trifluoroethyl 15-hydroxy-15-(4-methylphenyl)pentadecanoate 8.7 Compound 8.6 
(200 mg, 0.621 mmol) was dissolved in Et2O (7 mL) and the mixture was cooled down to -78 
°C. p-Tolylmagnesium bromide (0.93 mL, 0.466 mmol, 0.5 M in Et2O) was added dropwise and 
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the mixture was stirred at -78 °C for 2 h upon which a saturated solution of NH4Cl (10 mL) was 
added to quench the reaction and the biphasic mixture was stirred and allowed to warm up to 
room temperature. The mixture was extracted with Et2O (2 x 10 mL). The combined organic 
layers were washed with water (10 mL) and brine (10 mL), dried over Na2SO4, filtered and 
concentrated under reduced pressure. Purification by flash chromatography (0 to 20 % EtOAc 
in hexanes) afforded 8.7 as a colorless oil (22 mg, 10 %).
  
 
